[go: up one dir, main page]

WO2025155883A1 - Photobiostimulation oculaire - Google Patents

Photobiostimulation oculaire

Info

Publication number
WO2025155883A1
WO2025155883A1 PCT/US2025/012142 US2025012142W WO2025155883A1 WO 2025155883 A1 WO2025155883 A1 WO 2025155883A1 US 2025012142 W US2025012142 W US 2025012142W WO 2025155883 A1 WO2025155883 A1 WO 2025155883A1
Authority
WO
WIPO (PCT)
Prior art keywords
light
bio
stimulation
processor
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2025/012142
Other languages
English (en)
Inventor
Ronald Blum
Anita BROACH
Jack Loeb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurorays LLC
Original Assignee
Neurorays LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/827,782 external-priority patent/US12409337B2/en
Application filed by Neurorays LLC filed Critical Neurorays LLC
Publication of WO2025155883A1 publication Critical patent/WO2025155883A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0618—Psychological treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016—Operational features thereof
    • A61B3/0025—Operational features thereof characterised by electronic signal processing, e.g. eye models
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/103—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining refraction, e.g. refractometers, skiascopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B45/00—Circuit arrangements for operating light-emitting diodes [LED]
    • H05B45/20—Controlling the colour of the light
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
    • H05B47/10—Controlling the light source
    • H05B47/105—Controlling the light source in response to determined parameters
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
    • H05B47/10—Controlling the light source
    • H05B47/16—Controlling the light source by timing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/1005—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring distances inside the eye, e.g. thickness of the cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
    • A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0664—Details
    • A61N2005/0667—Filters

Definitions

  • Retinal ganglion cells collectively transmit image-forming and non-image forming visual information from the retina to several regions in the thalamus, hypothalamus, and mesencephalon, or midbrain. There are about 1.2 to 1.5 million retinal ganglion cells in the human retina.
  • the melanopsin-containing retinal ganglion cells represent only between 0.3% and 0.8% of the total ganglion cells of the retina.
  • Amacrine cells are named for their presumed lack of an axon. They come in many shapes and sizes and are synaptically active in the inner plexiform layer (IPL).
  • IPL inner plexiform layer
  • DACs dopaminergic amacrine cells
  • Dopaminergic amacrine cells make up less than 1% of all amacrine cells in the retina. DACs are the main source of dopamine in the retina and are one of the rarest cell types in the retina, with a density of about 10–100 per mm. DACs are the first retinal neurons to be identified neurochemically.
  • the optic nerve head (optic disk) is composed of neural, vascular, and connective tissues.
  • the convergence of axons of retinal ganglion cells (RG) at the optic disc creates the neuroretinal rim that surrounds the cup, a central shallow depression in the optic disc.
  • the macula is a small, round area in the center of the retina, the light-sensitive layer of tissue at the back of the eye.
  • posterior zone or central zone
  • far-periphery zone radius>15 mm.
  • FIG. 5 it shows pupil size relative to ambient light, by way of example only, a pupil size can be 3.5 mm at 550 lux, 4.2 mm at 350 lux, 5.2 mm at 150 lux, 5.03 mm at 40 lux, and 5.4 mm at 2 lux.
  • myopia is a common eye disease that causes light rays to bend and focus in front of the retina instead of on it. This makes distant objects appear blurry, while nearby objects appear normal. There is a silent epidemic of myopia in the world. It is forecasted that by 2050 approximately 50% of the world’s population will be myopic. The number of myopes forecasted is approximately 5 billion.
  • Hyperopia farsightedness
  • Astigmatism is a common eye problem that occurs when the cornea or lens of the eye is an abnormal shape, causing light to bend differently as it enters the eye.
  • DR Diabetic retinopathy
  • Retinitis pigmentosa is a rare genetic disorder that affects the retina, the light-sensitive part of the eye at the back. RP causes the retina’s photoreceptor cells to gradually break down over time, leading to vision loss. Symptoms often start in childhood or adolescence and include night blindness and peripheral vision loss. This may begin in the far and mid periphery of the retina and progresses centrally from the peripheral retina.
  • the visible light wavelength spectrum is the segment of the electromagnetic spectrum that the human eye can view. More simply, this range of wavelengths is called visible light. Typically, the human eye can detect wavelengths from 380 to 700 nanometers.
  • the human retina also contains macular xanthophylls (X), yellow pigments found to be composed of two chromatographically separable components (i) lutein and (ii) zeaxanthin, whose absorption spectrum is a broad band ( ⁇ 100 nm width) with a spectral center between the short and medium-long wavelength photoreceptor pigments of the retina (peak ⁇ 460 nm).
  • Rhodopsin a visual pigment found in photoreceptor rods, has a peak sensitivity to blue-green light at around 500 nanometers (nm). This means that rhodopsin absorbs green-blue light most strongly, which gives it a reddish-purple appearance.
  • the peak for melanopsin is ⁇ 480nm.
  • light wavelengths predominantly fall within the wavelength range of at least one of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm, which can be utilized in addition to what is stated within the embodiment description.
  • the desired wavelength band of the above will depend upon the type of ocular photo-bio-stimulation that is desired to produce the desired physiological response. Thus, for any embodiment disclosed within this invention disclosure, any of the above ranges of wavelengths can be applied over and beyond what may be stated.
  • the ocular photo-bio-modulation light source can be modulated light wavelength ranges between blue (450nm – 495nm) and bluish green / cyan (495nm – 520nm).
  • the light can be flickered or modulated when providing ocular photo-bio-stimulation therapy to the brain. In other embodiments the light is devoid of a flicker.
  • the ocular photo-bio-light source can flicker or be modulated at a rate of 40Hz +/- 20Hz. In certain embodiments the range is between 40Hz – 65Hz.
  • the ocular photo- bio-light source can be flickered or modulated at a rate of 40Hz +/- 10Hz.
  • the ocular photo-bio-light source can flicker or be modulated at a rate of 3Hz – 10 Hz.
  • the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered lens/optic to have improved or maximum vison clarity.
  • Embodiments taught herein must balance numerous components that contribute to the ability of the sunglass lens to cause the production of dopamine or increase the production of dopamine in the eye’s retina of the wearer of the sunglass lens, or cause the production or increase the production of one or more of dopamine, serotonin, norepinephrine in the brain, while also providing the appropriate level of clear distance and / or near vision clarity for the wearer of the sunglass lens.
  • the invention can further provide the appropriate color balance of light wavelengths transmitted from the sunglass lens to the eye of the wearer of the sunglass lens, so that either the wearer of the sunglass lens by way of subjective measurements or the sunglass lens by way of objective measurements can pass the ISO and / or ANSI traffic light test.
  • An embodiment can be that of a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits a higher percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm, than a lens or optic comprises an average visible light transmission percentage within the range of 380nm – 780nm and passes the ISO 12312-1 sunglass traffic light/signal test.
  • biofeedback can be utilized to confirm that one or more of, increased dopamine, serotonin, or norepinephrine, is being produced within the brain of a patient having ocular photo-bio-stimulation therapy.
  • Such biofeedback can be comparing one or more of: increased blink rate of the eye(s) of the patient being treated, increased diameter of pupil(s) of the patient being treated, and/or increased heart rate of the patient being treated to that of a base line for the same activity prior to the ocular photo-bio-stimulation therapy.
  • one or more of a timer, geolocation, an alarm (such as by way of example only, sound, vibration, light, or image), and/or wireless or wired communication to notify a remote third party can be incorporated or associated with eyewear providing ocular photo-bio- stimulation therapy.
  • FIG. 1 shows background information for purposes of explaining the invention herein.
  • FIG. 2 shows background information for purposes of explaining the invention herein.
  • FIG. 3 shows background information for purposes of explaining the invention herein.
  • FIG. 4 shows background information for purposes of explaining the invention herein.
  • FIG. 5 shows background information for purposes of explaining the invention herein.
  • FIG. 6 shows background information for purposes of explaining the invention herein.
  • FIG. 7 shows background information for purposes of explaining the invention herein.
  • FIG. 8 shows background information for purposes of explaining the invention herein.
  • FIG. 9 shows background information for purposes of explaining the invention herein.
  • FIG. 10 shows background information for purposes of explaining the invention herein.
  • FIG. 11 shows background information for purposes of explaining the invention herein.
  • FIG. 12 shows an embodiment of the current invention as described herein.
  • FIG. 13 shows an embodiment of the current invention as described herein.
  • FIG. 14 shows an embodiment of the current invention as described herein.
  • FIG. 15 shows an embodiment of the current invention as described herein. [000141] FIG.
  • FIG. 16 shows an embodiment of the current invention as described herein, with the invention shown at the top of the steering wheel.
  • FIG. 17 shows an embodiment of the current invention as described herein.
  • FIG. 18 shows an embodiment of the current invention as described herein.
  • FIG. 19A-F shows an embodiment of the current invention as described herein.
  • FIG. 20A-C shows an embodiment of the current invention as described herein.
  • FIG. 21A-D shows an embodiment of the current invention as described herein.
  • FIG. 22 shows an embodiment of the current invention as described herein.
  • FIG. 23A-B shows an embodiment of the current invention as described herein.
  • FIG. 24 shows an embodiment of the current invention as described herein.
  • FIG. 25A-C shows an embodiment of the current invention as described herein.
  • FIG. 26 shows an embodiment of the current invention as described herein.
  • FIG. 27 shows an embodiment of the current invention as described herein.
  • FIG. 28 shows an embodiment of the current invention as described herein.
  • FIG. 29 shows an embodiment of the current invention as described herein.
  • FIG. 30 shows an embodiment of the current invention as described herein.
  • FIG. 31 shows an embodiment of the current invention as described herein.
  • FIG. 32 shows an embodiment of the current invention as described herein.
  • FIG. 33 shows an embodiment of the current invention as described herein. [000159] FIG.
  • FIG. 34 shows an embodiment of the current invention as described herein.
  • FIG. 35 shows an embodiment of the current invention as described herein.
  • FIG. 36 shows an embodiment of the current invention as described herein.
  • FIG. 37 shows an embodiment of the current invention as described herein.
  • FIG. 38 shows an embodiment of the current invention as described herein.
  • FIG. 39 shows an embodiment of the current invention as described herein.
  • FIG. 40 shows an embodiment of the current invention as described herein.
  • FIG. 41 shows an embodiment of the current invention as described herein.
  • FIG. 42 shows an embodiment of the current invention as described herein.
  • FIG. 43 shows an embodiment of the current invention as described herein.
  • FIG. 63 is a graph showing functionality of the current invention as described herein.
  • FIG. 64 is a graph showing functionality of the current invention as described herein.
  • FIG. 65 is a graph showing functionality of the current invention as described herein.
  • FIG. 66 is a graph showing functionality of the current invention as described herein.
  • FIG. 67 is a chart showing improvements provided by the current invention over conventional eyewear.
  • FIG. 68 is a chart showing improvements provided by the current invention over conventional eyewear.
  • FIG. 69 shows sunlight spectrum at a point of time during the day.
  • FIG. 70 shows sunlight spectrum at a point of time during the day.
  • FIG.196 FIG.
  • the patient can play games (including with distance removed other people receiving treatment), use e-mail, or perform e-communication, while receiving ocular photo-bio-stimulation therapy.
  • a computer application can be used to manage such light therapy.
  • the lenses being worn can be any type of myopia control lenses (e.g., Essilor Stellest Lens (H.A.L.T.), Zeiss Myocare, HoyaDims Miyosmart, Sightglass Vision (contrast reduction/diffusion), or chromatic aberration focused lenses or chromatic aberration refocused lenses.
  • the lenses can be cleared or filtered.
  • FIG. 87 shows that a combination can be used to stimulation the production of dopamine in the eye and/or brain of the user, the brightness level in lux is preferably turned up to display up 1,000 lux (or more ore less) or greater brightness intensity, such as up to 2,000 lux.
  • FIG. 88 shows an example of an embodiment described herein, such as a cell phone, tablet computer, laptop computer, desktop computer, electronic display, which can be used along with a computer application embodiment. It can be used for ocular photo-bio-stimulation for myopia control or prevention. It can also be used for treating neurological neurotransmitter deficiency disorder, such as deficiencies of one or more of: dopamine, serotonin, or norepinephrine in the brain.
  • FIG. 90 shows an example of an embodiment described herein, such as a cell phone, tablet computer, laptop computer, desktop computer, electronic display, which can be used along with a computer application embodiment. It can be used for ocular photo-bio-stimulation for myopia control or prevention. It can also be used for treating neurological neurotransmitter deficiency disorder, such as deficiencies of one or more of: dopamine, serotonin, or norepinephrine in the brain.
  • neurological neurotransmitter deficiency disorder such as deficiencies of one or more of: dopamine, serotonin, or norepinephrine in the brain.
  • 91 shows an example of an embodiment described herein, such as a cell phone, tablet computer, laptop computer, desktop computer, electronic display, which can be used along with a computer application embodiment. It can be used for ocular photo-bio-stimulation for myopia control or prevention. It can also be used for treating neurological neurotransmitter deficiency disorder, such as deficiencies of one or more of: dopamine, serotonin, or norepinephrine in the brain.
  • the device can include optional sensors that sense a distance from the screen compared to the user’s face or eyes and can adjust the brightness of the screen up or down to maintain a preferred level of lux display light. It can be used with or without a lens or optic worn by the user receiving ocular photo-bio-stimulation light.
  • the computer application system generated display can provide a programmable border, color wavelengths, and programmable intensity.
  • the border can be of any shape or size, and can all or partly be programmable.
  • the display screen can have content that shrinks and a blue or blue green border within the wavelength range of 450 nm – 510 nm provides ocular photo-bio-stimulation to the user.
  • the light can be amplified by additional emitters.
  • the light wavelengths striking the eye of the user of the electronic display can be blended to include light wavelengths given off by the added light emitters shown on the bottom of the phone pictured. This can affect the response as shown in the inset graph.
  • blue and/or blue green light emitters can be attached to the display and controlled, for example, by a computer application. This can allow for adding additional light transmission within the range of 450 nm – 510 nm to the light being transmitted by they display to the user, thus blending additional blue and/or blue green (cyan) light to the wavelengths of light being display on the display.
  • FIG. 92 shows that a computer application can be used to manage the device. In aspects, children (or people of any age) in different locations can compete with one another with games while receiving ocular photo-bio-stimulation light therapy. [000218] FIG.
  • FIG. 95 shows an example of a cell phone display providing ocular photo-bio- stimulation light through a lens or optic to a user.
  • the lens or optic can be any one of: Sightglass Vision (diffusion / contrast reduction) myopia control lens; Hoya Miyosmart (D.I.M.S. technology) myopia control lens; Essilor Stellest (H.A.L.T.
  • FIG. 97 shows an example of a cell phone display providing ocular photo-bio- stimulation light through a lens or optic to a user.
  • the lens or optic can be the patient’s conventional lens to correct his or her myopia to 20/20 vision or their best visual acuity.
  • DETAILED DESCRIPTION OF THE INVENTION [000223] Definitions: [000224] As used herein, ambient light can be that of indoor artificial light or sunlight. Ambient light as used herein can be that which would be in addition to that of a light emitter.
  • Ocular photo-bio-stimulation is an umbrella term.
  • Ocular photo- bio-stimulation is a biological non-invasive technique of using light to stimulate a neuron(s) or other cells within, on, or about the eye for the purpose of generating a physiological response within the human body. Such stimulation can directly or indirectly amount to stimulation or inhibition of a biological, neurological or chemical process within the human body.
  • optogenetic therapy is broadly defined as a form of photo-bio- stimulation.
  • photo-bio-modulation is broadly defined as a form of photo-bio- stimulation.
  • the visible light spectrum is as follows: Visible Light Spectrum (electromagnetic radiation spectrum) can be divided by color: blue/violet (400nm – 450nm), blue (450nm – 495), bluish green (495-520nm), green (521nm - 556nm), yellow (556nm – 590nm), orange (590nm – 625nm), and/or red (625nm – 700nm).
  • blue can be from 400nm – 520nm.
  • Blue light wavelengths are considered from 400nm – 500nm, with bluish green being between, 490nm and 520nm, with 450nm to 495nm being bright blue.
  • Cyan light wavelengths are considered to be bluish green and between 495 nm and 520 nm.
  • HEV stands for high energy violet light. The HEV light within the range of 400nm – 440nm can be harmful to the retina of the eye, and more specifically 410nm – 430nm appears to be the most harmful.
  • UV light which stands for ultraviolet light has wavelengths which are less than 400nm in wavelength or said another way 399nm or less.
  • BVA stands for the level of vision when considering the best visual correction of a patient’s distance vision needs. For example, that of 20/25, 20/20, or 20/15.
  • a wavelength within the range of, by way of example only, 480nm +/- 30nm means any single wavelength or wavelengths found within the range of 480nm +/- 30nm.
  • a wavelength within the range of, by way of example only, 530nm +/- 20nm means any single wavelength or wavelengths found within the range of 530nm +/- 30nm.
  • a wavelength within the range of, by way of example only, 650nm +/- 30nm means any single wavelength or wavelengths found within the range of 650nm +/- 30nm.
  • a wavelength band or wavelengths band means one or more wavelengths of light within a certain range.
  • 480nm +/- 30nm predominantly transmits one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- includes the predominant (or most) light wavelengths within that wavelength range transmitted to the eye(s) of the wearer.
  • wavelength band is a band of light wavelengths that run concurrent with a beginning wavelength and ending wavelength.
  • a transmission peak is the peak light wavelength or wavelengths having the highest light transmission that fall within a band of light wavelengths.
  • a transmission peak can be that of a curve or a plateau.
  • an image can be generated by light or by the absence of light when surrounded by a lighted image (in the case of a black image).
  • a black image can also be generated by the colors of: blue, magenta, and yellow.
  • a light emitter can be any a component that converts an electrical signal into a light signal. Light emitters can be, for example only, LEDs, OLEDs, TOLEDs. micro-OLEDs, micro-LEDs, micro-ileds, iLEDs, quantum dots, florescent lights, incandescent lights, and/or the sun.
  • a light source can be any artificial light source that comprises a light emitter or light emitters or a light source can be that of the sun.
  • an electronic display screen can be that of any electronic display screen.
  • an optical filter is any device or material that changes the spectral distribution of a light beam spectrally selectively or non-selectively.
  • an optic is a material that transmits light. An optic can be part of an optical system. However, a lens can also be an optic.
  • an optic can be any kind of optic.
  • a lens can be an optic, or an optic can be a lens.
  • a lens is an optic that focuses or defocuses light.
  • a lens is a transmissive optical device that focuses or disperses a light beam by means of refraction.
  • a lens can be any kind of lens.
  • a lens can be of any optical power including plano, unless that an optical power is specified in the disclosure.
  • optical power can be any optical power of a lens or optic including plano optical power. It is common in the optical industry to refer to lens having no optical power as plano optical power.
  • a lens with optical power can refract and focus light to that of a focal point.
  • plano optical power means the lens or optic comprises no optical power.
  • the lens may be of a plano optical power (meaning no optical power) the lens in most cases (by way of example only) can comprise a lens structure, diameter, curvature, thickness and ultraviolet protection for the wearer eyes.
  • a candle at 1 meter distance gives 1 photopic lux of light.
  • Typical room illumination is in the order of 300-500 lux, whereas outdoor light varies from 1,500 lux on a cloudy day to 100,000 lux on a sunny day.
  • light intensity or luminous intensity is measured in lumens per square foot (footcandles) or lumens per square meter (lux).
  • Lumens measure the intensity of light emitted by a luminaire, while lux is a measurement of the light that is achieved and perceived.
  • Lux in some cases, is a more important measurement because it relates brightness to distance from the light source.
  • a near eye display is an electronic display that is within 30mm or less (in most cases 20mm or less) of the cornea of the eye of the user.
  • a near eye display can comprise or be aligned and in optical communication with a micro-lens array.
  • the use of a micro- lens array allows for the user to see a clear virtual image from said near eye display.
  • the near eye display is used to provide defocused light and in these cases a micro-lens array is not utilized.
  • a see-through near eye display is an electronic near eye display that the eye of the user can see a real image by looking through.
  • a micro-lens array allows for the user to see a clear virtual image from said near eye display.
  • a micro- lens array can be fabricated to defocus light or diffuse light.
  • a non-see-though near eye display is an electronic near eye display that the eye of the user cannot see a real image through.
  • the use of a micro-lens array allows for the user to see a clear virtual image from said near eye display.
  • a micro-lens array can be fabricated to defocus light or diffuse light.
  • an eyewear apparatus includes any device or apparatus described herein that filters, treats, changes, enhances, diffuses, focuses, defocuses, transmits, generates, or otherwise is capable of producing or affecting light in such a way that the light can be used for ocular photo-bio-stimulation purposes.
  • a micro-lens array is a structure made up of many small lenses, or microlenses, that are arranged in a patterned manner.
  • a micro-lens array can comprise hundreds, thousands or millions of micro-lenses.
  • a micro-lens array as used herein can be for one or more of, providing focused light, defocused light, diffused light, and/or filtered light.
  • a chromatic aberration focused lens or optic can be that of a peripheral refocused chromatic aberration lens or optic.
  • a chromatic aberration focused lens is a lens or optic where a portion or all of the lens peripheral to the central zone of the lens, focuses one or more of the chromatic aberration wavelength bands (blue, green, red) farther away from the lens or optic. Said another way, while the central zone maintains its normal focus of chromatic aberration wavelength bands, the chromatic aberration wavelength bands peripheral to the central zone focuses farther from the lens or optic than those of the central zone.
  • the frame of an electronic display can be the other edge or a frame that goes around the outer edge of the display.
  • programable means software, memory, or an electrical component that was one or more of, programed during the fabrication of the device, can be programmed after fabrication, can be programed after fabrication remotely, and/or can be programed by the consumer after purchase.
  • a vehicle means any type of vehicle. By way of example only, an automobile, a car, a truck, a bus, a ship, a boat, an airplane, a trolley, a train, a tram, a spaceship, a motorcycle, etc.
  • a film or optic comprising the appropriate filter can be applied over or in front of an electronic display or optic to allow for the desired wavelengths of light to be transmitted.
  • the film or optic comprising the filter can be attachable and removable from the display screen or built into the screen (or optic).
  • the resulting axial elongation occurs when the eye’s ocular structure is unable to provide an offsetting force equal to or larger than that of the force causing axial elongation.
  • the weakness of the opposing ocular structural is due to a deficiency of dopamine present in the retina.
  • dopamine present in the retina.
  • ample retinal dopamine is required to increase choroid thickness and maintain a healthy sclera, both of which generate an offsetting force of resistance to axial elongation of the eye.
  • the following embodiment provides for the prevention of myopia or slowing or stopping myopia progression.
  • An embodiment of the invention is that of identifying children susceptible to myopia and treating them before their myopia develops.
  • a diagnostic test can be performed to determine the level of dopamine in the eye or eyes of a child.
  • ERG electronic retinal deficiency disorder
  • a refractive examination can be performed, whether subjective or objective, using a retinoscope, automatic refractor, or phoropter. Accordingly, the results can be used to identify those children who have 0.75D of hyperopia or less of hyperopia. Such children would include emmetropes.
  • the result of these two tests (electroretinogram and refraction) can then identify which children are susceptible to becoming myopic.
  • an additional test for contrast sensitivity can be performed.
  • Low contrast sensitivity can be an indication of a dopamine deficiency.
  • an embodiment for the prevention of myopia is: 1) Identify those children 6 years old or older (or even younger) who have low levels of dopamine in their retina; 2) Test those children to identify their BVA (best distance visual acuity) refractive status; and 3) If the refractive status of the child is +0.75D or less hyperopia and their ocular dopamine test indicates low dopamine, begin therapy to increase retinal dopamine. [000310] For those children who already have myopia it is important to stop or slow the progression of myopia as the child ages. Thus, it is important to increase the level of retinal dopamine in those children. Embodiments for increasing dopamine in the eye’s retina are disclosed herein.
  • An embodiment of the current invention can be that of a device that is capable of determining a level of dopamine in the eye’s retina of a patient, while also determining a refractive status of the eye.
  • a device can measure if the patient’s eye comprises dopamine at a level that meets or exceeds “X”, wherein X represents the level of dopamine deficiency, and also measure if the same eye comprises a refractive status that is less than “Y” diopters of hyperopia or is emmetropia or myopic.
  • Such a device can measure if the patient’s eye comprises dopamine at a level that meets or exceeds “X”, wherein X represents the level of dopamine deficiency, and also measure if the same eye comprises a best distance refractive correction that measures +0.75D or less of hyperopia.
  • An embodiment can be an instrument for identifying a child or young adult that is susceptible to developing myopia, wherein the child or young adult is 25 years or younger, wherein the instrument determines if the child or young adult’s eye comprises dopamine at a level that meets or exceeds “X”, wherein X represents the level of dopamine deficiency, and wherein the instrument can also determine if the same eye’s distance refractive correction (being that of the best distance correction optical power) is that of +0.75D or less.
  • An embodiment can be an instrument for identifying a child or young adult that is susceptible for developing myopia, wherein the child or young adult is 25 years or younger, wherein the instrument determines if the child or young adult’s eye comprises dopamine at a level that meets or exceeds “X”, wherein X represents the level of dopamine deficiency, and wherein the instrument can also measure if the same eye’s refractive correction, being that of the best distance correction optical power, is that of a spherical equivalent that is +0.75D or less hyperopic.
  • Such a device could determine both the level of dopamine in the retina or eye and the refractive status simultaneously or in succession.
  • Such a device could be one of, handheld, a tabletop instrument, attachable to a slit lamp bio microscope, or attachable to a phoropter stand.
  • a device could be a combination ERG instrument and an autorefractor.
  • An embodiment can be that of an instrument for identifying a child or young adult that is susceptible for developing myopia, wherein the child or young adult is 25 years or younger, wherein the instrument determines if the child or young adult’s eye comprises dopamine at a level that exceeds “X”, wherein X represents the level of dopamine deficiency, and wherein the instrument can also determine if the same eye’s distance refractive correction (being that of the best distance correction optical power) is that of +0.75D or less.
  • the following tests can be performed by: A. ERG (more specifically measuring the B Wave Amplitude of an ERG) B.
  • An embodiment can be that of an instrument for treating myopia progression, wherein the instrument can determine a level of dopamine in the eye, wherein the instrument can also determine if the eye’s refraction requires an increase in minus optical power.
  • an instrument can be that of an electroretinogram (ERG).
  • ERG electroretinogram
  • Such an instrument can be handheld, or table mounted. For testing children, the use of a handheld ERG instrument that uses electrodes connected to the skin of the patient is recommended as opposed to corneal electrodes.
  • the testing of the child’s contrast sensitivity can also give an indication of a dopamine deficiency. Poor contrast sensitivity can be such an indication.
  • the instrument further comprises the ability to provide ocular photo-bio-stimulation. Artificial intelligence (AI) can be incorporated into such an instrument to further help with optimizing such a diagnosis and treatment.
  • AI Artificial intelligence
  • the following is a listing of diagnostic testing and providing myopia control light therapy, and such an instrument embodiment could comprise: a. ERG (more specifically measuring the B Wave Amplitude of an ERG) b. Measuring contrast sensitivity c. Measuring Refractive Error d. Measuring or checking the scleral thickness e.
  • the diagnostic and myopia control therapy instrument can comprise a combination handheld or table mounted instrument that comprises three or more of the following: a. ERG testing (for measuring the B wave amplitude) b. Optical biometer (for measuring the axial length of the eye) c. Auto-refractor (for measuring the refractive error of the eye) d. Contrast sensitivity tester (for measuring the contrast sensitivity of the eye) e. Measurement of scleral thickness of the eye f.
  • the diagnostic and myopia control therapy instrument can comprise a combination handheld or table mounted instrument that comprises four or more of the following: a. ERG testing (for measuring the B wave amplitude) b. Optical biometer (for measuring the axial length of the eye) c. Auto-refractor (for measuring the refractive error of the eye) d. Contrast sensitivity tester (for measuring the contrast sensitivity of the eye) e. Measurement of scleral thickness of the eye f.
  • the diagnostic and myopia control therapy instrument can comprise a combination handheld or table mounted instrument that comprises five or more, six or more, seven or more, or eight or more of the following: a. ERG testing (for measuring the B wave amplitude) b. Optical biometer (for measuring the axial length of the eye) c. Auto-refractor (for measuring the refractive error of the eye) d. Contrast sensitivity tester (for measuring the contrast sensitivity of the eye) e. Measurement of scleral thickness of the eye f.
  • Ocular photo-bio-stimulation for providing light therapy to increase dopamine production in the retina
  • AI Artificial Intelligence
  • ML Machine Learning
  • An embodiment can be that of an instrument for treating myopia progression, wherein the instrument can determine a level of dopamine in the eye, wherein the instrument can also determine if the eye’s refraction requires an increase in minus optical power.
  • Such an instrument can be that of an electroretinogram (ERG).
  • ERG electroretinogram
  • Such an instrument can be handheld, or table mounted. For testing children, the use of a handheld ERG instrument that uses electrodes connected to the skin of the patient is recommended as opposed to corneal electrodes.
  • An embodiment can be that of an instrument for preventing or treating myopia, wherein the instrument can determine a level of dopamine in a patient’s eye’s retina, wherein the instrument can also determine the optical power required to achieve for the same eye of the patient its best distance vision correction or best distance visual acuity.
  • Artificial intelligence can be incorporated into such an instrument to further help with optimizing such a diagnosis and treatment.
  • a means for determining an indication of the level of dopamine in the retina of the eye of a patient one or more of the following can be measured; the B wave amplitude of an electroretinogram, the thickness of the choroid and / or sclera. Such thickness can be measured (by way of example only) by a Cirrus HD-OCT 5000.
  • a contrast sensitivity test that indicates low contrast sensitivity can also indicate a dopamine deficiency.
  • Artificial intelligence (AI) can be incorporated into such an instrument to further help with optimizing such diagnosis and treatment.
  • An embodiment for slowing or preventing myopia can comprise modulation of the image or light source.
  • An embodiment can comprise a light source or light emitter having a light intensity of at least one of: 300 lux or greater, 500 lux or greater, 1,000 lux or greater, or 5,000 lux or greater.
  • An embodiment can comprise light that strikes the eye of the user or wearer of at least one of: 300 Lux or greater, 500 lux or greater, 1,000 lux or greater, or 5,000 lux or greater.
  • An embodiment can comprise an ocular-photo-bio-stimulation time of 1 minute to 5 minutes, 5 minutes to 30 minutes, or one hour or less.
  • an ocular-photo-bio-stimulation time can be that of normal daily wear of the eyewear.
  • Another embodiment of the invention can be a diagnostic test to determine the thickness of the choroid and / or scleral thickness of the eye or eyes of a child.
  • an OCT test can be performed at an early age, (for example) 6 years and older. When such a test is performed one can identify if a child has a dopamine deficiency disorder by way of measuring the choroidal and / or scleral thickness and / or testing the child’s contrast sensitivity.
  • a refractive examination can be performed, whether subjective or objective, using a retinoscope, automatic refractor, or phoropter. Accordingly, the results can be used to identify those children who have 0.75D of hyperopia or less hyperopia. Such children would include emmetropes.
  • the result of these two tests (electroretinogram and refraction) can then identify which children are susceptible to becoming myopic. Upon identifying a child that is susceptible to becoming myopic, one can begin treatment for ocular dopamine generation. Such means of treatment are identified in this invention disclosure.
  • a further indication of increased dopamine production can be by way of measuring an increase in the child’s contrast sensitivity.
  • an additional indication of increased dopamine production can be by way of performing and ERG test whereby the ERG test indicates an increase in the B wave amplitude.
  • Artificial intelligence (AI) can be incorporated into such a diagnostic test to further help with optimizing such diagnosis and treatment.
  • an embodiment for the prevention of myopia is: 4) Identify those children 6 years old or older (or even younger) who have low levels of dopamine in their retina. 5) Test those children to identify their BVA (best distance visual acuity) refractive status; and 6) If the refractive status of the child is +0.75D or less hyperopia and their choroidal and / or scleral thickness indicates a low dopamine level, begin therapy to increase retinal dopamine and choroidal and / or scleral thickness. [000332] For those children who already have myopia it is important to stop or slow the progression of myopia as the child ages. Thus, it is important to increase the level of retinal dopamine in those children.
  • Embodiments for increasing dopamine in the eye’s retina are disclosed [000333] Ocular Photo-Bio-Stimulation with Inventive Embodiments [000334] Embodiments disclosed herein can provide ocular photo-bio-stimulation through light stimulation of specific wavelengths to the eye’s retina, and, in some embodiments, to the entire eye’s retina, the retina peripheral to the fovea, and/or the retina peripheral to the macula.
  • the light stimulation is targeted at or to the rods.
  • the light stimulation is targeted at or to the ganglion cells. In still other embodiments, it is targeted at or to the rods and the ganglion cells.
  • the ganglion cells targeted or stimulated are the melanopsin containing ganglion cells (ipRGCs) or can also be called mRGCs.
  • ipRGCs melanopsin containing ganglion cells
  • mRGCs ganglion cells
  • Embodiments herein teach the stimulation of the rods and / or ipRGCs with specific light wavelengths.
  • the retina of the human eye contains 100+M rods, 1M ganglion cells but fewer than 7,000 ipRGCs which are the ganglion cells that contain melanopsin.
  • ipRGCs are less sensitive to photic stimulation and their response kinetics are slow compared to that of rods and cones.
  • ocular photo-bio-stimulation blue light having wavelengths within the range of 450nm to 510nm can be used, or, for increasing dopamine in the eye and/or retina, ocular photo- bio-stimulation red light wavelengths of 650nm +/- 30nm can be utilized.
  • the objective of ocular photo-bio-stimulation is to increase dopamine within the eye’s retina and the brain.
  • the objective of ocular photo-bio-stimulation is to reduce pain.
  • the objective of ocular photo-bio-stimulation is to reduce the severity of a headache.
  • green light having wavelengths within the range of 530nm +/- 20nm can be utilized.
  • the use of light wavelengths in the range of 650nm +/- 30nm can improve mitochondria function and / or reduce age related inflammation in the eye of the user.
  • the objective is to improve mitochondria function and / or reduce age related inflammation in the eye’s retina of the user.
  • the objective of ocular photo-bio-stimulation is to increase the number or healthy mitochondria present within the ocular photo-bio-stimulation, the area of the retina in which the ocular photo-bio-stimulation has targeted.
  • light wavelengths predominantly fall within one of the wavelength ranges of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm, and can be utilized in addition to what is stated within the embodiments.
  • wavelength band of the above will depend upon the type of ocular photo-bio-stimulation that is desired to produce the desired physiological response.
  • Biofeedback or diagnostics involving one or more of, pupil size increase, lid blink rate increase, heart rate increase, or blood oxygen level increase can be an indication of increased production or stimulation of dopamine or norepinephrine in the brain and in some cases serotonin.
  • An increase in contrast sensitivity, B wave amplitude of an ERG, scleral thickening, and/or slowing of axial length eye growth can indicate an increase in the production of dopamine in the retina.
  • the peak spectral curve of the wavelength range that strike the eye’s retina falls within the wavelength range of one: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • Embodiments providing ocular photo-bio-stimulation can filter or block damaging high energy blue light, UV, and reduce bright light visual discomfort.
  • Melanopsin photopigment expressed in intrinsically photosensitive retinal ganglion cells plays a crucial role in the adaptation of mammals to their ambient light environment through non-image-forming (NIF) visual responses.
  • ipRGCs are structurally and functionally distinct from classical rod/cone photoreceptors and have unique properties including single-photon response, long response latency, photon integration over time, and slow deactivation.
  • Embodiments disclosed herein that are directed to increasing dopamine in an individual’s eye’s retina or dopamine in the brain of the individual whose eye was stimulated, attempt to use wavelength ranges that cover the peak sensitivities for melanopsin (480nm) and also for rhodopsin (500nm).
  • the invention when generating dopamine in the eye or the brain via the eye light, utilizes light wavelengths that strike the eye’s retina, which fall within at least one of the wavelength ranges of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm which would include blue, bluish green and green wavelengths.
  • These light wavelength ranges can be generated by light emitters, filtered optics or filtered lenses.
  • the transmission peak of the wavelength range that strike the eye’s retina fall within one of the wavelength ranges of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • the wavelength range that strike the eye’s retina fall within at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • the blended light wavelengths of the light emitter(s) and also the ambient light comprises wavelengths of light that strike the eye’s retina fall within one of the wavelength ranges of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • Examples only of light emitters that emit light wavelengths which significantly excite melanopsin and rhodopsin in the retina of the human eye can be, by way of example only, Green LED light, Blue LED light, Cold White LED light, and/or Sunlight.
  • light wavelength from either a filtered optic, filtered lens, and/or light emitter(s), that strikes the retina of the eye are selected so that the radiation peak of these wavelengths falls between the peak melanopsin sensitivity (480nm, and rhodopsin sensitivity (500nm)).
  • the transmission peak of these wavelengths falls within the range of 480nm and 500nm.
  • the overall light transmission through the filtered optic or filtered lens can be 50% or less, 40% or less, or 30% or less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 50% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when not looking through the filtered optic or filtered lens.
  • the objective of ocular photo-bio-stimulation is to increase the alertness of the individual being treated with ocular photo-bio-stimulation.
  • blue light having wavelengths within the range of 450nm to 510nm can be utilized.
  • the objective of ocular photo-bio-stimulation is to increase the slowing down, to slow the progressing of, or to stop myopia of the individual being treated with ocular photo-bio-stimulation.
  • blue light having wavelengths within the range of 450nm to 510nm, or red light within the wavelength range of 650nm +/- 30nm or 700nm +/- 30nm can be utilized.
  • Such ocular photo-bio-stimulation wavelengths can be applied to a large portion of the eye’s retina to stimulate the ipRGC ganglion cells and / or rods, or to the ganglion axons of the optic nerve head for the purposes of generating increased retinal dopamine.
  • the objective of ocular photo-bio-stimulation is to treat or correct a neurological abnormality of the individual being treated with the ocular photo-bio- stimulation.
  • blue light having wavelengths within the range of 450nm to 510nm can be utilized.
  • Neurological abnormalities that may be treatable by ocular photo-bio-stimulation are by way of example only: Alzheimer’s, cognitive disorders, ADD, ADHD, depression, anxiety, and/or Parkinson’s disorder.
  • the objective of ocular photo-bio-stimulation is to prevent myopia from occurring with the individual being treated with the ocular photo-bio- stimulation.
  • the objective of ocular photo-bio-stimulation is to treat or correct an ocular abnormality of the individual being treated with ocular photo-bio-stimulation.
  • the use of the appropriate light wavelengths must be employed when treating with ocular photo-bio-stimulation.
  • Ocular abnormalities that may be treatable by ocular photo-bio-stimulation are by way of example only: myopia, AMD, dry AMD, diabetic retinopathy, retinal degenerative disease, glaucoma, optic neuropathy, cataract, and/or meibomian gland disfunction leading to dry eye.
  • biofeedback can be utilized to confirm that increased dopamine and / or serotonin is being produced within the brain of a patient having ocular photo-bio- stimulation therapy.
  • An embodiment can comprise a light source or light emitter having a light intensity of at least one of: 300 lux or greater, 400 lux or greater, 500 lux or greater, 1,000 lux or greater, or 5,000 lux or greater, or 10,000 lux or greater.
  • the sun is considered to be a light emitter.
  • various electronic devices or components, chemical-based devices or components, or electro-chemical devices or components that emit light are considered light emitters.
  • sunlight and artificial light each qualify as ambient light.
  • An embodiment can comprise an ocular-photo-bio-stimulation time of 1 minute to 5 minutes, 5 minutes to 30 minutes, or one hour or less.
  • such an ocular-photo-bio-stimulation time can be that of normal daily wear of the eyewear. It has been found that the longer the ocular photo-bio-stimulation the eye becomes more sensitive to lower wavelengths of light, thus there is a shift in retinal sensitivity. It appears the retina becomes less sensitive and thus there is a shift in the direction towards melanopsin absorption curves from that of rhodopsin absorption curves.
  • the retina which includes melanopsin, rhodopsin, and the cones opsins
  • Age also affects the melanopsin absorption curves; at age 20 the peak sensitivity of melanopsin is 488nm and by age 80 the peak sensitivity if 503nm. So, while time of stimulation shifts the retinal sensitivity to the left and lower wavelengths, age shifts the sensitivity of melanopsin to the right.
  • Biofeedback or diagnostics involving one or more of, pupil size increase, lid blink rate increase, heart rate increase, and/or blood oxygen level increase can be an indication of increased production or stimulation of dopamine or norepinephrine in the brain and in some cases serotonin.
  • An increase in contrast sensitivity, B wave amplitude of an ERG, scleral thickening, and/or slowing of axial length eye growth can indicate an increase in the production of dopamine in the retina.
  • An embodiment can be that of a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits a higher percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage within the range of 380nm – 780nm and passes the ISO 12312-1 sunglass traffic light/signal test.
  • An embodiment can be that of a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits a higher percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage within the range of 380nm – 780nm to qualify for category 2 or category 3 sunglasses and further passes the ISO 12312-1 sunglass traffic light/signal test.
  • An embodiment can be a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits 40% or greater percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage within the range of 380nm – 780nm to qualify for category 2 or category 3 sunglasses and further passes the ISO 12312-1 sunglass traffic light/signal test.
  • An embodiment can be a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits 40% or greater percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage within the range of 380nm – 780nm to qualify for category 3 sunglasses and further passes the ISO 12312-1 sunglass traffic light/signal test.
  • Electronic Devices for Ocular Photo-Bio-Modulation or Ocular Photo-Bio- Stimulation [000364] Ocular Photo-Bio-Stimulation Cell Phone Case [000365] FIG. 13 shows an embodiment of the current invention.
  • a cell phone case which can comprise, among other things, enabling electronics and a blue lighted border that circumvents all or part of the cell phone.
  • the lighted border of the cell phone case can be programmed for one or more light intensity, wavelength, modulation or flicker, start time, and/or end time.
  • the cell phone case can comprise a sensor to measure the distance from a user to the case and the light intensity can be automatically or manually adjusted to provide that appropriate level of light intensity required for the ocular photo-bio-stimulation therapy.
  • the cell phone case comprises its own ocular photo-bio- stimulation light source.
  • the cell phone or cell phone case can utilize the light given off by the flashlight of the cell phone.
  • the cell phone can comprise light pipes or waveguides.
  • the inside of the cell phone case is comprised of highly reflective material.
  • the cell phone case can fit around part or all of the cell phone in such a manner whereby there is a space formed between the wall of the cell phone case and the side or sides of the cell phone that extends partially around or fully around the cell phone.
  • Ocular photo-bio-stimulation light can be radiated from the light emitter or emitters through this space.
  • the ocular photo-bio-stimulation light is emitted forward through the front thickness of one or more walls of the cell phone case.
  • the ocular photo-bio-stimulation light is emitted through the back of the cell phone case.
  • the subject or patient must turn the cell phone case around when receiving ocular photo-bio-stimulation therapy.
  • the electronic display screen or the housing device which houses the electronic display screen can identify the distance from the eye of the user and can automatically adjust the intensity of the blue, green, or red-light border to be appropriate for such a distance.
  • the electronic display screen or the housing of the electronic display screen can comprise a distance sensor and optionally facial recognition.
  • the border light intensity can be adjusted automatically or manually depending upon the ambient lighting available in the room or space.
  • the lighted border can comprise wavelengths within the range of one or more of: 441nm or greater, 460nm +/- 20nm, 470nm +/- 20nm, 460nm – 520nm, or 480nm +/- 30nm.
  • the ocular photo-bio-stimulation effect targeted can be one or more of (by way of example only), increased dopamine in the eye; the prevention of, slowing down of, or stopping of myopia; increasing dopamine in the brain; increasing alertness; and/or reducing depression severity.
  • a lighted border can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of: 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted border can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the lighted border can be 500 lux or more, 1,000 lux or more, 2,000 lux or more, and so on.
  • an electronic display can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted electronic display can provide ocular photo-bio- stimulation.
  • the lighted border can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • an ocular photo-bio-stimulation light source can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of; 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted ocular photo- bio-stimulation light source can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the ocular photo-bio-stimulation light source can be 500 lux or more, 1,000 lux or more, 2,000 lux or more, and so on.
  • the number of lumens given off from the ocular photo-bio-stimulation light source can be 25 lumens or more, 50 lumens or more, 100 lumens or more, 200 lumens or more, and so on.
  • the blended light wavelengths of the light emitter(s) and also the ambient light comprises wavelengths of light that strike the eye’s retina falling within one of the wavelength ranges of certain embodiments and/or the range of 450nm – 520nm.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • a filtered optic or lens that predominantly transmits within the wavelength range of at least one of 460nm – 520nm or 470nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of at least one of 460nm- 520nm, 470nm to 520nm, or 480nm – 520nm.
  • This can be most beneficial when stimulating the production of increased dopamine in the retina of an eye.
  • This can be most beneficial when stimulating the production of increased dopamine in a brain by way of stimulating the retina of an eye.
  • the light border can have an intensity of 300 lux or greater.
  • the light border can have an intensity of 400 lux or greater.
  • the light border can have an intensity of 1,000 lux or greater.
  • the light border can have an intensity of 5,000 lux or greater.
  • the time of ocular photo- bio-stimulation treatment can be 5 minutes to 10 minutes.
  • the time of ocular photo-bio- stimulation treatment can be 10 minutes to 30 minutes.
  • the time of ocular photo-bio-stimulation treatment can be 30 minutes to 1 hour.
  • the time of ocular photo-bio-stimulation treatment can be 30 minutes or more.
  • the amount of required light intensity given off by an ocular photo-bio-stimulation artificial light source (not the sun) is dependent upon the distance of the light source from the eye of the subject receiving ocular photo-bio-stimulation treatment, the age of the subject, and whether or not the subject is wearing a eyeglass that either filters and/or refracts light. In most, but not all cases, for most handheld devices that give off ocular photo-bio-stimulation, the light intensity needs to be 60 lumens of more leaving the ocular photo-bio-stimulation light source.
  • the intensity of this green light border can be adjustable or programed to a setting.
  • the intensity can modulate.
  • the intensity can be adjustable or fixed.
  • the light wavelength can be adjusted or fixed.
  • such a border can appear on one’s electronic display screen at 7:00am and remain there until 8:00am when it will disappear.
  • the green light can cause the user of the electronic display to have, by way of example only, reduced pain.
  • the cell phone case border can act as a design feature allowing for different colored lights that can be programable during the day or at night. In most, but not all cases the lighted board is in the front periphery (that faces the user) of the cell phone case that surrounds the cell phone. The light can modulate or flicker.
  • a cell phone case comprises the appropriate enabling electronics and comprises a red-light border.
  • the red light can be comprised of wavelengths of red light, for example only, 660nm +/- 10nm or 650nm +/- 30nm.
  • the border of red-light can appear for a certain time interval that can be programed or preset.
  • the intensity of this red-light border can be adjustable or programed to a setting.
  • the intensity can modulate.
  • the light can modulate or flicker.
  • the intensity can be adjustable or fixed.
  • the light wavelength can be adjusted or fixed. By way of example only, such a border can appear at 10:00 pm and be turned off prior to the user when going to sleep.
  • the red light can cause the user of the electronic display to become more relaxed before going to sleep.
  • the cell phone case border can act as a design feature allowing for different colored lights that can be programable during the day or at night.
  • the lighted board is in the front periphery (that faces the user) of the cell phone case that surrounds the cell phone.
  • the light can be programable with regards to one or more of: light intensity, wavelength, modulation or flicker, start time, and/or end time.
  • sequencing strong light intensity of green light wavelengths, then bluish green light wavelengths, and then blue light wavelengths can provide for the maximum retinal stimulation.
  • emit green for 1 – 5 seconds emit bluish green for 10 – 60 seconds, then emit blue for 60 seconds, and so on... until the ocular photo-bio-stimulation is ceased.
  • the ocular photo-bio-stimulation light can modulate within the range of, one of: 5 Hz to 15 Hz, 10Hz to 20Hz, or 40Hz +/- 20Hz.
  • the ocular photo-bio-stimulation light source cannot modulate and thus has zero Hz.
  • an invisible white light spectral flickering can occur.
  • the ocular photo-bio-modulation light source can be modulated within the ranges between blue (450nm – 495nm) and green (495nm- 570nm).
  • the ocular photo-bio-stimulation light can then stimulate, one or more of dopamine, serotonin, and/or norepinephrine in the brain.
  • the invention can be used to stimulate production or increase the production of dopamine in the eye’s retina of the user.
  • a lighted border can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of; 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • the white light can comprise peaks of light wavelengths of: 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted border can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the lighted border can be one of, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • an ocular photo-bio-stimulation light source can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of the wavelength range that strike the eye’s retina falls within the wavelength range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm or 700nm +/- 30nm.
  • the electronic display screen or the housing device which houses the electronic display screen can identify the distance from the eye of the user and can automatically adjust the intensity and size and shape of the blue, green, or red-light border to be appropriate for such a distance.
  • the electronic display screen or the housing of the electronic display screen comprises a distance sensor and optionally facial recognition.
  • the border light intensity can be adjusted automatically or manually depending upon the ambient lighting available in the room or space.
  • a diffuser can be placed over the light emitters.
  • the ocular photo- bio-stimulation effect targeted can be one or more of (by way of example only), increased dopamine in the eye; prevention of myopia; slowing or stopping myopia; healing myopia; improving myopia diagnosis; increasing one or more of dopamine, serotonin or norepinephrine in the brain; increasing alertness; and/or reducing depression severity.
  • the lighted border can comprise wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the ocular photo-bio- stimulation effect targeted can be one or more of (by way of example only), increased mitochondrial health or mitochondrial numbers within the retina of the eye for the purposes of reducing the severity or improving a retinal disease / disorder such as one or more (by way of example only), dry AMD, retinitis pigmentosa, and/or diabetic retinopathy.
  • the red wavelength border light can also be of help with dry eye conditions whereby the tear layer evaporates too quickly by way of stimulating the lids meibomian glands.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm).
  • rhodopsin and melanopsin can be stimulated or excited.
  • a filtered optic or lens that predominantly transmits within the wavelength range of at least one of 460nm – 520nm or 470nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of at least one of 460nm to 520nm or 470nm to 520nm. This would include blue, bluish green and green wavelengths. This can be most beneficial when stimulating the production of increased dopamine in the retina of an eye.
  • the programable border can be of any shape and can partially or fully surround a central area of the electronic display.
  • the ocular photo-bio-stimulation light can comprise a timer to provide the appropriate level of ocular photo- bio-stimulation therapy.
  • Another embodiment can be that of an lighted electronic display screen frame, wherein the electronic display screen frame comprises an ocular photo-bio-stimulation light border around the display screen, wherein the programable ocular photo-bio-stimulation light border provides one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10n
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted border can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the ocular photo-bio-stimulation light source can be one of, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted electronic display can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the ocular photo-bio-stimulation light source can be one of, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • the white light can comprise peaks of light wavelengths of; 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted ocular photo- bio-stimulation light source can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the ocular photo-bio-stimulation light source can be one of, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • an embodiment can be a blue light border comprising light wavelengths within the wavelength range of 480nm +/- 30nm, with the media content being displayed centrally. Said another way the blue light border was fully or partially around the central media that was being displayed.
  • the lighting provided can be automatic and timed to occur for certain periods of usage time or manually set by the user. It can be programed to provide desired light wavelength and intensity for providing ocular photo-bio- stimulation therapy.
  • Such an electronic display can be, by way of example only, a cell phone display screen, tablet display screen, laptop computer display screen, desktop computer display screen, or television display screen.
  • Such a lighted border can be that of a lighted frame itself that houses the display, or a light that attaches to the display screen’s outer frame.
  • the photo-bio- stimulation border light can be programable with regards to one or more of: light intensity, wavelength, modulation or flicker, start time, and/or end time. If the border light is fixed to the frame of the electronic display or built into the frame of the electronic display, the size of the border light will be of a fixed size.
  • the ocular photo-bio-stimulation light can comprise a timer to provide the appropriate time for photo-bio-stimulation therapy [000411]
  • the transmission peak of the wavelength range that strike the eye’s retina falls within the wavelength range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • the blended light wavelengths of the light emitter(s) and also the ambient light comprise wavelengths of light that strike the eye’s retina, which fall within the wavelength ranges of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm.
  • the frame of the display screen can be the outer edge or a frame that goes around the outer edge.
  • a diffuser can be placed over the light emitters.
  • a filter or filters are used so to permit a higher concentration of wavelengths within the range of one of 480nm +/- 30nm, 530nm +/- 20nm, or 650nm +/- 30nm, to be transmitted from the light source.
  • the photo-bio-stimulation light can modulate.
  • the photo-bio-stimulation light can be comprised of a plurality of light emitters.
  • the lighted border can comprise wavelengths within the range of at least one of: 441nm or greater, or 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • the same can be provided for a red-light border within the wavelengths 630nm +/- 20nm or 650nm +/- 30nm, or 650nm – 700nm.
  • the ocular photo-bio-stimulation effect targeted can be one or more of (by way of example only), increased mitochondrial health or mitochondrial numbers within the retina of the eye for the purposes of reducing the severity or improving a retinal disease / disorder such as one or more (by way of example only), dry AMD, retinitis pigmentosa, and/or diabetic retinopathy.
  • the red wavelength border light can also be of help with dry eye conditions whereby the tear layer evaporates too quickly.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • a filtered optic or lens that predominantly transmits within the wavelength range of 460nm – 520nm or 470nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of 460nm to 520nm, 470nm to 520nm, or 480nm – 520nm. This would include blue, bluish green and green wavelengths.
  • light wavelengths within the range of 700nm +/- 30nm can be utilized. Wavelengths of 710 nm LED light has been shown to not have any detrimental effect on dopamine neurons in substantia nigra of the brain.
  • the following would apply in determining the border size needed to stimulate dopamine in the eye of the user and/or one or more of dopamine, serotonin or norepinephrine in the brain.
  • This assumes the iPhone is held 11 inches from the eye of a 12-year-old user, that the user is wearing clear glasses (no filter), and that the user’s eye is attenuating the blue light at a rate of 30% before striking the child’s retina, and upon striking the retina of the child’s eye the light does so with an intensity of 400 lux.
  • the iPhone 16 maximum brightness of white light is 2,000 nits, thus 186 lumens.
  • the total square mm of a peripheral zone around the cell phone display of an iPhone 16 that is approximately 8mm wide would equal approximately 3,104 square mm.
  • having an 8mm peripheral border of white light around the image or text on an iPhone 16 would appear to be sufficient for providing 60 + lumens of light, in this particular example only. That would leave 66mm – 16mm or 50mm by 144m – 16mm or 128mm.
  • the screen size would be 50mm X 128mm for text, email, or games when the border appeared to provide light therapy.
  • the time of stimulation of the retina can affect the retina sensitivity (which includes melanopsin, rhodopsin, and cones’ opsin).
  • 1 second of exposure is most sensitive by the retina at 510nm; 10 seconds of exposure at 500nm; and/or 100 seconds of exposure at 480nm.
  • the color of the ocular photo-bio-stimulation light can be alternated in a sequence.
  • green wavelengths, then blue green wavelengths, then blue wavelengths, then white light can be done to maximize the stimulation effect of light wavelength versus time on retinal excitation.
  • the ocular photo-bio-stimulation light can modulate within the range of at least one of: 5 Hz to 15 Hz, 10Hz to 20Hz, and/or 40Hz +/- 20Hz.
  • the ocular photo-bio-stimulation light source cannot modulate and thus has zero Hz.
  • an invisible white light spectral flickering can occur.
  • the invention can result in a significant improvement in the subject’s improving one or more of: depression, cognitive ability, alertness, and decision making.
  • visually 40Hz +/- 10Hz can be annoying and distracting for a user.
  • an invisible spectral flickering can occur.
  • the ocular photo-bio-modulation light source can be modulated within the ranges between blue (450nm – 495nm) and bluish green / cyan (495nm – 520nm).
  • the ocular photo-bio- modulation light source can be modulated within the ranges between blue (450nm – 495nm) and green (495nm- 570nm). The ocular photo-bio-stimulation light can then stimulate, one or more of dopamine, serotonin, and/or norepinephrine in the brain.
  • the invention can be used to stimulate production or increase the production of dopamine in the eye’s retina of the user.
  • Ocular Photo-Bio-Stimulation Steering Wheel, dashboard, or instrument panel of a Vehicle Ocular photo-bio-stimulation while driving, flying, or navigating a vehicle on land, sea, or air, can be used to increase alertness, improve cognitive ability, and speed decision-making.
  • Ocular photo-bio-stimulation has been shown to increase one or more of dopamine, serotonin or norepinephrine in the brain.
  • Biofeedback involving one or more of, pupil size increase, lid blink increase, heart rate increase, and/or blood oxygen level increase can be an indication of increased production or stimulation of dopamine or norepinephrine in the brain and in some cases serotonin.
  • the amount of required light intensity given off by an ocular photo-bio-stimulation artificial light source is dependent upon the distance of the light source from the eye of the subject receiving ocular photo-bio-stimulation treatment, the age of the subject, and whether or not the subject is wearing an eyeglass that either filters or refracts light.
  • the light intensity needs to be at least one of: 60 lumens of more, 80 lumens or more, or 100 lumens or more, leaving the ocular photo-bio-stimulation light source.
  • the ocular photo-bio-stimulation light source is located on or in the steering wheel, the number of lumens required of the light source would be less than if the ocular photo- bio-stimulation light source was located on or in the dashboard.
  • the ocular photo-bio-stimulation light can modulate within the range of at least one of: 5 Hz to 15 Hz, 10Hz to 20Hz, or 40Hz +/- 20Hz. In other embodiments the light cannot modulate and thus has Zero Hz.
  • the invention can result in a significant improvement in one or more of the subject’s mood, cognitive ability, alertness, and decision making.
  • the ocular photo-bio- modulation light source can be modulated within the ranges between blue (450nm – 495nm) and bluish green / cyan (495nm – 520nm). In still other embodiments which reduce visual unpleasantness, the ocular photo-bio-modulation light source can be modulated within the ranges between blue (450nm – 495nm) and green (495nm- 570nm).
  • the ocular photo-bio-stimulation light can stimulate, one or more of dopamine, serotonin, or norepinephrine in the brain.
  • the steering wheel can vibrate at a modulation rate of 40 Hz+/- 10Hz during the time of which ocular photo-bio-stimulation is occurring.
  • the ocular photo-bio-stimulation light and vibration can then stimulate one or more of dopamine, or serotonin, norepinephrine in the brain.
  • the grip portion of the steering wheel is what vibrates, and in other embodiments the hub and the grip section vibrate.
  • the steering wheel and the seat vibrate at 40 Hz +/- 10 Hz.
  • only the steering wheel vibrates at a modulation rate of 40 Hz +/- 10 Hz without any ocular photo-bio-modulation for the purposes of one or more of, improving mood, increasing alertness, increasing cognitive ability, and speeding decision-making.
  • the steering wheel and the seat vibrate at 40 Hz +/- 10Hz without any ocular photo-bio-stimulation.
  • the driver’s seat can vibrate at a modulation rate of 40 Hz +/- 10Hz during the time of which ocular photo-bio-stimulation is occurring.
  • the ocular photo-bio-stimulation light and vibration can then stimulate, one or more of dopamine, serotonin, or norepinephrine in the brain.
  • the bottom of the seat (which the driver sits on) is what vibrates, and in other embodiments the bottom of the seat (which the driver sits on) and the seat back section vibrate.
  • the driver’s seat vibrates, and the ocular photo-bio-stimulation occurs at 40 Hz +/- 10 Hz. In still other embodiments only the driver’s seat vibrates at a modulation rate of 40 Hz +/- 10 Hz without any ocular photo-bio-modulation for the purposes of one or more of increasing alertness, increasing cognitive ability, and speeding decision-making. And in still other embodiments the driver’s seat and the steering wheel vibrate at 40 Hz +/- 10Hz without any ocular photo-bio-stimulation. [000428] In certain embodiments an ocular photo-bio-stimulation light source can comprise wavelengths of light within the range of 440nm to 700nm.
  • the white light can comprise peaks of light wavelengths of; 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted ocular photo-bio-stimulation light source can provide ocular photo-bio- stimulation.
  • the light intensity of lux given off from the ocular photo-bio-stimulation light source can be one of, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • the number of lumens given off from the ocular photo-bio- stimulation light source can be one of, 50 lumens or more, 100 lumens or more, or 200 lumens or more.
  • the light emitter(s) can be covered by a diffuser.
  • the light emitters can be without a diffuser.
  • embodiments include an ocular photo-bio-stimulation approach that can be implemented to keep a driver of a vehicle alert when driving day or night.
  • the embodiment can be that of a system that comprises an ocular photo-bio-stimulation light source, a steering wheel or a portion of a steering wheel, one or more sensors, electronics, and optional artificial intelligence (AI).
  • AI artificial intelligence
  • the system can also include vibration of the steering wheel, use of the radio, and an optional personal assistant.
  • An ocular photo-bio-stimulation light source can be attached to or incorporated with a portion of the steering wheel having wavelengths of light within the wavelength range of one or more of, 480nm +/- 30nm (blue and blue green), 530nm +/- 20 nm (green), and/or 650nm +/- 30nm (red).
  • the ocular photo-bio-stimulation light source can provide a light intensity of 250 lux or more, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • the ocular photo-bio- stimulation light source can provide a light intensity of 50 lumens or more, 100 lumens or more, 250 lumens or more, or 500 lumens or more.
  • the light striking the retina of the eye of the driver can be 300 lux or more, 400 lux or more, or 500 lux or more.
  • Ocular photo-bio-stimulation has been shown to stimulate one or more of dopamine, serotonin or norepinephrine in the brain.
  • the ocular photo-bio-stimulation light source can be attachable, detachable, or permanently built into a steering wheel.
  • the ocular photo-bio-stimulation light source can be built into the rim or grip section of a steering wheel.
  • the ocular photo-bio-stimulation light source can be attached to the rim or grip section of a steering wheel.
  • the ocular photo-bio-stimulation light source can be built into a portion of the central or hub portion of a steering wheel.
  • the ocular photo-bio-stimulation light source can be attached to the central or hub portion of a steering wheel.
  • the ocular photo-bio-stimulation light source can be built into a portion of the dashboard of a vehicle.
  • the ocular photo-bio-stimulation light source can be attached to portion of the dashboard of a vehicle.
  • the system can comprise its own power source.
  • the system can utilize the electrical power of the automobile.
  • the ocular photo-bio-stimulation light source or its light emitter(s) can be manually or automatically adjustable so as to be pointed or angled upward such that an imaginary straight line can be drawn from the center of a light emitter directly entering the pupil of the driver’s eye. It is important that the light rays from ocular photo-bio-stimulation light source are not blocked by the upper lids of the driver.
  • the ocular photo-bio-stimulation light source can be programed to come on after a timed period of driving.
  • the control can be automatic or manual.
  • the light can be modulated or flicker when being used if desired.
  • the ocular photo-bio-stimulation effect targeted is, in aspects, increased alertness of the driver, improved cognitive ability, faster decision making and faster reaction time.
  • the ocular photo-bio-stimulation light source can comprise a sensor to measure the distance from a user to the ocular photo-bio- stimulation light source and the light intensity can be automatically or manually adjusted to provide that appropriate level of light intensity required for the ocular photo-bio-stimulation effect based upon at any given time the distance of the driver’s eyes from the ocular photo-bio- stimulation light source.
  • the steering wheel can comprise sensors to determine if the driver is becoming less alert.
  • the dashboard can comprise sensors to determine if the driver is becoming less alert.
  • the automobile or vehicle can comprise sensors to determine if the driver is becoming less alert. Should the sensors detect that the driver is becoming less alert or falling asleep, the sensors can cause the ocular photo-bio-stimulation light source to automatically turn on or change.
  • the sensors can also cause the steering wheel to vibrate.
  • the sensors can also cause the horn to sound.
  • the sensors can also cause a personal assistant to orally by way of the radio, in aspects, to wake up and/or pull over.
  • facial recognition within the automobile or vehicle can learn and identify the driver’s identity and sense the amount of drive time when the specific driver becomes less alert.
  • the automobile or vehicle will know in advance certain driving habits of the driver and will then turn on and off the ocular photo-bio-stimulation light source in accordance with those learned driving habits or experiences of the driver.
  • Artificial intelligence (AI) and ML can be incorporated within the embodiment to optimize the desired physiological effect for the driver.
  • Biofeedback or diagnostics involving one or more of, pupil size increase, lid blink rate increase, heart rate increase, and/or blood oxygen level increase, can be an indication of increase production or stimulation of dopamine or norepinephrine in the brain and in some cases serotonin.
  • the light can be further programmed to turn on if the car senses the driver is not alert.
  • a diffuser can be placed over the light emitters.
  • a filter or filters are used to permit a higher concentration of wavelengths within the range of 480nm +/- 30nm to be transmitted from the light source.
  • Artificial intelligence (AI) and ML can be incorporated within the embodiment to optimize the desired physiological effect for the driver.
  • the light can have an intensity of 300 lux or greater.
  • the light can have an intensity of 400 lux or greater.
  • the light can have an intensity of 1,000 lux or greater.
  • the light can have an intensity of 5,000 lux or greater.
  • the time of ocular photo-bio-stimulation treatment can be 5 minutes – 10 minutes.
  • An embodiment of the invention which can be utilized to improve the alertness of any pilot, driver, or steerer of a vehicle, and can be a system that employs blue, bluish green or green light of the wavelengths predominantly within the range of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or 500nm +/- 30nm, and wherein the blue light strikes the retina of the eye(s) of the pilot, driver, or steerer of the vehicle, is hereby disclosed.
  • the blue lights can be programed to turn on automatically when the pilot, driver, or steerer of the vehicle shows signs of fatigue.
  • the blue lights can be turned on manually when the pilot, driver, or steerer of the vehicle feels signs of fatigue.
  • the blue lights can be modulated to turn on for X period of time and turn off for Y period of time.
  • the lights can be set to turn on for, by way of example, only 2 minutes every 2 hours of driving time and then turned off until it is time for them to be turned on. This timing sequence can be set manually by the driver or automatically programmed.
  • the intensity of the blue lights can become brighter during daytime and less bright during nighttime.
  • the lights can be controlled by a dimmer or programed to maintain a certain intensity depending upon ambient light in the vehicle.
  • the steering wheel can comprise one or more pressure sensor(s) such that when the pilot, driver, or steerer feels tired or desires to manually set such a hand pressure sensitive system, it can be set to the pressure threshold as desired by the pilot, driver, or steerer.
  • an alert system within the car can cause the driver to become more awake or alert.
  • a system can use, by way of example only, sound, light, electrical shock, and/or vibration to increase the alertness of the pilot, driver, or steerer.
  • a vision system can also be utilized to further identify the lack of alertness on the part of the pilot, driver, or steerer.
  • a vision system can also be utilized to further identify the lack of alertness on the part of the pilot, driver, or steerer.
  • Artificial intelligence can be incorporated within the embodiment to optimize the desired physiological effect for the driver.
  • an ocular photo-bio-stimulation light source can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • embodiments include an ocular photo-bio-stimulation therapy lamp, wherein the ocular photo-bio-stimulation therapy lamp comprises an ocular photo- bio-stimulation light(s), wherein the lamp can be programable, wherein the lamp can provide one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm, wherein one or a plurality of light emitters that generate the
  • the light or lamp can comprise a distance sensor.
  • the ocular photo-bio- stimulation light or lamp can be comprised of one light emitter or a plurality of light emitters.
  • the ocular photo-bio-stimulation light source can increase the production of dopamine in the eye and/or one or more of dopamine, serotonin or norepinephrine in the brain.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens, which predominantly transmits within the wavelength range of at least one of 460nm – 520nm or 470nm to 520nm, and/or by utilizing a light source or light emitter that predominately transmits within the wavelength range of at least one of 460nm- 520nm, 470nm to 520nm, or 480nm to 520nm.
  • the ocular photo-bio- stimulation light or lamp comprises a distance sensor and optionally facial recognition.
  • the light intensity can be adjusted automatically or manually depending upon the ambient lighting available in the room or space.
  • a diffuser can be placed over the light emitters.
  • a filter or filters are used so as to permit a higher concentration of wavelengths within the range of at least one of: 480nm +/- 30nm, 480nm +/- 20nm, 500nm +/- 30nm, 500nm +/- 20nm, 510nm +/- 30nm, 510nm +/- 20nm, 530nm +/- 20nm, 650nm +/- 30nm490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm, to be transmitted from the light source.
  • the ocular photo-bio-stimulation light or lamp can modulate or flicker.
  • the ocular photo-bio-stimulation light or lamp can comprise a timer to provide the appropriate level of ocular photo-bio-stimulation therapy.
  • the ocular photo-bio-stimulation light or lamp can comprise wavelengths within the range of 441nm or greater, or 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm
  • the ocular photo-bio-stimulation effect targeted can be one or more of (by way of example only), increased dopamine in the eye, prevention of myopia, slowing or stopping myopia, increasing or one or more of dopamine, serotonin or norepinephrine in the brain, increasing alertness, and/or reducing depression severity.
  • the ocular photo-bio-stimulation light or lamp can comprise wavelengths within the range of 530nm +/- 10nm, or 530nm +/- 15nm, or 530nm +/- 20nm, or 500nm to 550nm.
  • the ocular photo-bio-stimulation effect targeted can be one or more of (by way of example only), reduced pain severity, reduced frequency of headaches, and/or reduced frequency of migraines.
  • the ocular photo-bio-stimulation light or lamp can comprise wavelengths within the range of 630nm +/- 20nm or 650nm +/- 30nm, or 650nm – 700n or 700nm +/- 30nm.
  • the ocular photo-bio-stimulation effect targeted can be one or more of (by way of example only), increased mitochondrial health or mitochondrial numbers within the retina of the eye for the purposes of reducing the severity or improving a retinal disease / disorder such as one or more (by way of example only), dry AMD, retinitis pigmentosa, and/or diabetic retinopathy.
  • the ocular photo-bio-stimulation light or lamp can also be of help with dry eye conditions whereby the tear layer evaporates too quickly.
  • the ocular photo-bio-stimulation light can modulate within the range of, one of: 5 Hz to 15 Hz, 10Hz to 20Hz, or 40Hz +/- 20Hz.
  • the ocular photo-bio-stimulation light source cannot modulate and thus has zero Hz.
  • an invisible white light spectral flickering can occur.
  • the invention can result in a significant improvement of one or more of: depression, cognitive ability, alertness, and decision making of the user.
  • visually 40Hz +/- 10Hz can be annoying and distracting for a user.
  • an invisible spectral flickering can occur.
  • the ocular photo-bio-modulation light source can be modulated within the ranges between blue (450nm – 495nm) and bluish green / cyan (495nm – 520nm). In still other embodiments which reduce visual unpleasantness the ocular photo-bio-modulation light source can be modulated within the ranges between blue (450nm – 495nm) and green (495nm- 570nm).
  • the ocular photo-bio- stimulation light can then stimulate, one or more of dopamine, serotonin, or norepinephrine in the brain.
  • an ocular photo-bio-stimulation light source can comprise wavelengths of light within the range of 440nm to 700nm.
  • the lighted border can be a white lighted border.
  • the white light can comprise peaks of light wavelengths of 460nm +/- 10nm, 525nm +/- 10nm, and/or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted ocular photo- bio-stimulation light source can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from the ocular photo-bio-stimulation light source can be one of, 250 lux or more, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • the number of lumens given off from the ocular photo-bio-stimulation light source can be one of, 10 lumens or more, 25 lumens or more 50 lumens or more, or 100 lumens or more.
  • Eyewear embodiments for ocular photo-bio-stimulation can comprise a lens or optic that permits a wearer to view an image, wherein certain light wavelengths that pass from the eyewear or the optic stimulates dopamine or serotonin of the wearer, wherein certain of the light wavelengths are of the blue light, and wherein the highest concentration of blue, bluish green, or green light, that reach the eye of the wearer falls within the wavelengths range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or
  • Blue, bluish green, green light radiation wavelengths can be within the range of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or 500nm +/- 30nm, and can increase alertness and concentration, by way of example, upon waking in the morning or during the day when tired and less alert.
  • wavelengths within the range of 650nm +/- 30nm or 650nm - 700nm, or 700nm +/- 30nm can be used. It is further known that low levels of dopamine can be associated, by way of example only, with ADHD, myopia and Parkinson disease.
  • the ocular photo-bio-stimulation light source can increase the production of dopamine in the eye and/or one or more of dopamine, serotonin or norepinephrine in the brain.
  • Embodiments providing ocular photo-bio-stimulation can filter or block damaging high energy blue light, UV, and reduce bright light visual discomfort.
  • the eyewear or optic can comprise green light within the range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or 500nm +/- 30nm.
  • Green light wavelengths can, in aspects, reduce the sensation of pain.
  • the eyewear or an optic can comprise red light within the range of 660nm +/- 20nm, 650nm +/- 30nm, or 600nm to 700nm. Red light wavelengths within the range of 660nm +/- 20nm, 600nm to 700nm, or 700nm +/- 30nm, can be soothing, calming and relaxing to the brain, thereby assisting with (by way of example) going to sleep.
  • the eyewear and/or optic can be any type of eyewear or optic known to one of ordinary skill in the art.
  • the eyewear and/or optic can be disposable.
  • the eyewear and/or optic can be an insert that can be inserted or attached to existing eyewear.
  • the eyewear and/or optic can be a component that is removable or permanently attached to existing eyewear.
  • an optic can be a lens.
  • a lens can be an optic.
  • a lens or optic can comprise optical power.
  • a lens or optic can comprise no optical power.
  • an optic can be any item that transmits light, such as a lens, flat sheet of transparent plastic or glass, film, light diffuser, window, etc., as would be understood by one of ordinary skill in the art. [000465]
  • the optic can comprise a single bandpass filter to provide for the transmission of the desired light wavelengths.
  • the optic can comprise a double bandpass filter to provide for the transmission of the desired light wavelengths.
  • the level of transmission of light to the eye’s retina used in the various embodiments disclosed herein can be provided at one of scotopic, mesopic, and/or photopic light levels. In embodiments the light level is above 400 lux and is in the higher end of mesopic and most of the time photopic.
  • ambient light can be filtered or engineered by the design of the optic or lens to spread or focus over the retina, including that of the optic nerve head.
  • the blue wavelength band of chromatic aberration is engineered by way of the optic design or optic power to focus on or within the retina peripheral to the macula.
  • the optic can be an ophthalmic lens.
  • the optic can be a thin plastic or glass section or part having no optical power that transmits light.
  • An optic can be a window.
  • An optic can be a light diffuser.
  • An optic can be a film.
  • the optic can comprise optical power.
  • the optic can comprise prescription optical power.
  • the optic can comprise no optical power.
  • the optic can be a spectacle lens.
  • the optic can be a contact lens.
  • the optic can be an intra ocular lens. [000467] In some embodiments the highest concentration of blue light radiation or blue wavelengths falls within the range of 460nm +/- 20 nm or 470nm +/- 20nm or 480nm +/- 30nm or 450nm – 520nm.
  • the highest concentration of blue light radiation or blue wavelengths falls within 460nm +/- 35 nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls within the range of 460nm +/- 20 nm. In some embodiments the highest concentration of blue light radiation falls within the range of 470nm +/- 15 nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls within the range of 470nm +/- 20 nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls within the range of 470nm +/- 25nm. In some embodiments the highest concentration of blue light radiation falls within the range of 480nm +/- 10 nm.
  • the highest concentration of blue light radiation falls within the range of 480nm +/- 15nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls within the range of 480nm +/- 20 nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls within the range of 480nm +/- 30 nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls above 449nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls above 454nm. In some embodiments the highest concentration of blue light radiation or blue wavelengths falls above 459nm. [000468]
  • the eyewear or optic can cause the wearer to be, by way of example only, more alert and/or have better concentration.
  • wavelengths within the range 460nm +/- 10nm or 470nm +/- 20nm, more specifically within the range of 480nm +/-30nm are known to produce dopamine within the human eyes’ retina and brain.
  • wavelengths within the range of 650nm – 700nm can be used to increase alertness by increasing dopamine production.
  • Light wavelengths within the wavelength range of 480nm +/- 30nm and 650nm +/- 30nm can excite the melanopsin containing ipRGC and/or rods so as to cause an increase in dopamine and/or serotonin production in the retina of an eye.
  • blue light wavelengths below 450nm are blocked or filtered. In certain embodiments the blue light wavelengths below 450nm and above 490nm are blocked or filtered. In certain embodiments all light wavelengths below 450nm and above 490nm are blocked or filtered. In certain embodiments the blue light wavelengths below 450nm and above 480nm are blocked or filtered. In certain embodiments all light wavelengths below 450nm and above 480nm are blocked or filtered. In certain embodiments all light wavelengths below 450nm and above 510nm are blocked or filtered. As used herein a filter is intended to filter light and affect the transmission thereof.
  • a filter can affect/block or reduce the transmission of certain ranges of light wavelengths.
  • the filter blocks and/or filters certain light wavelengths while transmitting others.
  • the optic can be an ophthalmic lens.
  • the optic can be a thin plastic, film, or glass section or part having non-optical power that transmits light.
  • An optic can be a light diffuser.
  • the optic can be antireflection coated.
  • the optic can be slightly tinted.
  • the optic can be without a color or tint.
  • the optic can be mostly clear of color.
  • the optic can be scratch resistant coated.
  • the optic can be surface treated like any ophthalmic lens.
  • the optic can be an electrochromic lens.
  • the lens or optic can be a chromatic aberration focused lens.
  • the design can include one or more of refractive or diffractive, or a combination of refractive and diffractive.
  • An example of a refractive/diffractive design is one of a lens or optic that comprises a central optic zone having refractive curves (comprising a spherical power or plano / no power) and a zone that is outside of the central zone that comprises Fresnel optical prismatic elements.
  • the lens can be completely a Fresnel diffractive lens in the central zone and the peripheral zone.
  • the peripheral zone can be of an optical power that is more minus or less plus optical power than the central zone.
  • the central zone can be plano and the peripheral zone can be within the range of -0.75D to – 5.00D or in certain embodiments having an optical power within the range of -1.00 D - -2.00D.
  • a lens or optic can be worn or utilized when providing ocular photo-bio-stimulation therapy to an eye.
  • This lens or optic can be worn in addition to the wearer’s conventional eyeglasses when the ocular photo-bio-stimulation therapy is being provided or applied. And it can be removed for normal daily use when the ocular photo-bio- stimulation therapy is no longer being provided or applied. In certain embodiments it is worn in front of and in optical communication with the wearer’s conventional eyeglasses.
  • the lens or optic can be of a design that can include one or more of refractive, or diffractive, or a combination of refractive and diffractive.
  • a refractive / diffractive design is one of a lens or optic that comprises a central optic zone having refractive curves (comprising a spherical power or plano / no power) and a zone that is outside of the central zone that comprises Fresnel optical prismatic elements.
  • the lens can be completely a Fresnel diffractive lens in the central zone and the peripheral zone.
  • the peripheral zone can be of an optical power that is more plus or less minus optical power than the central zone.
  • the central zone can be plano and the peripheral zone can be within the range of +0.75D to + 5.00D or in certain embodiments having an optical power within the range of +1.00 D to +2.00D.
  • Such a lens or optic can be worn or utilized when providing ocular photo-bio-stimulation therapy to an eye. This lens or optic can be worn in addition to the wearer’s conventional eyeglasses when the ocular photo-bio-stimulation therapy is being provided or applied. And it can be removed for normal daily use when the ocular photo-bio-stimulation therapy is no longer being provided or applied.
  • Eyewear can be of any type of eyewear worn around or in the eye. Eyewear as used herein can comprise any eyewear, by way of example only: spectacles, sunglasses, disposable eyewear, goggles, dress eyewear, safety eyewear, sports eyewear, clip-on eyewear, fit-over eyewear, military eyewear, smart eyewear, XR eyewear, AR eyewear, VR eyewear, MR eyewear, contact lens, intra-ocular lenses, or corneal implant. When required the eyewear can comprise a power source and the appropriate electronics needed.
  • Non-prescription can mean non optical power.
  • Plano means no optical power.
  • Optical power can mean all optical powers.
  • the optic can be made of plastic or glass.
  • the use of the word filter means in most cases reducing, but not fully eliminating. However, in some cases, filtering can mean eliminating.
  • the use of the word blocking means eliminating.
  • Diffusing means to spread out. Defocus means not focusing on the retina of the eye of the user.
  • the eyewear or optic can comprise one or more of: a notch filter, bandpass filter, selective blue light filter, absorptive filter, interference filter, a plurality of filters, or a combination of any one or more.
  • a bandpass filter can be a type of interference filter.
  • An interference filter can be a bandpass filter.
  • the filter can be used in association with one or more lenses, lens blank, optic, and/or optical blank.
  • the filter can be in optical communication with one or more of: a lens, lens blank, optic, optical blank, or another filter.
  • the filter can be applied to one or more of: the concave surface, convex surface, or buried or embedded within the lens, lens blank, optic, or optical blank.
  • the filter can be separated and/or distance separated and in optical communication with one or more of: the lens, lens blank, optic, and/or optical blank.
  • a filter can be used in combination with another filter.
  • a filter can be used in optical communication with a distance separated filter.
  • a filtered optic or filtered lens can be that of an optic or lens that comprises one or more of: an interference filter, bandpass filter, neutral density filter, notch filter, absorption filter, absorber(s), dyes, and/or selective blue light filter.
  • an interference filter bandpass filter
  • neutral density filter notch filter
  • absorption filter absorber(s), dyes, and/or selective blue light filter.
  • absorber(s) dyes, and/or selective blue light filter.
  • the overall light transmission through the filtered optic or filtered lens can be 50% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 50% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the overall light transmission through the filtered optic or filtered lens can be 40% of less or 30% or less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 40% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the eyewear or optic can comprise one or more of blue light emitter(s), green light emitter(s), and/or red-light emitter(s).
  • Examples of light emitters can be, by way of example only, LEDs, OLEDs, micro-OLEDs, micro-LEDs, quantum dots, iLEDs, fluorescent, incandescent, and/or the sun.
  • a light emitter and be any light source that gives off light radiation.
  • a light ring is utilized to minimize pupil constriction. This occurs as the eye being treated can fixate on a distant object through the center of the light ring while the light of the light ring is stimulating the photoreceptors of the eye. This further allows for providing light exposure to the peripheral retina of the eye.
  • the light can flicker.
  • the light can modulate.
  • the light can modulate within the modulation range of 5 Hz and 15 Hz.
  • the light intensity utilized can be 300 lux or greater, 400 lux or greater, 1000 lux or greater, or 10,000 lux or greater.
  • eyewear can comprise blue or red-light emitters facing towards the eye of the wearer, facing inward and reflecting off the optic supported by the eyewear, and/or facing towards the wearer’s pupil(s).
  • a band of blue, green, or red- light wavelengths can be varied in intensification of light radiation.
  • the highest concentration of blue, green, or red-light radiation being transmitted can be varied in terms of light radiation.
  • the blue, bluish green or green light emitters can comprise a wavelength within 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or 500nm +/- 30nm.
  • the blue light emitters can comprise a wavelength greater than 449nm but less than 510nm.
  • the blended light wavelengths of the light emitter(s) and also the ambient light comprises wavelengths of light that strike the eye’s retina can fall within one of the wavelength ranges of at least one of: 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30n
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of 460nm – 520nm or 470nm to 520nm or by utilizing a light source or light emitter that predominately transmits within the wavelength range of 460nm- 520nm, 470nm to 520nm, or 480nm +/- 30nm. This would include blue, bluish green and green wavelengths.
  • the blue or green or red-light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of most, but not all, blue or green or red light.
  • the blue or green or red-light light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of all blue or green or red-light light.
  • the wavelengths range being transmitted to the eye of the wearer can be within the range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • Certain green light emitters within the wavelength range 500nm and 530nm can increase dopamine in the brain.
  • the red-light emitters can excite one or more of, the macula cones, retinal rods and melanopsin containing ipRGCs.
  • Certain blue light wavelengths increase alertness, focus, and cause the generation of dopamine in the eye and the brain.
  • Certain blue light wavelengths can slow or stop myopia progression.
  • Certain blue light wavelengths can prevent myopia from occurring in the first place.
  • Certain green light wavelengths decrease pain.
  • Certain red-light wavelengths increase calmness and relaxation.
  • Certain red-light wavelengths increase dopamine production and increase alertness.
  • Certain red-light wavelengths of 650nm +/- 30nm or 700nm +/- 30nm can improve the health of mitochondria.
  • the range of wavelength band includes the peaks of the most sensitive points from rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • the range of 460nm – 520nm or 470nm – 520nm, or 480nm – 520nm can be used. This would include blue, bluish green and green wavelengths.
  • the intensity of the light intensity of the ocular photo-bio-stimulation light can be in certain cases, by way of example only, 300 lux or greater. In other cases, by way of example it is less than 500 lux.
  • the light emitter can have blue light wavelengths within the range of 460nm +/-20nm or 470nm +/- 20nm or 450nm to 510nm and can be blended with white light such as providing a blue wavelength enhanced or enriched by or with white light.
  • certain fluorescent light that provides indoor warm white lighting can provide blue light wavelengths within the range of 460nm +/-20nm or 470nm +/- 20nm or 450nm to 510nm.
  • a white florescent light can be used with a blue light emitter.
  • certain incandescent light that provides indoor lighting can also provide blue light wavelengths within the range of 460nm +/-20nm or 470nm +/- 20nm or 450nm to 510nm.
  • certain incandescent light that florescent light that provides indoor lighting can be used with an LED having blue light wavelengths within the range of 460nm +/-20nm or 470nm +/- 20nm or 450nm to 510nm.
  • a white LED can be provided in combination with a blue LED having wavelengths within the range of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, or 495nm +/- 30nm.
  • a white light emitter can be provided in combination with a blue light emitter having wavelengths within the range of 460nm +/-20nm or 470nm +/- 20nm or 450nm to 510nm.
  • a blue LED can provide a level of blue light within the wavelength range of 460nm +/-20nm or 470nm +/- 20nm or 450nm to 510nm.
  • the ocular photo-bio-stimulation light source can increase the production of dopamine in the eye and/or one or more of dopamine, serotonin or norepinephrine in the brain.
  • the light emitter can have green wavelengths within the range of 500nm – 520nm, 510nm to 540nm, or 530nm +/- 20nm, and be blended with white light such as providing a green wavelength enhanced or enriched by or with white light.
  • certain fluorescent light that provides indoor warm white lighting can also provide green wavelengths within the range of 500nm to 540nm.
  • a white florescent light can be used with a green light emitter.
  • certain incandescent light that provides indoor lighting can also provide green light wavelengths within the range 510nm to 540nm.
  • certain incandescent light that florescent light that provides indoor lighting can be used with by way of example, an LED having green light wavelengths within the range of 500nm – 520nm, 520nm +/- 10nm, 530nm +/-20nm, or 510nm to 540nm.
  • a white LED can be provided in combination with a green LED having wavelengths within the range of 530nm +/- 20nm, 530nm +/- 20nm, or 510nm to 540nm.
  • a white light emitter can be provided in combination with a green light emitter having wavelengths within the range of 500nm +/- 10nm, 520nm +/- 10nm, 530nm +/- 20nm, or 510nm to 540nm.
  • the light emitter can have red wavelengths within the range of 630nm +/- 20nm, 650nm +/- 30nm, or 600nm to 700nm, and be blended with white light such to provide a red wavelength enhanced or enriched white light.
  • certain fluorescent light that provides indoor warm white lighting can also provide red wavelengths within the range of range of 630nm +/- 20nm, 650nm +/-30n, or 600nm to 700nm.
  • a white florescent light can be used with a red-light emitter.
  • certain incandescent light that provides indoor lighting can also provide red-light wavelengths within the range of 630nm +/- 20nm, 650nm +/-30nm, or 600nm to 700nm.
  • certain incandescent light that florescent light that provides indoor lighting can be used with an LED having red-light wavelengths within the range of range of 660nm +/- 20nm, 650nm+/-30nm, or 600nm to 700nm.
  • a white LED can be provided in combination with a red LED having wavelengths within the range of range of 630nm +/- 20nm, 650nm +/-30nm, or 600nm to 700nm.
  • a white light emitter can be provided in combination with a red-light emitter having wavelengths within the range of range of 630nm +/- 20nm, 650nm +/- 30nm or 600nm to 700nm, or 700nm +/- 30nm.
  • the blue light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of most, but not all, blue light.
  • the blue light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of all blue light.
  • the blue light emitters can be located around the backside of the eye-wire of an eyeglass frame closest to the eye of the wearer permitting the center of the optic to be free of most, but not all, blue light.
  • the blue light emitters can be covered by a diffuser.
  • the blue light wavelengths can strike or mostly strike the non-macular area of the retina, while mostly visible light wavelengths that pass through the center of the optic can strike or mostly strike the macular area of the retina.
  • the optic can be tinted blue and blue light emitters can shine through the tinted optic.
  • the optic can be tinted blue and blue light emitters can reflect off the surface of the optic.
  • the optic can be tinted blue and white light emitters can shine through the blue tinted optic.
  • the blue light emitters which are located on the backside of the eyewear can be pointed towards the pupil of the eye of the wearer. In other embodiments the blue light emitters are perpendicular to the backside of the eyewear and can point towards the face of the wearer. [000491] In embodiments the green light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of most, but not all, green light. In embodiments the green light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of all green light.
  • the green light emitters can be located around the backside of the eye-wire of an eyeglass frame closest to the eye of the wearer permitting the center of the optic to be free of most, but not all, green light.
  • the green light emitters can be covered by a diffuser.
  • the green light wavelengths can strike or mostly strike the macular and non-macular area of the retina, while mostly visible light wavelengths that pass through the center of the optic can strike or mostly strike the macular area of the retina.
  • the optic can be tinted green and green light emitters can shine through the green tinted optic.
  • the optic can be tinted green and green light emitters can reflect off one of the surfaces of the optic.
  • the optic can be tinted green and white light emitters can shine through the green tinted optic.
  • the green light emitters which are located on the backside of the eyewear can be pointed towards the pupil of the eye of the wearer. In other embodiments the green light emitters are perpendicular to the backside of the eyewear and can point towards the face of the wearer. [000492]
  • the red-light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of most, but not all, red light. In embodiments the red-light emitters can be located around the periphery of a clear or lightly tinted optic permitting the center of the optic to be free of all red light.
  • the red-light emitters can be located around the backside of the eye-wire of an eyeglass frame closest to the eye of the wearer permitting the center of the optic to be free of most, but not all, red light.
  • the red- light emitters can be covered by a diffuser.
  • the red-light wavelengths can strike or mostly strike the macular and non-macular area of the retina, while mostly visible light wavelengths that pass through the center of the optic can strike or mostly strike the macular area of the retina.
  • the optic can be tinted red and red-light emitters can shine through the red tinted optic.
  • the optic can be tinted red and red-light emitters can reflect off of one of the surfaces of the optic.
  • the optic can be tinted red and white light emitters can shine through the red tinted optic.
  • the eyewear houses or supports an optic which can comprise an eyeglass prescription. In certain embodiments the eyewear houses or supports an optic which can comprise an eyeglass lens that is non-prescription.
  • the eyewear can be disposable, comprising a colored optic such that when viewing a bright light source transmits light wavelengths within the range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm or 700nm +/-
  • the eyewear can be disposable, comprising a colored optic such that when viewing a bright light source transmits light wavelengths within the range of 500nm – 520nm or 530nm +/- 20nm to the eye of the wearer.
  • the eyewear can be disposable, comprising a colored optic such that when viewing a distant separated bright light source transmits light wavelengths within the range of 630nm +/- 20nm, 650nm +/- 30nm, or 600nm to 700nm, or 700nm +/- 30nm, to the eye of the wearer.
  • the eyewear houses or supports an optic that comprises blue light emitters having blue light wavelengths within the range of 441nm to 500nm, or 460nm +/- 20nm or 470nm +/- 20nm or 480nm +/-30nm.
  • the eyewear houses or supports an optic that comprises a blue color having blue wavelength within the range of 441nm to 500nm, or 460nm +/- 20nm or 470nm +/- 20nm or 480nm +/-30nm, while, in aspects, filtering or blocking blue light wavelengths of 440nm or below.
  • the eyewear houses or supports an optic that comprises a blue color having blue light wavelengths within the range of 441nm to 500nm, or 460nm +/- 20nm or 470nm +/- 20nm or 480nm +/-30nm, and wherein the blue light wavelengths transmitted below 441nm have been reduced in number or intensity.
  • a bandpass filter transmits wavelengths within the range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the eyewear houses or supports an optic that comprises green light emitters having green light wavelengths within the range of 510nm – 540nm or 530nm +/- 20nm or 520nm +/- 10nm. In certain embodiments the eyewear houses or supports an optic that comprises a green color having green light wavelengths within the range of 510nm – 540nm or 530nm +/- 20nm. [000495] In some embodiments the eyewear or optic can comprise red-light emitters. In certain other embodiments the eyewear or optic can comprise blue, bluish green, green, and/or red- light emitters. In such cases the light emitters are used for improving, by way of example only, increased alertness and cognitive ability.
  • the light emitters can emit wavelengths within the range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the red-light can be of a red-light within the wavelength range of 660nm +/- 30nm or 650nm +/- 30nm or 660 nm +/- 20nm.
  • the blue light can have wavelengths within the range of 441nm to 500nm, or 460nm +/- 20nm or 470nm +/- 20nm or 480nm +/-30nm, while if needed filtering or blocking within the range of 420nm +/- 20nm.
  • the green light can have wavelengths within the range of 510nm – 540nm or 530nm +/- 20nm.
  • the red-light wavelengths can be within the range of 630nm +/- 20nm, or 650nm +/- 30nm, or 660nm +/- 30nm, or 600nm to 700nm, or 700nm +/- 30nm.
  • a plurality of light emitters can be utilized to provide one or more of the preceding wavelength bands.
  • the eyewear or optic can comprise white light emitters that shine on a blue colored lens or optic, or a green colored lens or optic, or a red colored lens or optic. Examples of light emitters can be, by way of example only: LEDs, OLEDs, micro-OLEDs, micro- LEDs, iLEDs, and/or quantum dots.
  • a plurality of light emitters can be utilized.
  • a clip-on optic or flip-up or down optic can attach to the eyewear (see, FIG.21A-D).
  • the eyewear can comprise a prescription lens or non-prescription lens.
  • the eyewear can comprise a lens having optical power or having non-optical power (plano power).
  • one or more lens housed or supported by the eyewear can comprise a blue color having blue wavelengths within the range 450nm to 500nm or 460nm +/- 20nm, or 470nm +/- 20nm, or 480nm +/- 30nm, and can filter or block blue wavelengths below 450nm.
  • the housing of the clip-on optic or flip-up and down optic can attach to the eyewear, by way of example only, magnetically, mechanically, and/or by a tension mount. (See, FIGs.21A-D and FIG. 22.)
  • the optic can be attached to the lens housed by the eyewear by way of example only, with magnets, removable adhesive, and/or through static energy.
  • Other embodiments may include a ring, a band, or a section of blue or green or red-light emitters, which can be adhered to the lens or optic surface, attached to the lens or optic surface, or embedded within the lens or optic surface, wherein the lens or optic is supported or housed by an eyeglass frame or eyewear.
  • a ring, band, or a section of blue or green or red-light emitters can be adhered to the lens or optic surface, attached to the lens or optic surface, or embedded within the lens or optic surface, such that it can be inserted or such that it is supported or stabilized on an eyeglass frame or eyewear.
  • the filters and/or emitters and related embodiments can be removeable inserts, such as attached to a lens, attached to eyewear, inserted into a lens, or embedded in a lens. (See, FIG.19A-F.) [000501]
  • the blue, or green, or red-light, or white light emitters can provide light covering a central portion of the lens or optic.
  • the blue, green, or red-light, or white light emitters can provide light covering a peripheral portion of the lens or optic leaving the center of the lens or optic mostly clear of blue, green, red, or white light.
  • the blue, green, red or white light emitters can provide light covering a portion of the lens or optic. (See, FIGs.20A-C.) [000502]
  • the blue, or green, or red-light, or white light emitters can be distance separated from the optic.
  • the light emitters can be covered by a diffuser to spread and soften the light. The light can be directed towards the eye of the wearer. The light can be directed towards the pupils of the eyes of the wearer.
  • the light source or emitter can modulate for example, within the range of one of 5 Hz – 15 Hz, 10Hz to 20Hz, or 40Hz +/- 20Hz. In certain embodiments the light source or emitter can modulate, for example 10 times per second or less. In certain embodiments the light source or emitter can modulate (on and off), for example, 20 times per second or less. In other embodiments the light source or emitter can modulate, for example, 50 times per second or less. And in still other embodiments the light emitter or emitter can modulate, for example, 100 times per second or less. In still other embodiments the light does not modulate or flicker.
  • utilizing blue light as the light source can be of an intensity of 300 lux or more.
  • the intensity can be of 500 lux or more. In other embodiments the intensity can be of 1,000 lux or more.
  • the time of treatment with the light source can be 1 hour or less. In other embodiments the time of treatment can be 30 minutes or less. In still other embodiments it can be 10 minutes or less. And in still other embodiments it can be 5 minutes or less.
  • the green light source can have an intensity of 250 lux or more. In other embodiments the intensity can be 500 lux or more. In other embodiments the intensity can be 1,000 lux or more.
  • the time of treatment with the light source can be 1 hour or less. In other embodiments the time of treatment can be 30 minutes or less. In still other embodiments it can be 10 minutes or less. And in still other embodiments it can be 5 minutes or less.
  • the red-light source can have an intensity of 400 lux or more. In other embodiments the intensity can be of 500 lux or more. In other embodiments the intensity can be of 1,000 lux or more. In other embodiments the intensity can be of 5,000 lux or more.
  • an embodiment can include a clip-on optic or flip-up or down optic comprising a lens having optical power or having non-optical power (plano power).
  • the clip-on optic or flip-up or down optic can transmit blue wavelengths within the range of 441nm – 500nm, or 460nm +/- 20nm, or 470nm +/- 20nm, or 480nm +/-30nm, such as, in cases, using a bandpass filter.
  • the clip-on optic or flip-up or down optic can be clear of color and comprise blue light emitters having blue wavelengths predominately or solely within the range of 441nm – 500nm, or 460nm +/- 20nm, or 470nm +/- 20nm, or 480nm +/-30nm, around its periphery of that of the housing that supports the optic.
  • a housing can be a frame or an eyewear frame.
  • the clip-on optic or flip-up or down optic can transmit blue light (e.g., using one or more light emitter 2102) wavelengths within the range of 441nm – 500nm, or 460nm +/- 20nm, or 470nm +/- 20nm, or 480nm +/-30nm, and the lens housed by the eyewear can filter or block blue wavelengths 440nm or below.
  • the forward optic farthest away from the eye of the wearer can provide or emit a blue color having wavelengths within the range of 441nm – 500nm, or 460nm +/- 20nm, or 470nm +/- 20nm, or 480nm +/-30nm.
  • the filter can be an absorption filter.
  • Any of the clip-on optics or flip-up or down optics can be attachable and detachable to the eyewear, eyewear frame, or optic/lens; in other words, any of the clip-on optics or flip-up or down optics can be attachable and detachable to a frame, or any of the clip-on optics or flip-up or down optics can be integral with or embedded within the frame.
  • the clip-on optic or flip-up or down optic can comprise a lens having optical power or having non-optical power (plano power).
  • the clip-on optic or flip-up or down optic can comprise transmission of green light wavelengths predominately or solely within the range of 480nm +/- 30nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or 500nm +/- 30nm.
  • the clip-on optic or flip-up or down optic can be clear of color and comprise green light emitters having wavelengths within the range of 500nm – 550nm, or 530nm +/- 20nm, around its periphery of that of the housing that supports the optic.
  • a housing can be a frame or an eyewear frame.
  • the forward optic furthest away from the eye of the wearer can provide or emit green wavelengths within the range of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, or 500nm +/- 30nm.
  • the forward optic is that of the clip-on or flip down optic and the optic located behind the clip-on or flip down optic is that of the eyewear optic comprising an optical power.
  • the optic can be a clip on or flip down filter.
  • the filter can be a bandpass filter.
  • the filter can be an interference filter.
  • the filter can be an absorption filter.
  • the clip-on optic or flip-up or down optic can comprise a lens having optical power or having non-optical power (plano power).
  • the clip-on optic or flip-up or down optic can comprise transmission of red-light wavelengths predominately or solely within the range of 630nm +/- 20nm, 650nm +/- 30nm, or 600nm – 700nm.
  • the clip-on optic or flip-up or down optic can be clear of color and comprise red light emitters having wavelengths within the range of 630nm +/- 20nm, 650nm +/- 30nm, or 600nm – 700nm, or 700nm +/- 30nm, around its periphery of that of the housing that supports the optic.
  • a housing can be a frame or an eyewear frame.
  • the forward optic farthest away from the eye of the wearer can provide or emit red wavelengths within the range of 630nm +/- 20nm, 650nm +/- 30nm, or 600nm – 700nm, or 700nm +/- 30nm.
  • the forward optic is that of the clip-on or flip down optic and the optic located behind the clip-on or flip down optic is that of the eyewear optic comprising an optical power.
  • the optic can be a clip on or flip down filter.
  • the filter can be a bandpass filter.
  • the filter can be an interference filter.
  • the filter can be an absorption filter.
  • an embodiment can include white light emitters (with or without a diffuser) 2103.
  • the clip-on optic or flip-up or down optic can be prescription, or not.
  • the lenses can be tinted, or not 2104.
  • the lenses can include one or more filter.
  • white LEDs are pointed towards the eye of the wearer, and they can transmit trough a filter 2105 (e.g., blue lens comprising notch filter or bandpass filter while transmitting especially between 480 +/- 30nm).
  • a filter 2105 e.g., blue lens comprising notch filter or bandpass filter while transmitting especially between 480 +/- 30nm.
  • the appropriate enabling electronics to drive, power, control, modulate, dim or brighten the light emitters are part of or in association with the embodiments even if not identified within the illustrations.
  • one or more of a bandpass filter, notch filter, interference filter, dye absorption filter, specialized filter, coating, and/or dye can be utilized to achieve the desired wavelengths transmission results.
  • the eyewear and/or optic can be comprised of a non-prescription optic that can by way of example only, one or more of: disposable, repeatably rolled up when not in use and extends back out when in use such that it utilizes pressure to attach to and eyewear frame, rests by way of arms on existing eyewear that is being worn, fits over existing eyewear, and/or clips or snaps on to existing eyewear.
  • the non-prescription eyewear or optic can further be comprised of either a light wavelength filtered material or a light wavelength bandpass material.
  • the eyewear or optic can be largely darkened, only allowing the transmission of 20% or less of the light through.
  • the eyewear or optic can be largely darkened, only allowing the transmission of 15% or less of the light through.
  • the eyewear or optic can be largely darkened, only allowing the transmission of 10% or less of the light through. [000511]
  • Such a transmission will cause the pupil of the eye(s) to enlarge fully or slightly. This increase in the size of the pupil(s) then permits a larger area of the retina to be exposed to the light wavelengths that are being transmitted to the eye(s).
  • a defocusing lens can be utilized with the eyewear or optic.
  • a defocusing lens can be housed within the eyewear, attached to the eyewear or optic, or worn behind the eyewear or optic. In most, but not all cases, the defocusing lens is on the backside of the bandpass filter between the filter and the eye of the wearer or user.
  • embodiments can cause the pupil to partially or fully enlarge, thus allowing more of the retina to become exposed to the transmitted light wavelengths. This is especially helpful with blue light wavelengths of 460 nm or greater to 480nm or greater, or 510nm or less, where the blue light wavelength is intended to cause the wearer to become more alert or focused.
  • the pupil of the eye constricts and reduces the amount of retina that is stimulated. It is one of the purposes of the invention to stimulate a larger amount of the retina, thus increasing the amount of dopamine produced.
  • This can be accomplished by way of one or more of: defocused light, reducing or eliminating accommodative pupil constriction by fixating on a distant object, utilizing dim light, utilizing red light when possible, and/or utilizing a bandpass filter thus reducing the overall light transmission by way of allowing only the desired light wavelengths to be transmitted.
  • the bandpass filter can be a single bandpass filter or a double bandpass filter.
  • the filter can be a hybrid filter.
  • a bandpass filter can be an interference filter.
  • the degree of darkness of the sunglasses or treatment glasses can provide one of or more of: scotopic condition, reduced mesopic conditions, and reduced photopic conditions.
  • FIG. 23A shows examples of ocular photo-bio-stimulation disposable (or non-disposable) light wavelength filtered optic eyewear; the disposable eyewear can be made, by way of example only, a darkly tinted or near opaque colored plastic material having plastic or paper arms that are supported by the wearer’s ears, to wear over or around the user’s conventional eyeglasses, if needed. The wearer can look at a distance separated bright light source while wearing the disposable eyewear for a time.
  • Such a bright light source can be one of LED, OLED, iLED, quantum dots, fluorescent, incandescent, sun light, laser, plasma display, TV display, tablet display, cell phone display, computer display, or electronic display.
  • a defocusing lens can be utilized with the eyewear or optic. Such a defocusing lens can be housed within the eyewear, attached to the eyewear or optic, or worn behind the eyewear or optic. In most, but not all cases, the defocusing lens is on the backside of the filter between the filter and the eye of the wearer or user.
  • FIG.23B shows examples of ocular photo-bio-stimulation disposable (or non-disposable) light wavelength filtered optic eyewear;
  • the disposable eyewear can be made, by way of example only, a darkly tinted or near opaque colored plastic material having plastic or paper arms that are supported by the wearer’s ears, to wear over or around the user’s conventional eyeglasses, if needed.
  • the wearer can look at a distance separated bright light source while wearing the disposable eyewear for a time.
  • a bright light source can be one of LED, OLED, iLED, quantum dots, fluorescent, incandescent, sun light, laser, plasma display, TV display, tablet display, cell phone display, computer display, or electronic display.
  • a defocusing lens can be utilized with the eyewear or optic.
  • the embodiment can be eyewear comprising an optic, wherein the eyewear when worn causes the pupil of an eye to enlarge in diameter, wherein the optic transmits light radiation having wavelengths of light within the range of 450nm and 510nm and wherein the optic transmits 40% or less of visible light.
  • Eyewear that comprises side shields can be used to assist in blocking light coming in from the periphery.
  • the optic can comprise a filter or filters.
  • the wavelengths of light that can be transmitted are within the range of 460nm + / - 10nm or 480nm +/- 30nm or 450nm – 520nm.
  • the optic can transmit 30% or less visible light.
  • the optic can transmit 20% or less visible light.
  • the optic can transmit 15% or less of visible light.
  • the optic can transmit 10% or less visible light.
  • the eyewear can be one of: rollable eyewear, clip-on eyewear, disposable eyewear, fit-over eyewear, or flip down or up eyewear.
  • the eyewear can block or filter light from striking the eyes of the wearer by way of the sides and optics of the eyewear.
  • the eyewear can block or filters light from striking the eyes of the wearer by way of the optics of the eyewear.
  • the eyewear can comprise wrap around optics.
  • the optics can have no optical power or can be of plano power.
  • the optics can be non- prescription.
  • the optics can comprise optical power.
  • the eyewear can fit over or in front of prescription optics.
  • eyewear comprises an optic that comprises one or more of a bandpass filter, interference filter, absorption filter, selective wavelengths filter, neutral density filter, and/or notch filter, such that the optic can transmit either light wavelengths within the range of at least one of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or light wavelength and intensity.
  • One or both optic(s) of the eyewear can comprise no optical power (plano).
  • the optic(s) can be comprised of one or more of: ophthalmic plastic, CR 39, Trivex, mid index, high index ophthalmic materials, polycarbonate, or glass. The higher the index the less longitudinal chromatic aberration. By way of example only, CR39 will have less longitudinal chromatic aberration than polycarbonate.
  • a filter can be added to an optic, in this case a lens or lens blank by way of, imbibed, coated, having an absorptive dye intermixed with the lens matrix material, or surface cast.
  • the filter can be added, by one of: an outer layer, a separate filter that is adjacent to the lens or lens blank, and/or a separate filter that is distance separated but in optical alignment with the lens or lens blank.
  • a thin surface cast layer that filters can be placed on the front convex surface of the lens or lens blank.
  • Conventional finishing layers such as, by way of example only, hard scratch resistant coating or an anti-reflective layer or coating can be placed on top of the surface cast layer.
  • a spherical surface cast layer on the front surface works well with the concave surface providing the astigmatic curve and the curve that causes the spherical power to be what is required.
  • Such a concave surface can be fabricated by way of surfacing or free forming.
  • the same surface cast front convex surface can be utilized and the PAL surface can be free formed on the concave surface of the lens, lens blank or semi-finished lens blank.
  • An embodiment can be that of a filtered lens or filtered optic that comprises a surface cast layer.
  • the surface cast layer can provide all or the majority of the filtering effect.
  • the lens or lens blank can provide the UV filtering, while the surface cast layer can provide the remainder of the filtering.
  • the surface cast layer comprises two standard dyes, two notch filters, one IR dye, and one UV absorber.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 40% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 40% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 30% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 40% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 20% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 40% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 40% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 50% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 30% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 50% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 20% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 50% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 40% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 60% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation that comprises a surface cast layer, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 30% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 60% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 30% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 40% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 20% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 40% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 20% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 50% or more.
  • An embodiment can be that of a filtered lens or filtered optic for ocular photo-bio- stimulation, whereby the filtered lens or filtered optic comprises an overall visible light transmission of 40% or less and comprises light transmission through the filtered lens or filtered optic and measured within the range of 450nm – 520nm of 60% or more.
  • a filter or filters is/are applied to the convex side of the lens, lens blank, or semi-finished lens blank.
  • the filter or filters is/are applied to the concave side of the lens, lens blank, or semi-finished lens blank.
  • the filter or filters is/are applied to both sides of the lens, lens blank, or semi-finished lens blank.
  • the filter or filters is/are applied to matrix of the lens, lens blank, or semi-finished lens blank.
  • the filter or filters is/are embedded within the lens, lens blank, or semi-finished lens blank. Still in other embodiments the filter or filters is/are separated and placed in optical alignment with the lens, lens blank or semi-finished lens blank.
  • a filter or filters transmitting predominantly blue light wavelengths can be utilized in the morning hours and a filter or filters transmitting predominantly red-light wavelengths can be utilized in the afternoon hours.
  • This can be accomplished by having an attachable, detachable front piece comprising or housing the bandpass filter that by way of example only, clips on and off or magnetically attaches to the front or sides of the eyewear, or that attaches by way of pressure on the sides of the eyewear, or that attach mechanically to the eyewear. This allows for swapping the bandpass filters based upon the time of day being used or the filter(s) desired.
  • the prescription optic or nonprescription (plano) optic (which can include defocus or that of a separate defocusing optic) is housed or supported by the base frame to which the detachable front piece is releasably attached.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of at least one of, 460nm – 520nm, 450nm – 520nm, 470nm to 520nm, or 480nm +/- 30nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of at least one of 460nm- 520nm, 470nm to 520nm, or 480nm to 520nm. This would include blue, bluish green and green wavelengths. This can be most beneficial when stimulating the production of increased dopamine in the retina of an eye.
  • an embodiment for ocular photo-bio-stimulation can be fit over eyewear that fits over the wearer’s conventional vision correction eyewear.
  • Such an embodiment can comprise: [000542] Lens(es) or optic(s) that transmit predominately wavelengths within the range of, by way of example only, at least one of: 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm or 700nm +/- 30nm, to the retina(s) of the user’s eye(s).
  • Such lens(es) or optic(s) can comprise lens(es) or optic(s) comprising one or more filters, or the one or more filters can be separated and in optical alignment with the lens(es) or optic(s); [000544] Such lens(es) or optic(s) can also comprise a defocusing optic or a light dispersion optic; [000545] Such lens(es) or optic(s) can comprise optical power or no optical power; and/or [000546] Optionally, such lens(es) or optic(s) can comprise plus optical power or minus optical power for generating a defocus to enlarge the area of retina stimulated by the desired ocular photo-bio-stimulation therapy light wavelength(s).
  • Eyewear for ocular photo-bio-stimulation wherein the eyewear fits over conventional eyewear worn by a wearer (see, e.g., FIGs.25a-c), wherein the fit over eyewear predominantly transmits one or more light wavelengths within the range of at least one of: 450 nm – 500 nm, 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm or 700nm+/- 30nm, to the eye(s
  • Embodiments of the above inventive optical system as taught herein attempt to keep the user’s eye pupil diameter as large as possible during treatment of the eye(s) by one or more of the following: 1) user distance viewing fixation – eliminates accommodative pupil constriction, 2) Lower Level of light intensity being transmitted, 3) utilization of a red wavelength light emitter or emitters), and/or 4) utilization of a red-light filter. While the inventive system will work with a mydriatic pharmaceutical, the inventive embodiments have been designed to work without the use of a mydriatic pharmaceutical, too.
  • An embodiment can be eyewear that fits over conventional eyewear worn by a wearer, wherein the fit-over eyewear predominantly transmits one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm+/- 30nm, to the eye(s) of the user, wherein the fit over eyewear comprises a filter or filters, and wherein the conventional eyewear houses lenses for correcting the distance vision needs of the wear
  • the fit-over eyewear can also comprise one or more light emitters.
  • An embodiment can be eyewear that fits over conventional eyewear worn by a wearer, wherein the fit over eyewear predominantly transmits one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm+/- 30nm, to the eye(s) of the user, wherein the fit over eyewear comprises a filter or filters, and wherein the conventional
  • the fit-over eyewear can also comprise one or more light emitters.
  • An embodiment can be eyewear that fits over conventional eyewear worn by a wearer, wherein the fit over eyewear predominantly transmits one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or filters, eyewear of the wearer, and wherein the fit over eyewear comprises a light diffusing lens or optic.
  • the fit-over eyewear can also comprise one or more light emitters.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of 460nm – 520nm or 470nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of 460nm- 520nm or 470nm to 520nm.
  • An embodiment for ocular photo-bio-stimulation can be by way of example only, one of a clip on, magnetic attachable, or pressure attachable eyewear that is attachable and detachable from the wearer’s conventional vision correction eyewear.
  • Such an embodiment can comprise: [000554] Another embodiment includes a second eyewear to be worn by a wearer, wherein the second eyewear when worn is in optical communication with a first eyewear worn by a wearer, wherein the second eyewear comprises a filtered lens or filtered optic, wherein the filtered lens or filtered optic of the second eyewear predominantly transmits at a light wavelength transmission rate of 50% or more within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/
  • Each filtered lens or filtered optic can be comprised of two or more of: filters, absorbing dyes, light absorbers, or any combination thereof.
  • the filtered lens or filtered optic can comprise one or more of: an interference filter, absorption filter, light absorber, neutral density filter, bandpass filter, notch filter, or selective blue light filter.
  • the filtered lens or filtered optic can comprise two or more of interference filter, absorption filter, neutral density filter, bandpass filter, notch filter, or selective blue light filter.
  • the second eyewear can be releasably attachable to the first eyewear.
  • the second eyewear can be clip on eyewear, magnetic attachable eyewear, pressure mounted eyewear, rollable eyewear, or statically attachable eyewear.
  • the filtered lens or filtered optic can comprise a predominant light wavelength transmission that is within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm+/- 30nm, which can be 40% or greater.
  • the filtered lens or filtered optic can increase choroidal thickness and reduce axial elongation of the wearer’s eye.
  • the filtered lens or filtered optic can slow down myopia progression of the wearer’s eye.
  • the filtered lens or filtered optic can comprise a peak light transmission spectral curve that falls within at least one of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm+/- 30nm.
  • the first eyewear lens for correcting the distance vision of the wearer can comprise a central zone for correcting the distance vision needs of the wearer and an increased minus optical power zone peripheral to that of the central zone.
  • the first eyewear lens can comprise optical power or optics that provide peripheral vision defocus.
  • the first eyewear lens can comprise an optical power or optics that provide peripheral vision light diffusion or dispersion.
  • the first eyewear lens can comprise optical power or optics that provide a reduction in peripheral vision contrast seen by the eye of a wearer.
  • the light transmitted by the filtered lens or optic can increase dopamine or serotonin in the wearer’s eye.
  • the light transmitted by the filtered lens or optic increases dopamine or serotonin in the wearer’s brain.
  • the light transmitted by the filtered lens or filtered optic can increase retinal mitochondrial function.
  • the second eyewear can comprise one or more of timer, alarm, or wireless communication.
  • the second eyewear can comprise a biofeedback component.
  • the wearer’s pupil of the second eyewear and the first eyewear can reduce in size absent of wearing the second eyewear and first eyewear when in ambient room light or sunlight.
  • the filtered lens or filtered optic can generate defocused light.
  • the filtered lens or filtered optic can generate dispersed light, diffused light, or light having less image contrast.
  • Such lens(es) or optic(s) can comprise lens(es) or optic(s) comprising one or more filters, or the one or more filters can be separated and in optical alignment with the lens(es) or optic(s); [000561] Such lens(es) or optic(s) can also comprise a defocusing optic or a light dispersion optic; [000562] Such lens(es) or optic(s) can comprise optical power or no optical power; and/or [000563] Optionally, such lens(es) or optic(s) can comprise plus optical power or minus optical power for generating a defocus to enlarge the area of retina stimulated by the desired ocular photo-bio-stimulation therapy light wavelength(s).
  • Ocular photo-bio-stimulation embodiments of the above inventive optical system as taught herein attempt to keep the user’s eye pupil diameter as large as possible during treatment of the eye(s) by one or more of the following; 1) user distance viewing fixation – eliminates accommodative pupil constriction, 2) Lower Level of light intensity being transmitted, 3) utilization of a red wavelength light emitter or emitters), and/or 4) utilization of a red-light filter. While the inventive system will work with a mydriatic pharmaceutical, the inventive embodiments have been designed to work without the use of a mydriatic pharmaceutical, too.
  • An embodiment can be that of eyewear that is attachable to conventional eyewear worn by a wearer/user, wherein the attachable eyewear predominantly transmits one or more light wavelengths within the range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm+/- 30nm, to the eye(s) of the wearer, wherein the fit over eyewear comprises a filter or filters, and wherein the conventional eyewear houses lenses for correcting the
  • a defocusing lens or optic is a lens or optic that causes light to not focus on the retina of the wearer’s eye.
  • dispersed light can be that of defocused light. In certain embodiments it focuses in front of the retina and in other embodiments it focuses behind the retina. And in still other embodiments it never focuses.
  • a defocusing lens can be utilized with a filter.
  • a defocusing lens can comprise a filter.
  • a defocusing lens can be utilized with a bandpass filter.
  • a defocusing lens can comprise a bandpass filter.
  • a defocusing lens can be utilized with an interference filter.
  • a defocusing lens can comprise an interference filter.
  • the multifocal lens can comprise a central zone having optical power that focuses light on the fovea / macular area and a peripheral defocusing zone or zones having plus optical power.
  • the multifocal lens can comprise a central zone of clear vision and a peripheral zone(s) of defocused light.
  • the defocusing optic can be an electronic display.
  • the defocusing optic can be attached to a filter, or distance separated from a filter or a portion of a filter.
  • the multifocal optic can be attached to a filter, or distance separated from a filter or a portion of the filter.
  • a filter is located on the front convex surface of the optic.
  • the filter can be on either surface or buried in between either surface.
  • a lens comprising the desired optical power for correcting the refractive power of the eye of the wearer is located between a filter (which can be on or in an optic) and the front of the eye of the wearer / user.
  • a lens comprising the desired optical power for correcting the refractive power of the eye of the wearer is attached to a filter (which can be on or in an optic) and the front of the eye of the wearer / user.
  • the defocus can be caused by one or more of, of a single vision lens, multifocal lens, light scatter material, prism, applicator attached to lens surface, Fresnel optic, holographic optic, micro-lens array, and/or scratched surface of the optic.
  • the defocusing element(s) can be located off center on or in the optic.
  • the defocusing elements can be located centered on or in the optic.
  • the defocusing elements can be located on or in the periphery of the optic.
  • the defocusing elements can be embedded within the optic.
  • the defocusing elements can be attached to the optic.
  • the defocusing element can be attachable and detachable to the optic.
  • the defocusing elements can be located peripheral to a central zone of the optic.
  • the light defocusing optic can comprise one or more of: a positive power convex lens design, negative power concave lens design, spherocylindrical lens design, prismatic lens design, aspheric lens design, Fresnel lens design, micro-lens array design, nano or micro-structure materials, concentric rings, grooves, scratches, and/or surface curves on the convex or concave side of the optic.
  • the nano or micro-structure materials of a different index of refraction from the optic matrix material can be embedded within the optic matrix.
  • the electrochromic lens zone can be in the lens to coincide where light wavelengths can strike an area of the retina having a concentration of rods.
  • certain electroactive optical materials or material properties cause light to disperse into blue, green and red wavelength bundles.
  • an electroactive liquid crystal layer can cause slight dispersion when electricity is applied and when no electricity is applied the electroactive element returns the lens zone to a clear nondispersive lens zone.
  • the zone can be located around that of the central zone of the lens and at a location that optimizes dispersed light wavelengths of light striking an area of the retina peripheral to the macula having a high concentration of rods.
  • nano or micro-structure particle materials can be used to disperse light. Examples of nano or micro-structure particle materials can be, by way of example only, polycrystalline ceramics like, by example, transparent alumina consisting of birefringent crystals.
  • defocus is causing or having the light rays to be defocused on the retina of the wearer or user of the optic.
  • the optic that creates the defocus can be rotated either manually or automatically.
  • the defocus optic can be rotated by a motor.
  • the rotation can help spread the defocused light wavelengths over the retina painting the retina with the defocused light as the defocused optic is rotated.
  • the optic area of defocus can be from the entire optic.
  • the area of defocus can be from the central zone.
  • the central zone can be 9mm, 10mm, or 11mm in diameter.
  • the defocus can be from the peripheral zone of the optic.
  • the peripheral zone can be any area outside of the central zone.
  • defocus means the light rays do not focus to a point on the retina of the eye of the user. In certain embodiments the light rays focus in front of the retina.
  • any of the eyewear, lamp, electronic display, and/or lighting embodiments disclosed herein, including those comprising a bandpass filter, can also comprise a neutral density filter.
  • a neutral density filter in addition to a band pass filter it is possible to adjust the light intensity transmission of the transmitted wavelengths to provide for an enlargement of the pupil(s) of the wearer.
  • the neutral density filter can be separate from the bandpass filter.
  • the neutral density filter can be built into the bandpass filter.
  • the neutral density filter can be attached to the bandpass filter.
  • the neutral density filter can be integral with the bandpass filter.
  • Utilizing a neutral density filter is important when the intensity of the light that is being transmitted by the optic exceeds a threshold where it constricts the pupil of the eye of the wearer or user of the optic.
  • Embodiments disclosed herein prefer for the pupil of the eye to be as large as possible when the desired light wavelengths are being exposed to the retina.
  • the pupil(s) of the eye(s) of the wearer or user of the lens or optic would be 3mm or larger in diameter.
  • the pupil(s) of the eye of the wearer or user of the lens or optic would be 4mm or larger in diameter.
  • the pupil(s) of the eye(s) of the wearer or user of the optic would be 5mm or larger in diameter.
  • the light source providing wavelengths of light within the range of light wavelengths of 480nm +/- 30nm, 450nm – 520nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm or 600nm – 700nm, or 700nm +/- 30nm, can be moved relative to one of the eye, cornea, or pupil of the subject whose retina is being exposed to such light wavelengths, or the eye, cornea, or pupil of the subject can be moved relative to the light
  • Ocular photo-bio-stimulation eyewear can be that of wrap around eyewear.
  • Ocular photo-bio stimulation eyewear can comprise side shields for the purposes of blocking peripheral light rays.
  • Another embodiment can be that of a wearable eyewear device comprising a filtered lens or filtered optic, wherein the filtered lens or filtered optic provides a light transmission rate of 40% or more, 50% or more, or 60% or more, of ocular photo-bio-stimulation light through and measured within a light wavelength range of at least one of: 480nm +/-30nm or 500nm +/- 20nm to an eye of a wearer of the wearable eyewear device, and wherein the filtered lens or filtered optic further provides an overall visible light transmission rate of 50% or less, 40% or less, or 30% or less.
  • a wearable eyewear device comprising a filtered lens or filtered optic, wherein the filtered lens or filtered optic provides a light transmission rate of 40% or more, 50% or more, or 60% or more, of ocular photo-bio-stimulation light through and measured within light wavelength ranges of a combination of 450nm +/- 30nm, 450nm – 520nm, and/or 580nm +/-20nm, to an eye of a wearer of the wearable eyewear device,
  • Such a lens can be designed to have a purplish color.
  • a wearable eyewear device comprising a filtered lens or filtered optic, wherein the filtered lens or filtered optic provides a light transmission rate of 40% or more, 50% or more, or 60% or more, of ocular photo-bio-stimulation light through and measured within light wavelength ranges of a combination of 450nm +/- 30nm, 450nm – 520nm, 550nm +/- 30nm, and/or 650nm +/-30nm, to an eye of a wearer of the wearable eyewear device, and wherein the filtered lens or filtered optic further provides an overall visible light transmission rate of 50% or less, 40% or less, or 30% or less.
  • Another embodiment can be that of a wearable eyewear device comprising a filtered lens or filtered optic, wherein the filtered lens or filtered optic provides a light transmission rate of 50% or more or 60% or more of ocular photo-bio-stimulation light through and measured within a light wavelength range of 700nm +/- 30nm to an eye of a wearer of the wearable eyewear device, and wherein the filtered lens or filtered optic further provides an overall visible light transmission rate of 50% or less, 40% or less, or 30% or less.
  • the filtered lens or filtered optic can comprise optical power or can be plano (devoid of optical power).
  • the overall visible light transmission through the filtered lens or filtered optic and an eyeglass lens is 40% or less or 30% or less.
  • the wearable eyewear device can be utilized in association with a light source, wherein the light source has an intensity of 2,000 lux or greater, and wherein a transmission intensity of light is within a wavelength range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of 460nm – 520nm or 470nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of 460nm- 520nm, 470nm to 520nm, or 480nm – 520nm.
  • This would include blue, bluish green and green wavelengths. This can be most beneficial when stimulating the production of increased dopamine in the retina of an eye. This can be most beneficial when stimulating the production of increased dopamine in a brain by way of stimulating the retina of an eye.
  • the lenslets can be comprised of -0.35D to -5.00D negative power.
  • the lenslets can be aspheric.
  • the defocus zone can be comprised of a microlens array.
  • the defocus zone can be comprised of optical power steps.
  • the defocus zone can be comprised of light scatter elements.
  • the defocus zone can be comprised of liquid crystal.
  • the liquid crystal can switch on and off by way of an electrical potential change. Such a defocus can be that of either light scatter or a change in the refractive optical power of the lens’ defocus zone.
  • the liquid crystal can be switched to increase or decrease optical power.
  • the liquid crystal can be switched to cause light scatter.
  • the liquid crystal can be switched to eliminate most or all of the light scatter or to eliminate any change of optical power.
  • the lens By utilizing a switchable liquid crystal defocus zone, the lens can provide the desired level of ocular photo-bio-stimulation which can then be turned on or off as needed.
  • the ability to electrically switch liquid crystal for that of optical power generation or light scattering is known in the art. [000611] In reference to FIG.
  • a photo-bio-stimulation filtered defocused lens which can be a lens that comprises: a central zone for correcting distance focus for the wearer and small enough to establish an effective functional zone; a selected fill factor to deliver high efficacy while preserving good wearability; a central zone of 4mm – 6mm; and added surface power within the range of +0.50D to +3.50D or -0.35D to -5.00D; and [000612]
  • the filtering can predominantly transmit light wavelengths within the range of light wavelengths of one or more of the following, 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +//- 30n
  • a photo-bio-stimulation lens can filter and predominantly transmit light wavelengths within the range of light wavelengths of one or more of the following, 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 600nm – 700nm, or 700 nm+/- 30nm, while at the same time filtering and blocking wavelengths within the range of light wavelengths of one or more of: 449nm – 421nm and 419nm,
  • the overall light transmission through the filtered optic or filtered lens can be 50% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 50% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the overall light transmission through the filtered optic or filtered lens can be 40% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 40% or more.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of at least one of 460nm – 520nm or 470nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of at least one of 460nm- 520nm, 470nm to 520nm, or 480 nm to 520nm.
  • a photo-bio-stimulation filtered defocused lens which can be a lens that comprises: A spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology; a central optical zone (9mm ⁇ ) for correcting distance refractive error of the wearer, and surrounding treatment zone with honeycomb array of lenslets (each 1.03mm).
  • the lenslets have a relative positive power within the range of +0.50D to +3.50D.
  • the filtered lens can predominantly transmit light wavelengths within the range of light wavelengths of one or more of the following, 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 600nm – 700nm, or 700nm+/- 30nm, while at the same time filtering and blocking wavelengths within the range of light wavelengths of one or more of: 449nm – 421nm and 419nm – 400nm
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of at least one of 460nm – 520nm, 470nm to 520nm, or 480nm – 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of at least one o, 460nm- 520nm, 470nm to 520nm, or 480nm – 520nm.
  • a photo-bio-stimulation filtered defocused lens which can be a lens that comprises: a spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology; a central optical zone (9mm ⁇ ) for correcting distance refractive error of the wearer, and intermediate treatment zone with honeycomb micro-lens array of lenslets (each 1.03mm ⁇ ).
  • the lenslets have a relative positive power within the range of +0.50D to +3.50D or -0.35D to -5.00D. There are spaces between the lenslets where the single vision correction is accessible.
  • the filtered lens can predominantly transmit light wavelengths within the range of light wavelengths of one or more of the following 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 600nm – 700nm, or 700 nm+/- 30nm, while at the same time filtering and blocking wavelengths within the range of light wavelengths of one or more of: 449nm – 421nm and 419nm – 400nm.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of one of, 460nm – 520nm, 470nm to 520nm, or 480nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of one of 460nm- 520nm, 470nm to 520nm, or 480nm to 520nm.
  • the defocus zone can be comprised of minus optical power.
  • the defocus zone can be comprised of minus optical power being more minus optical power or less plus optical power than the central zone’s optical power.
  • the minus of optical power increase over that of the central zone’s optical power can be within the range of -0.35D to -5.00D.
  • Such a lens can comprise a downward channel or zone of increasing positive optical power offsetting some or all of the added minus power.
  • Such a downward channel can connect to a reading zone of increased positive optical power within the range of +1.00D to +3.25D over that of the central zone’s optical power.
  • the lenslets can be comprised of -0.35D to -5.00D negative power.
  • the lenslets can be aspheric.
  • the defocus zone can be comprised of a microlens array.
  • the defocus zone can be comprised of optical power steps.
  • the defocus zone can be comprised of light scatter elements.
  • the defocus zone can be comprised of liquid crystal.
  • the liquid crystal can switch on and off by way of an electrical potential change. Such a defocus can be that of either light scatter or a change in the refractive optical power of the lens’ defocus zone.
  • the liquid crystal can be switched to increase or decrease optical power.
  • the liquid crystal can be switched to cause light scatter.
  • the liquid crystal can be switched to eliminate most or all of the light scatter or to eliminate any change of optical power.
  • the lens can provide the desired level of ocular photo-bio-stimulation which can then be turned on or off as needed.
  • An embodiment can be that of a lens or optic for ocular photo-bio-stimulation, wherein the lens or optic comprises a central zone and a zone of defocus, wherein the zone of defocus is peripheral to the central zone, wherein the zone of defocus is comprised of liquid crystal, wherein the defocus is one of optical defocus, light scattering, or light dispersion, wherein the liquid crystal can be switched on or off to remove defocus or provide peripheral defocus, and wherein the central zone of the lens remains capable of providing a wearer with clear distance vision.
  • An embodiment can be that of a lens or optic for ocular photo-bio-stimulation, wherein the lens or optic comprises a central zone and a zone of defocus, wherein the zone of defocus is peripheral to the central zone, wherein the lens or optic is that of a filtered lens or optic, and wherein the lens or optic predominantly transmits light wavelengths within the wavelength range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700
  • the defocus can be that of either an optical power defocus or light scattering or light dispersion.
  • lenslets When lenslets cause an optical power defocus, such lenslets can be of optical power within the optical power range of +0.35D to +5.00D or – 0.35D to -5.00D.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens, that predominantly transmits within the wavelength range of one of 460nm – 520nm, 470nm to 520nm, or 480 to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of one of, 460nm- 520nm, 470nm to 520nm, or 480nm to 520nm. This would include blue, bluish green and green wavelengths. This can be most beneficial when stimulating the production of increased dopamine in the retina of an eye. This can be most beneficial when stimulating the production of increased dopamine in a brain by way of stimulating the retina of an eye.
  • An embodiment can be that of a lens or optic for ocular photo-bio-stimulation, wherein the lens or optic comprises a central zone and a zone of defocus, wherein the zone of defocus is peripheral to the central zone, wherein the lens or optic further comprises an add power zone comprised of an increased positive optical power compared to one of the lens’ or optic’s peripheral zone or the central zone.
  • the defocus can be that of either an optical power defocus or light scattering or light dispersion.
  • lenslets cause an optical power defocus, such lenslets can be of optical power within the optical power range of +0.35D to +5.00D or – 0.35D to -5.00D.
  • a photo-bio-stimulation filtered defocused lens can be a lens that comprises: a spectacle lens for myopia correction and control with Highly Aspherical Lenslet Target (H.A.L.T.) Technology; a central optical zone (9mm) for correcting distance refractive error of the wearer, with surrounding myopia control zone incorporating 1021 contiguous (touching) highly aspherical lenslets (each 1.12mm ⁇ ). Each lenslet does not have a single focal power, instead creating a 'volume of defocus' as a slow-down signal for eye growth.
  • Each of the 11 rings (or more or less rings) of lenslets features contiguous lenslets of similar asphericity, with successive rings having lenslets with different asphericities.
  • a photo-bio- stimulation filtered defocused lens can be a lens that comprises: a spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology; a central optical zone (9mm ⁇ ) for correcting distance refractive error of the wearer, and surrounding treatment zone with honeycomb array of lenslets (each 1.03mm).
  • the lenslets have a relative positive power within the range of -0.35D to -5.00D.
  • a photo-bio-stimulation filtered defocused lens can be a lens that comprises: a spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology; a central optical zone (9mm ⁇ ) for correcting distance refractive error of the wearer, and intermediate treatment zone with honeycomb array of lenslets (each 1.03mm ⁇ ).
  • the lenslets have a relative power within the range of -0.35D to -5.00D. There are spaces between the lenslets where the single vision correction is accessible.
  • another embodiment of a photo-bio-stimulation filtered defocused lens can be a lens that comprises: a spectacle lens for myopia correction and control with Defocus Incorporated Multiple Segments (DIMS) Technology; a central optical zone (9mm ⁇ ) for correcting distance refractive error of the wearer, and intermediate treatment zone with honeycomb micro-lens array of lenslets (each 1.03mm).
  • the lenslets have a relative positive power within the range of -0.35D to -5.00D. There are spaces between the lenslets where the single vision correction is accessible.
  • the embodiment further comprises a downward channel of increasing plus optical power or reducing minus optical power.
  • myopia control lenses can be utilized in combination with ocular photo-bio-stimulation therapy.
  • Such ocular photo-bio-stimulation can be with light wavelengths within the range of: 480nm +/- 30nm, 530nm +/- 20nm, and/or 650nm +/- 30nm.
  • Such ocular photo-bio-stimulation therapy can be applied while the subject or patient is wearing their myopia control lenses. This causes the light from the ocular photo-bio-stimulation light source to be spread across the eye’s retina of the subject or patient wearing the myopia control lens or lenses, stimulating the production of retinal dopamine.
  • the ocular photo-bio-stimulation therapy can be applied or provided to the subject or patient once or multiple times per day.
  • an invisible spectral flickering can occur.
  • the ocular photo-bio-modulation light source can be modulated within the ranges between blue (450nm – 495nm) and bluish green / cyan (495nm – 520nm).
  • the ocular photo-bio- modulation light source can be modulated within the ranges between blue (450nm – 495nm) and green (495nm- 570nm).
  • the ocular photo-bio-stimulation light can then stimulate dopamine, serotonin, or norepinephrine in the brain.
  • the front surface convex curve of the lens is preset when producing a lens blank and the back concave surface is fabricated to provide the proper optical powers.
  • the back surface concave curve of the lens is preset when producing a lens blank and the front convex surface is fabricated to provide the proper optical powers.
  • the back surface concave curve of the lens and the front convex surface are fabricated to provide the proper optical powers.
  • the peripheral zone optical power can be an increase in minus optical power compared to the central zone.
  • This needed increase in minus optical power or decreased plus optical power can be a constant depending upon the material type comprised by the chromatic aberration focused lens.
  • polycarbonate with an abbe of 30, a refractive index of 1.59, and a center thickness of 1.5mm will provide one constant number of increased minus or decreased plus optical power in the peripheral region of a chromatic aberration focused lens for most if not all optical powers.
  • CR39 with an abbe of 58, a refractive index of 1.49, and a center thickness of 2.0 mm will provide a different one constant number of increased minus or decreased plus optical power in the peripheral region of a chromatic aberration focused lens for most if not all optical powers.
  • An embodiment can be that of a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits a higher percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage(VLT) within the range of 380nm – 780nm to qualify for category 2 or category 3 sunglasses and further passes the ISO 12312-1 sunglass traffic light/signal test.
  • VLT average visible light transmission percentage
  • An embodiment can be that of a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits a higher percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage (VLT) within the range of 380nm – 780nm and passes the ISO 12312-1 sunglass traffic light/signal test with a red transmittance of 8% or greater, yellow transmittance of 6% or greater, and green transmittance of 6% or greater.
  • VLT visible light transmission percentage
  • An embodiment can be that of a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits a higher percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage (VLT) within the range of 380nm – 780nm to qualify for category 2 or category 3 sunglasses and further passes the ISO 12312-1 sunglass traffic light/signal test with a red transmittance of 8% or greater, yellow transmittance of 6% or greater, and green transmittance of 6% or greater.
  • VLT average visible light transmission percentage
  • An embodiment can be a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits 40% or greater percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage (VLT) within the range of 380nm – 780nm to qualify for category 2 or category 3 sunglasses and further passes the ANSI sunglass standards for Traffic Signals.
  • VLT average visible light transmission percentage
  • An embodiment can be a filtered lens or filtered optic or sunglass lens or sunglass optic that transmits 40% or greater percentage of blue light and bluish green light wavelengths within the wavelength range of one or more of 480nm +/- 30nm or 530nm +/- 20nm than the lens or optic comprises an average visible light transmission percentage (VLT) within the range of 380nm – 780nm to qualify for category 3 sunglasses and further passes ANSI sunglass standards for Traffic Signals.
  • VLT visible light transmission percentage
  • the blended light wavelengths of the light emitter(s) and also the ambient light comprises wavelengths of light that strike the eye’s retina fall within one of the wavelength ranges of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm or 700nm+/- 30nm.
  • the overall light transmission through the filtered optic or filtered lens can be 50% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 50% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the eye’s retina is exposed to blue light within the range of 450nm to 530nm, preferably 480 nm +/- 20 nm, the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered optic to have maximum vison clarity. However, in certain embodiments it is more important to provide ocular photo-bio-stimulation as opposed to maximum vision clarity. In these embodiments it is necessary to trick the wearer’s retinal neurological feedback that causes the pupil to constrict while still providing blue light within the range of 450nm – 530nm, preferably 480nm +/- 20nm, to strike the wearer’s / user’s retina.
  • the light source can modulate between (by way of example only, a black image and blue image comprised of light wavelengths within the range of 450 nm – 530 nm).
  • a black image and blue image comprised of light wavelengths within the range of 450 nm – 530 nm.
  • the pupil increases in size and then, when the blue wavelengths within the range of 450nm – 530nm become visible, the pupil constricts.
  • An embodiment can be an eyewear apparatus worn by a wearer comprising a filtered lens or filtered optic, wherein the filtered lens or filtered optic of the eyewear apparatus transmits light at a light wavelength transmission rate of 50% or more within a light wavelength range of at least one of: 480nm +/-30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm, to an eye of the wearer, and wherein the filtered lens or filtered optic of the eyewear
  • the overall light transmission through the filtered optic or filtered lens can be 40% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 40% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the eye’s retina is exposed to blue light within the range of 450nm to 530nm, preferably 480 nm +/- 20 nm, the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered optic to have maximum or improved vison clarity. However, in certain embodiments it is more important to provide ocular photo-bio-stimulation as opposed to maximum vision clarity. In these embodiments it is necessary to trick the wearer’s retinal neurological feedback that causes the pupil to constrict while still providing blue light within the range of 450nm – 530nm, preferably 480nm +/- 20nm to strike the wearer’s / user’s retina.
  • the overall light transmission through the filtered optic or filtered lens can be 30% of less, while the light transmission within the predominant transmitted wavelength range being transmitted to the eye can be 40% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the eye’s retina is exposed to blue light within the range of 450nm to 530nm, preferably 480 nm +/- 20 nm, the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered optic to have maximum vison clarity. However, in certain embodiments it is more important to provide ocular photo-bio-stimulation as opposed to maximum vision clarity. In these embodiments it is necessary to trick the wearer’s retinal neurological feedback that causes the pupil to constrict while still providing blue light within the range of 450nm – 530nm, preferably 480nm +/- 20nm to strike the wearer’s / user’s retina.
  • VLT Visible light transmission
  • FIG. 44 there are 5 sunglass categories of VLT. Sunglasses that fall within categories 2 and 3 are the most popular sunglasses. Category 2 transmits visible light between 18% - 43%. Categories, such as categories 3 or 4 filter or block most blue light wavelengths.
  • FIG. 45 most sunglass manufacturers lead their marketing by providing information on how much blue light is filtered or blocked with their sunglasses.
  • sunglasses that fit within categories 3, 4 and 5 provide substantial vision and ocular protection. However, given that they block or filter most blue light and transmit so little, they actually inhibit the production of dopamine in the eye of the wearer and possibly serotonin and dopamine in the brain of the wearer while being worn. This is true of all sunglasses that transmit 43% or less visible light wavelengths including those that are polarized or photochromatic. [000732] In reference to FIG.
  • sunglasses having an overall visible light transmission of 40% or less visible light while transmitting 41% or more blue light wavelengths within the range of 480nm +/- 30nm, and, in addition, that pass color transmission standards / requirements so to be able to permit the wearer to drive and properly identify the colors red and green, by way of example only, on a red light.
  • Sunglasses having a 41% or greater transmission within the wavelength range of 480nm +/- 30nm would transmit enough of the light wavelengths that are known to stimulate dopamine in the eye’s retina and in the brain of the wearer. This then could be most beneficial for individuals suffering from dopamine deficiency disorder.
  • Sunglasses having a 41% or greater transmission within the wavelength range of 650nm +/- 30nm would transmit enough of the light wavelengths that are known to stimulate dopamine in the eye’s retina and in the brain of the wearer. This then could be most beneficial for individuals suffering from dopamine deficiency disorder.
  • a sunglass lens or optic comprises two or more absorptive dyes, wherein one or more of the absorptive dyes filters or blocks light wavelengths within the range of 450nm downward to 400nm or lower, and one or more absorptive dyes that filter or block light wavelengths within the range of 490nn upward to 700nm or greater, and wherein the light transmission within the range of wavelengths of 450nm and 490nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more absorptive dyes can be imbibed into the surface or a surface coating of the lens or optic.
  • One or more absorptive dyes can be coated on one of the surfaces of the lens or optic.
  • One or more absorptive dyes can be imbibed or coated on the convex surface of the lens or optic.
  • One or more absorptive dyes can be imbibed or coated on the concave surface of the lens or optic.
  • One or more dyes can be incorporated within a surface cast layer that is applied or bonded to one or both surfaces of the lens or optic.
  • a sunglass lens or optic comprises two or more absorptive dyes, wherein one or more of the absorptive dyes filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more absorptive dyes filter or block light wavelengths within the range of 500nn upward to 700nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more absorptive dyes can be imbibed into the surface or a surface coating of the lens or optic.
  • One or more absorptive dyes can be coated on one of the surfaces of the lens or optic.
  • One or more absorptive dyes can be imbibed or coated on the convex surface of the lens or optic.
  • One or more absorptive dyes can be imbibed or coated on the concave surface of the lens or optic.
  • One or more dyes can be incorporated within a surface cast layer that is applied or bonded to one or both surfaces of the lens or optic.
  • a sunglass lens or optic comprises two or more absorptive dyes, wherein one or more of the absorptive dyes filters or blocks light wavelengths within the range of 450nm downward to 400nm or lower, and one or more absorptive dyes filter or block light wavelengths within the range of 490nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 450nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more absorptive dyes can be imbibed into the surface or a surface coating of the lens or optic.
  • a sunglass lens or optic comprises two or more absorptive dyes, wherein one or more of the absorptive dyes filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more absorptive dyes filter or block light wavelengths within the range of 500nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more absorptive dyes can be imbibed into the surface or a surface coating of the lens or optic.
  • One or more absorptive dyes can be coated on one of the surfaces of the lens or optic.
  • a sunglass lens or optic comprises two or more absorptive coatings, wherein one or more of the absorptive coatings filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more absorptive coatings filter or block light wavelengths within the range of 500nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more absorptive coatings can be coated on one of the surfaces of the lens or optic.
  • One or more absorptive coatings can be coated on the convex surface of the lens or optic.
  • One or more reflective coatings can be coated on one of the surfaces of the lens or optic.
  • One or more reflective coatings can be coated on the convex surface of the lens or optic.
  • One or more reflective coatings can be coated on the concave surface of the lens or optic.
  • the coating(s) can be coated by vacuum deposition.
  • the coating(s) can be coated by spin coating.
  • the coating(s) can be coated by surface cast coating or molding.
  • a sunglass lens or optic comprises two or more reflective coatings, wherein one or more of the reflective coatings filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more reflective coatings filter or block light wavelengths within the range of 500nn upward to 700nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings can be coated on one of the surfaces of the lens or optic.
  • One or more reflective coatings can be coated on the convex surface of the lens or optic.
  • One or more reflective coatings can be coated on the concave surface of the lens or optic.
  • a sunglass lens or optic comprises two or more reflective coatings, wherein one or more of the reflective coatings filters or blocks light wavelengths within the range of 450nm downward to 400nm or lower, and one or more reflective coatings filter or block light wavelengths within the range of 490nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 450nm and 490nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings can be coating on one of the surfaces of the lens or optic.
  • One or more reflective coatings can be coated on the convex surface of the lens or optic.
  • One or more reflective coatings can be coated on the concave surface of the lens or optic.
  • the coating(s) can be coated by vacuum deposition.
  • the coating(s) can be coated by spin coating.
  • the coating(s) can be coated by surface cast coating or molding.
  • a sunglass lens or optic comprises two or more reflective coatings, wherein one or more of the reflective coatings filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more reflective coatings filter or block light wavelengths within the range of 500nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings can be coated on the surface of the lens or optic.
  • One or more reflective coatings can be coated on the convex surface of the lens or optic.
  • One or more reflective coatings can be coated on the concave surface of the lens or optic.
  • a sunglass lens or optic comprises two or more reflective, or absorptive coatings and / or absorptive dyes, wherein one or more of the reflective coatings or absorptive coatings and / or absorptive dyes filters or blocks light wavelengths within the range of 450nm downward to 400nm or lower, and one or more reflective coatings or absorptive coatings and / or absorptive dyes filter or block light wavelengths within the range of 490nn upward to 700nm or greater, and wherein the light transmission within the range of wavelengths of 450nm and 490nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated and / or imbibed on a surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated and / or imbibed on the convex surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated and / or imbibed on the concave surface of the lens or optic.
  • the coating(s) can be coated by vacuum deposition.
  • the coating(s) can be coated by spin coating.
  • the coating(s) can be coated by surface casting.
  • a sunglass lens or optic comprises two or more reflective coatings or absorptive coatings and / or absorptive dyes, wherein one or more of the reflective coatings or absorptive coatings and / or absorptive dyes filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more reflective coatings or absorptive coatings and / or absorptive dyes filter or block light wavelengths within the range of 500nn upward to 700nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated on a surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on the convex surface of the lens or optic.
  • One or more reflective coatings can be coated or imbibed on the concave surface of the lens or optic.
  • the coating(s) can be coated by vacuum deposition.
  • the coating(s) can be coated by spin coating.
  • the coating(s) can be coated by surface casting.
  • the dyes(can) can be imbibed by use of a heat bath.
  • a sunglass lens or optic comprises two or more reflective coatings or absorptive coatings and / or absorptive dyes, wherein one or more of the reflective coatings or absorptive coatings and / or absorptive dyes filters or blocks light wavelengths within the range of 450nm downward to 400nm or lower, and one or more reflective coatings or absorptive coatings and / or absorptive dyes filter or block light wavelengths within the range of 490nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 450nm and 490nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on a surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on the convex surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on the concave surface of the lens or optic.
  • the coating(s) can be coated by vacuum deposition.
  • the coating(s) can be coated by spin coating.
  • the coating(s) can be coated by surface casting.
  • the dyes(can) can be imbibed by use of a heat bath.
  • a sunglass lens or optic comprises two or more reflective coatings, or absorptive coatings and / or absorptive dyes, wherein one or more of the reflective coatings, or absorptive coatings and / or absorptive dyes, filters or blocks light wavelengths within the range of 440nm downward to 400nm or lower, and one or more reflective coatings or absorptive coatings and / or absorptive dyes filter or block light wavelengths within the range of 500nn upward to 650nm or greater, and wherein the light transmission within the range of wavelengths of 440nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on the surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on the convex surface of the lens or optic.
  • One or more reflective coatings or absorptive coatings and / or absorptive dyes can be coated or imbibed on the concave surface of the lens or optic.
  • the coating(s) can be coated by vacuum deposition.
  • the coating(s) can be coated by spin coating.
  • the dyes(can) can be imbibed by use of a heat bath.
  • the coating(s) can be coated by surface cast coating or molding.
  • An embodiment as described herein is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 440nm and 490nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • the sunglass lens can comprise an absorptive filter.
  • the sunglass lens can comprise one or more reflective filters.
  • the sunglass lens can comprise one or more interference filters.
  • the sunglass lens can comprise one or more neutral density filters.
  • An embodiment as described herein is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 450nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • the sunglass lens can comprise an absorptive filter.
  • the sunglass lens can comprise one or more reflective filters.
  • the sunglass lens can comprise one or more interference filters.
  • the sunglass lens can comprise one or more neutral density filters.
  • An embodiment as described herein is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 460nm and 500nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • the sunglass lens can comprise an absorptive filter.
  • the sunglass lens can comprise one or more reflective filters.
  • the sunglass lens can comprise one or more interference filters.
  • the sunglass lens can comprise one or more neutral density filters.
  • the sunglass lens can comprise one or more reflective filters.
  • the sunglass lens can comprise one or more interference filters.
  • the sunglass lens can comprise one or more neutral density filters.
  • An embodiment as described herein is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • the sunglass lens can comprise an absorptive filter.
  • the sunglass lens can comprise one or more reflective filters.
  • the sunglass lens can comprise one or more interference filters.
  • the sunglass lens can comprise one or more neutral density filters.
  • Ocular photo-bio-stimulation sunglasses can be a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 440nm and 490nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 450nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 460nm and 510nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 475nm +/- 20nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 475nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 30% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the wherein the overall light visible transmission of the sunglass lens is 25% or less.
  • Ocular photo-bio-stimulation sunglasses can be a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 470nm and 520nm is 40% or more, and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment includes a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm and 520nm is 40% or more, and the overall visible light transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 490nm and 520nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 500nm +/- 20nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 490nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the visible light transmission within the range of wavelengths of 470nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • Ocular photo-bio-stimulation sunglasses can be a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more, and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment includes a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more, and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the visible light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 480nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 25% or less.
  • Ocular photo-bio-stimulation sunglasses can be a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more, and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment includes a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more, and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the visible light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 500nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 25% or less.
  • Ocular photo-bio-stimulation sunglasses can be a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more, and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment includes a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more, and the overall visible light transmission of the sunglass lens is 35% or less.
  • a sunglass lens or optic wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm+/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more and the overall light visible transmission of the sunglass lens is 35% or less.
  • Another embodiment is a sunglass lens or optic, wherein the visible light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 25% or less.
  • Another embodiment is a sunglass lens or optic, wherein the light transmission within the range of wavelengths of 650nm +/- 30nm or 700nm +/- 30nm is 40% or more and the overall visible light transmission of the sunglass lens is 20% or less.
  • another embodiment is that of a sunglass lens or optic, wherein the sunglass lens comprises two wavelength peaks of transmission, wherein one wavelength peak of transmission is within the wavelength range of 480nm +/- 30nm and a second wavelength peak of transmission is within the wavelength range of 650nm+/- 30nm or 700nm+/- 30nm, and wherein the light transmission of each peak is 40% or greater and wherein the overall visible light transmission of the sunglass lens is 40% or less.
  • Another embodiment is one wherein one wavelength peak of transmission is within the wavelength range of 480nm +/- 30nm and a second wavelength peak of transmission is within the wavelength range of 650nm+/- 30nm or 700nm+/- 30nm, and wherein the light transmission of each peak is 40% or greater and wherein the overall visible light transmission of the sunglass lens is 30% or less.
  • Another embodiment is wherein one wavelength peak of transmission is within the wavelength range of 480nm +/- 30nm and a second wavelength peak of transmission is within the wavelength range of 650nm+/- 30nm or 700nm+/- 30nm, and wherein the light transmission of each peak is 50% or greater and wherein the overall visible light transmission of the sunglass lens is 40% or less.
  • sunglass lens or optic comprises a peak of visible wavelength transmission, wherein the visible wavelength peak of transmission is within the wavelength range of 480nm +/- 30nm, and wherein the transmission peak of the wavelengths within the range of 480nm +/- 30nm is 40% or greater.
  • Additional embodiments include: A sunglass lens or sunglass optic, wherein the sunglass lens or sunglass optic provides light transmission of 40% or 50% or more of ocular photo- bio-stimulation light measured within a light wavelength range of 450nm – 510nm to an eye of a wearer of the sunglass lens or sunglass optic, wherein a light transmission curve spectra of the sunglass lens or sunglass optic when superimposed on a light absorption curve spectra of melanopsin and rhodopsin covers 50% or more or 75% or more of the melanopsin and rhodopsin absorption curve spectra, and wherein an overall visible light transmission of the sunglass lens or sunglass optic is 30% or less.
  • the sunglass lens or sunglass optic can comprise a peak visible light transmission within 540nm to 750nmnm that, in aspects, never exceeds 30%.
  • the sunglass lens or sunglass optic can be supported or housed by at least one of: eyewear, fit over eyewear, disposable eyewear, a helmet, augmented reality, virtual reality, mixed reality, modified reality, contact lens, an intraocular lens, a corneal implant, or sunglasses.
  • the sunglass lens or sunglass optic can transmit light having an intensity of 350 lux or greater.
  • the sunglass lens or sunglass optic can provide ocular photo-bio-stimulation light that includes a wavelength range of 450nm – 510nm, and wherein the ocular photo-bio-stimulation light including the wavelength range of 450nm-510nm stimulates a production of dopamine in the eye of the wearer.
  • the sunglass lens or sunglass optic can provide ocular photo-bio-stimulation light includes a wavelength range of 450nm – 510nm, and wherein the ocular photo-bio-stimulation light including the wavelength rage of 450nm – 510nm stimulates a production of dopamine or serotonin in a brain of the wearer.
  • the sunglass lens or sunglass optic can comprise a surface cast layer that filters light.
  • the sunglass lens or sunglass optic can comprise a lens matrix or optics matrix that filters or blocks ultraviolet light and / or is imbibed with a dye or light absorber.
  • the sunglass lens or sunglass optic can comprise one or more of: an interference filter, an absorption filter, a light absorber, dye, a neutral density filter, a bandpass filter, a notch filter, or a selective blue light filter.
  • the sunglass lens or sunglass optic can comprise an optical power, including plano optical power.
  • the filtered tint of the sunglass lens or sunglass optic can be fixed or constant.
  • the sunglass lens or sunglass optic can transmit 400 lux or more, or 500 lux or more within a range of 450nm – 510nm when worn in sunlight throughout a day from morning daylight until early sunset.
  • the sunglass lens or sunglass optic can provide a light transmission of 40% or more of ocular photo-bio-stimulation light measured over a range in excess of 30 nanometers within 450nm to 510nm or 450nm to 520nm to an eye of a wearer of the sunglass lens or sunglass optic, and the sunglass lens or sunglass optic can further provide an overall visible light transmission percentage of less than 40%.
  • a light transmission curve spectrum of the sunglass lens or sunglass optic within the range of 450nm – 510nm can overlap with a majority of light absorption curves spectra of melanopsin and rhodopsin.
  • the sunglass lens or sunglass optic can transmit light through the sunglass lens or sunglass optic within a wavelength range of 450nm – 510nm having an intensity of 350 lux or greater.
  • the sunglass lens or sunglass optic can comprise light transmission of 40% or more ocular photo-bio-stimulation light within the wavelength range of 450nm – 510nm stimulates production of dopamine in the eye of the wearer or a brain of the wearer.
  • the sunglass lens or sunglass optic can comprise a surface cast layer that filters light.
  • the sunglass lens or sunglass optic can comprise a lens matrix or optic matrix that filters or blocks ultraviolet light, and / or wherein the sunglass lens or sunglass optic is imbibed with a dye or light absorber.
  • the sunglass lens or sunglass optic can comprise an optical power, including plano optical power.
  • the sunglass lens or sunglass optic can be classified as a category 2 sunglass.
  • the sunglass lens or sunglass optic can be classified as a category 3 sunglass.
  • the sunglass lens or sunglass optic can provide an overall visible light transmission of 30% or less, wherein the sunglass lens or optic comprises light transmission within a range of 450nm – 510nm of 50% or greater, wherein when the sunglass lens or sunglass optic when worn by a wearer in sunlight of 20,000 lux or more, the sunglass lens or sunglass optic is capable of transmitting 400 lux or more, or 500 lux or more of light to an eye of the wearer within a range of 450nm – 510nm from morning until late afternoon.
  • the sunglass lens or sunglass optic can comprise a light transmission curve spectrum of the sunglass lens or sunglass optic within the range of 450nm – 510nm that overlaps with a majority of light absorption curve spectra of melanopsin and rhodopsin.
  • Light transmitted through the sunglass lens or sunglass optic can have a light intensity of 350 lux or greater after transmission through the sunglass lens or sunglass optic.
  • the sunglass lens or sunglass optic can be classified as category 2 sunglass or category 3 sunglasses.
  • the lens/optic/sunglasses can have overall visible light transmission of 18% or greater, 20% or greater, 30% or greater, and so on, while having a light transmission of 50% or more within the wavelength range of 450nm to 510nm.
  • the visible light transmission can be less than 18% or greater than 5%, while having a light transmission of 40% or more within the wavelength range of 450nm to 510nm.
  • Embodiments can transmit a light intensity of 350 lux or greater with in the range of 450nm to 510nm.
  • the sunglass lens or sunglass optic can comprise a surface cast layer that filters light.
  • the sunglass lens or sunglass optic can comprise a lens matrix or optic matrix that filters or blocks ultraviolet light, and / or wherein the sunglass lens or sunglass optic is imbibed with a dye or light absorber.
  • the sunglass lens or sunglass optic can comprise at least one of: an interference filter, an absorption filter, a light absorber, dye, a neutral density filter, a bandpass filter, a notch filter, or a selective blue light filter.
  • the sunglass lens or sunglass optic can comprise an optical power, including plano optical power.
  • the sunglass lens or sunglass optic can comprise a filter tint that is fixed or constant [000771]
  • An aspect of the invention includes: a sunglass lens or sunglass optic comprising a filter, wherein the sunglass lens transmits 350 lux or more, 400 lux or more, or 500 lux or more, of light intensity within a range of light wavelengths having a 45% or greater light transmission through the sunglass lens or sunglass optic, wherein the range of light wavelengths cover a majority of absorption curves or spectra of melanopsin and rhodopsin and also partially absorption curves or spectra of at least some opsins of an eye’s cones, wherein the sunglass lens provides an overall visible light transmission through the sunglass lens of 3% to 18%, and wherein the sunglass lens provides blended color balance transmission of light wavelengths permitting the sunglass lens to pass the International Organization for Standardization (ISO) and/or American National Standards Institute (ANSI) sunglass traffic light test.
  • ISO International Organization for Standardization
  • ANSI
  • a sunglass lens or sunglass optic comprises a filter, wherein the sunglass lens transmits 350 lux or more, 400 lux or more, or 500 lux or more, of light intensity within a range of light wavelengths having a 45% or greater light transmission, wherein the range of light wavelengths cover the majority of the absorption curves or spectra of melanopsin and rhodopsin, and partially the absorption curves or spectra of some of the cones’ opsins, wherein the sunglass lens comprises an overall visible light transmission through the sunglass lens of 18% to 43%, and wherein the sunglass lens provides blended color balance transmission of light wavelengths permitting the sunglass lens to pass the ISO and/or ANSI sunglass traffic light test.
  • the sunglass lens can comprise transmitted light intensity and light wavelengths within the light wavelength range that covers the majority of the absorption curves of melanopsin and/or rhodopsin, and partially the absorption curves of some of the cones’ opsins, cause the generation of dopamine within the eye of the wearer of the sunglass lens or sunglass optic, or increases the production of dopamine within an eye of the wearer of the sunglass lens.
  • the sunglass lens can comprise a ratio of transmitted light within the range that covers a majority of the absorption curves of melanopsin and rhodopsin compared to that of the overall visible light transmitted by said sunglass lens of 2.0 or greater.
  • the sunglass lens can transmit a range of visible light that covers the majority of the absorption curves of melanopsin and rhodopsin and partially the absorption curves of cones’ opsin is within a range 450nm – 530nm.
  • the range can be 450nm – 520nm.
  • the range can be 450nm – 510nm.
  • the range can be 450nm – 500nm.
  • the range can be 460nm – 500nm.
  • the sunglass lens can comprise a transmitted color balance of light wavelengths from the sunglass lens that provides for a red traffic signal transmittance of greater than or equal to 8%.
  • the sunglass lens can comprise a transmitted color balance of light wavelengths from the sunglass lens that provides for a yellow traffic signal transmittance of greater than or equal to 9%.
  • the sunglass lens can comprise a transmitted color balance of light wavelengths from the sunglass lens that provides for a green traffic signal transmittance of greater than or equal to 12%.
  • the sunglass lens can transmit 450 lux or more within the wavelength range of 450nm – 520nm while being worn outdoors in sunlight of 1,000 lux or more during morning until sunset.
  • the sunglass lens can transmit 450 lux or more within the wavelength range of 450nm – 520nm while being worn outdoors in sunlight of 10,000 lux or more during morning until sunset.
  • the sunglass lens can transmit 450 lux or more within the wavelength range of 450nm – 530nm while being worn outdoors in sunlight of 1,000 lux or more in an environment of sunshade from morning until sunset.
  • the sunglass lens can comprise a surface cast filtered layer.
  • the surface cast layer can be applied by molding and curing with light and / or heat.
  • the sunglass lens can be plano in optical power and wherein said layer comprises a thickness of 1.0mm or less, 0.75mm or less, or 0.50mm or less.
  • the sunglass lens can comprise a filter that provides a changeable tint.
  • the changeable tint can be that of a photochromatic tint.
  • the filter can be within the sunglass lens matrix, the filter can be a layer attached to the matrix, the filter can be imbibed into the matrix, the filter can be a surface cast layer affixed, attached, or bonded to the matrix, the filter can be a wafer adhered to the matrix, and/or the filter can be a wafer embedded into the matrix.
  • the sunglass lens can provide ultraviolet light (UV) protection.
  • the sunglass lens can provide high energy blue violet light protection (HEV). In most cases such protection is provided by reducing HEV transmitted light wavelengths within the range of 400nm – 440nm.
  • the sunglass lens can comprise a back surface anti-reflection coating.
  • the sunglass lens can comprise an anti-reflection coating on both surfaces.
  • the sunglass lens can comprise a scratch resistant coating.
  • the sunglass lens or sunglass optic can be comprised of ophthalmic plastic or glass material.
  • the sunglass lens or sunglass optic can comprise a plano power (no optical power).
  • the sunglass lens or sunglass optic can comprise optical power for correcting the distance and / or near vision needs of a wearer.
  • the sunglass lens or sunglass optic can comprise lenslets.
  • the sunglass lens or sunglass optic can comprise (H.A.L.T) highly aspheric lenslet target technology.
  • the sunglass lens or sunglass optic can comprise (DIMS) defocus incorporated multiple segments technology.
  • the sunglass lens or sunglass optic can comprise a chromatic aberration focused lens technology or a chromatic aberration refocused lens technology.
  • the sunglass lens or sunglass optic can comprise contrast reduction technology.
  • the sunglass lens or sunglass optic can comprise diffusion optics technology.
  • the sunglass lens or sunglass optic can be a myopia control sunglass lens.
  • the sunglass lens or sunglass optic can be housed by any type of eyewear.
  • the sunglass lens or sunglass optic can be inserted into any type of eyewear.
  • the sunglass lens or sunglass optic can be supported by any type of eyewear.
  • the sunglass lens or sunglass optic can be supported by any type of headwear.
  • the sunglass lens or sunglass optic can be incorporated into an XR (extended reality) device.
  • the sunglass lens or sunglass optic can be supported by or inserted into an XR (extended reality) device.
  • the sunglass lens or sunglass optic can be supported by or inserted into XR (extended reality) eyewear.
  • the sunglass lens or sunglass optic can be housed, supported, or incorporated, into disposable or fit over eyewear.
  • Embodiments of the performance of a sunglass lens take in to account: time of day, the amount of sunlight lux striking the sunglass lens, the amount of light intensity (lux) leaving the sunglass lens transmitted within a specified range of light wavelengths needed to stimulate dopamine in an eye of the user/wearer, the overall visible light transmission of the sunglass lens, the percentage of light transmission within a defined range of light wavelengths that cover the majority of the absorption curves of melanopsin and rhodopsin as well as certain of the cone opsins, the width of a range of wavelengths of light within the range of 450nm – 520nm, the color balance of light wavelengths needed to be transferred from the sunglass lens to the eye of the wearer, and the ability of the sunglass lens to pass the ISO and / or ANSI traffic light test.
  • Embodiments taught herein can preferably balance numerous components that contribute to the ability of the sunglass lens to cause the production of dopamine or increase the production of dopamine in the eye’s retina of the wearer of the sunglass lens, while also providing the appropriate level of clear distance and / or near vision clarity for the wearer of the sunglass lens, and further provide the appropriate color balance of light wavelengths transmitted from the sunglass lens to the eye of the wearer of the sunglass lens, so that either the wearer of the sunglass lens by way of subjective measurements or the sunglass lens by way of objective measurements can pass the ISO and / or ANSI traffic light test.
  • Various embodiments of a color balanced sunglass lens taught herein consider balancing a plurality of the following in such a manner so to provide a sunglass lens capable of transmitting 50% or more of light within the wavelength range of 450nm +/- 30nm, having an overall visible light transmission of 43% or less, or 18% or less, and be capable of passing the ISO and/or ANSI traffic signal test.
  • the colored balanced sunglasses can be designed and engineered to consider the 50% or more, 75% or more, or 90% or more of the following: 1) Time of day worn; 2) The amount of sunlight lux striking the sunglass lens; 3) The amount of light intensity (lux) or (lumens) leaving the sunglass lens transmitted within a specified range of light wavelengths needed to stimulate dopamine in an eye of the user/wearer; 4) The overall visible light transmission of the sunglass lens; 5) The percentage of light transmission within a defined range of light wavelengths that cover the majority of the absorption curves of melanopsin and rhodopsin as well as certain of the cone opsins; 6) The width of a range of wavelengths of light within the range of 450nm – 520nm; 7) The color balance of light wavelengths needed to be transferred from the sunglass lens to the eye of the wearer, and the ability of the sunglass lens to pass the ISO and / or ANSI traffic light test; 8) The % of visible light wavelength transmission of the various colors in order to
  • An embodiment #1 is that of a sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission of 43% or less, or 18% or less, and wherein the sunglass lens comprises a color balance transmission of: 8.1% average red transmission +/- 3% 12.3% average orange transmission +/- 3% 10.2% average yellow transmission +/- 3% 29.0% average green transmission +/- 3% 51.4% average blue transmission +/- 3% 13.5% average violet transmission +/- 3% And wherein the preceding color transmission % falls within a range of +/-2nm of the following: Red: 621 - 750 nm Orange: 591 - 620 nm Yellow: 571 - 590 nm Green: 496 - 570 nm Blue: 451 - 495 nm Violet: 380 - 450 nm [000779] Another embodiment #2 is that of a sunglass lens that provides a sunglass lens that
  • the invention utilizes and / or balances a plurality of dyes and at least one absorber.
  • the number of dyes is 3 (three) or more and one or more absorbers. In other embodiments the number of dyes is 5 (five) or more and one or more absorbers. In still other embodiments the number of dyes is 8 (eight) or more and one or more absorbers.
  • the sunglass lens can be AR (anti-reflective) coated on both sides. In other embodiments the sunglass lens is AR coated on the back side only.
  • the sunglass lens is hard scratch resistant coated, and AR coated.
  • Sample Conventional Gray Sunglass Lens 52.8% average red transmission versus 8.1% for inventive embodiment #1 or 10.3% for inventive embodiment #2 10.0% average orange transmission versus 12.3% for inventive embodiment #1 or 9.2% for inventive embodiment #2 9.7% average yellow transmission versus 10.2% for inventive embodiment #1 or 11.1% for inventive embodiment #2 12.0% average green transmission versus 29.0% for inventive embodiment #1 or 29.9% for inventive embodiment #2 13.6% average blue transmission versus 51.4% for inventive embodiment #1 or 51.7% for inventive embodiment #2 5.6% average violet transmission versus 13.5% for inventive embodiment #1 or 11.0% for inventive embodiment #2 Sample Conventional G15 Sunglass lens 55.0% average red transmission versus 8.1% for inventive embodiment #1 or 10.3% for inventive embodiment #2 11.5% average orange transmission versus 12.3% for inventive embodiment #1 or 9.2% for inventive embodiment #2 12.0% average yellow transmission versus 10.2% for inventive embodiment #1 or 11.1% for inventive embodiment #2 14.6% average green transmission
  • the sunglass lens can comprise: ⁇ Blue (451nm – 495nm) average light transmission that can be 2x or greater, or 3X or greater, or 4X or greater than red (621nm – 750nm) average light transmission; and / or ⁇ Blue (451nm – 495nm) average light transmission that can be 2x or greater, or 3X or greater, or 4X or greater than orange (591nm – 620nm) average light transmission; and / or ⁇ Blue (451nm – 495nm) average light transmission that can be 2x or greater, or 3X or greater, or 4X or greater than yellow (621nm – 750nm) average light transmission; and / or ⁇ Blue (451nm – 495nm) average light transmission that can be 2X or greater than green (496nm – 570nm) average light transmission; and / or ⁇ Blue (451nm – 495nm) average light transmission that can be 2X or greater than green (496nm
  • a color balanced sunglass lens embodiment can be a sunglass lens that passes the ISO and / or ANSI traffic signal tests, and wherein the sunglass lens comprises: ⁇ Blue (451nm – 495nm) wavelength average light transmission that is 2x or greater, or 3X or greater, or 4X or greater than red (621nm – 750nm) wavelength average light transmission; and / or ⁇ Blue (451nm – 495nm) wavelength average light transmission that is 2x or greater, or 3X or greater, or 4X or greater than orange (591nm – 620nm) wavelength average light transmission; and / or ⁇ Blue (451nm – 495nm) wavelength average light transmission that is 2x or greater, or 3X or greater, or 4X or greater than yellow (621nm – 750nm) wavelength average light transmission; and / or ⁇ Blue (451nm – 495nm) wavelength average light transmission that is 2X or greater than green (496nm – 570nm) wavelength
  • the sunglass lens can comprise an overall visible transmission within the range of 43% and 18%, and wherein the sunglass lens transmits 50% or greater light wavelengths within the range of 480nm +/- 30nm.
  • the sunglass lens can comprise an overall visible transmission within the range of 18% and 43%, and wherein the sunglass lens transmits 50% or greater light wavelengths within the range of 480nm +/- 30nm.
  • the sunglass lens can comprise 3 or more dyes and one or more absorber.
  • the sunglass lens can increase the production of dopamine in the eye and / or brain of the wearer.
  • Another color balanced sunglass lens embodiment can transmit 50% or more light wavelengths within the range of 480nm +/- 30nm and comprises an overall visible light transmission of 20% or less and wherein the following apply: ⁇ The average transmittance 400nm – 800nm (unweighted summation) is 20% or less; ⁇ The average transmittance 450nm – 510nm (unweighted summation) is 50% or greater; ⁇ The photopic transmittance is 25% or less; ⁇ The red traffic signal transmittance is 9% or greater; ⁇ The yellow traffic signal transmittance is 10% or greater; and ⁇ The green traffic signal transmittance is 25% or greater [000790]
  • the color balanced sunglass lens embodiment can also provide: ⁇ Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance; ⁇ Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance; and/or ⁇ Green traffic signal transmittance can be greater than red traffic signal transmission + yellow traffic signal transmitt
  • the color balanced sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the color balanced sunglass lens can increase the production of dopamine in the eye and / or brain of the wearer.
  • Another sunglass lens embodiment can transmit 50% or more light wavelengths within the range of 480nm +/- 30nm and comprises an overall visible light transmission of 18% or less, and wherein, ⁇ The average transmittance 400nm – 800nm (unweighted summation) is 20% or less; ⁇ The average transmittance 450nm – 510nm (unweighted summation) is 50% or greater; ⁇ The photopic transmittance is 25% or less; ⁇ The red traffic signal transmittance is 9% or greater; ⁇ The yellow traffic signal transmittance is 10% or greater; and ⁇ The green traffic signal transmittance is 25% or greater.
  • the sunglass lens embodiment can also provide: ⁇ Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance; ⁇ Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance; and/or ⁇ Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens embodiment can increase the production of dopamine in the eye and / or brain of the wearer [000795]
  • Another embodiment is that of a sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission within the range of 43% - 18% and wherein the sunglass lens comprises a color balance transmission of: ⁇ 8.1% average red transmission +/- 3%; ⁇ 12.3% average orange transmission +/- 3%; ⁇ 10.2% average yellow transmission +/- 3%; ⁇ 29.0% average green transmission +/- 3%; ⁇ 51.4% average blue transmission +/- 3%; ⁇ 13.5% average violet transmission +/- 3% ⁇ And wherein the preceding color transmission % falls within a range of +/-2nm of the following: a) Red: 621 - 750 nm b) Orange: 591 - 620 nm c) Yellow: 571 - 590 nm
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens can increase the production of dopamine in the eye and / or brain of the wearer.
  • the sunglass lens embodiment can also provide: ⁇ Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance; ⁇ Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance; and/or ⁇ Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance.
  • Another embodiment is that of a sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission within the range of 18% - 43% and wherein the sunglass lens comprises a color balance transmission of: ⁇ 8.1% average red transmission +/- 3% ⁇ 12.3% average orange transmission +/- 3% ⁇ 10.2% average yellow transmission +/- 3% ⁇ 29.0% average green transmission +/- 3% ⁇ 51.4% average blue transmission +/- 3% ⁇ 13.5% average violet transmission +/- 3% And wherein the preceding color transmission % falls within a range of +/-2nm of the following: a) Red: 621 - 750 nm b) Orange: 591 - 620 nm c) Yellow: 571 - 590 nm d) Green: 496 - 570 nm e) Blue: 451 - 495 nm f) Violet: 380
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens can increase the production of dopamine in the eye and / or brain of the wearer.
  • the sunglass lens embodiment can also provide: ⁇ Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance and ⁇ Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance and ⁇ Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance [000798]
  • Another embodiment is that of a sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission within the range of 43% - 18% and wherein the sunglass lens comprises a color balance transmission of: ⁇ 10.3% average red transmission +/- 3% ⁇ 9.2% average orange transmission +/- 3% ⁇ 11.1% average yellow transmission +/- 3% ⁇ 29.9% average green transmission +/- 3% ⁇ 51.7% average blue transmission +/- 3% ⁇ 11.0% average violet transmission +/- 3% And wherein the preceding color transmission % falls within a range of +/-2
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens can increase the production of dopamine in the eye and / or brain of the wearer.
  • the sunglass lens embodiment can also provide: ⁇ Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance and ⁇ Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance and ⁇ Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance [000799]
  • Another embodiment is that of a sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission within the range of 18% - 43% and wherein the sunglass lens comprises a color balance transmission of: 1. 10.3% average red transmission +/- 3% 2. 9.2% average orange transmission +/- 3% 3.
  • the sunglass lens embodiment color balance can comprise 50% or more of the above a - f.
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens can increase the production of dopamine in the eye and / or brain of the wearer.
  • the sunglass lens embodiment can also provide: 1. Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance; 2. Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance; and/or 3. Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance.
  • sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission within the range of 43% - 18%, and wherein the sunglass lens comprises a color balance transmission of: 1. Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance; 2. Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance; and/or 3. Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance.
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens embodiment can increase the production of dopamine in the eye and / or brain of the wearer.
  • Yet another sunglass lens embodiment can provide a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission within the range of 18% - 43%, and wherein the sunglass lens comprises a color balance transmission of: 1.
  • Green traffic signal transmittance can be greater than 2X that of yellow traffic signal transmittance; 2.
  • Green traffic signal transmittance can be greater than 2X that of red traffic signal transmittance; and/or 3.
  • Green traffic signal transmittance can be greater than red traffic signal transmittance + yellow traffic signal transmittance.
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens embodiment can increase the production of dopamine in the eye and / /or one or more of dopamine, serotonin or norepinephrine in the brain of the wearer.
  • Another embodiment is that of a sunglass lens that provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission of 30% or less, and wherein the sunglass lens comprises a color balance transmission of blue (451nm – 495nm) wavelength average light transmission that is 2X or greater than its green (496nm – 570nm) wavelength average light transmission.
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens embodiment can comprise a mostly plano power surface cast layer.
  • the sunglass lens embodiment can comprise a chromatic aberration focused lens or chromatic aberration refocused lens.
  • the sunglass lens embodiment can increase the production of dopamine in the eye and /or one or more of dopamine, serotonin or norepinephrine in the brain of the wearer [000803]
  • Another sunglass lens embodiment provides a transmission of light within the wavelength range of 480nm +/- 30nm of 50% or greater, wherein the sunglass lens comprises an overall visible wavelength transmission of 30% or less, and wherein the sunglass lens comprises a color balance transmission of blue (451nm – 495nm) wavelength average light transmission that is 1.5X or greater than its green (496nm – 570nm) wavelength average light transmission.
  • the sunglass lens embodiment can pass the ISO and / or ANSI traffic signal test.
  • the sunglass lens embodiment can comprise 3 (three) or more dyes and one or more absorber.
  • the sunglass lens embodiment can comprise a mostly plano power surface cast layer.
  • the sunglass lens embodiment can comprise a chromatic aberration focused lens or chromatic aberration refocused lens.
  • the sunglass lens embodiment can increase the production of dopamine in the eye and / or one or more of dopamine, serotonin or norepinephrine in the brain of the wearer.
  • Another embodiment can be that of a first sunglass lens that transmits the same or less light than a second sunglass lens, however, the perceived brightness when looking through the first sunglass lens is greater than when looking though the second sunglass lens.
  • the embodiment comprises sunglass R and sunglass S, wherein sunglass R comprises an overall visible light transmission of X%, wherein sunglass S that comprises an overall visible light transmission less than X%, and wherein the wearer’s perceived light transmission through sunglass S can be greater than the same wearer’s perceived light transmission of sunglass R.
  • the overall visible light transmission of sunglass S can be 5% or more less than sunglass R.
  • the wearer’s pupil size can be smaller when looking through sunglass S than when looking through sunglass R.
  • Another embodiment is the sunglass R wherein the wearer’s pupil size can be larger when looking through sunglass R than sunglass S. The wearer’s distance vision can appear clearer to the wearer of sunglass S than sunglass R.
  • the overall visible transmission of sunglass S can be 25% or less.
  • the light transmission percentage of sunglass S can be within a range of wavelengths within 450nm and 510 nm, and can be greater than sunglass R.
  • the wearer can perceive black and white contrast or color contrast to be greater in sunglass S compared to sunglass R.
  • Sunglass S can pass all tests associated with the ISO or ANSI traffic signal tests, including the daytime chromaticity tests.
  • Sunglass S can be polarized.
  • Sunglass S can be mirrored.
  • the XR device can receive an electronic download or preloaded with such software that controls or directs the manner in which ocular photo-bio-stimulation of the eye of the wearer is provided.
  • the ocular photo-bio-stimulation can increase the production of dopamine in the eye of the wearer or user of the XR device.
  • the ocular photo-bio-stimulation can increase the production of /or one or more of dopamine, serotonin or norepinephrine in the brain of the wearer or user of the XR device.
  • Biofeedback or diagnostics involving one or more of, pupil size increase, lid blink increase, heart rate increase, and/or blood oxygen level increase can be an indication of increase production or stimulation of dopamine or norepinephrine in the brain and in some cases serotonin. While an increase in contrast sensitivity, B wave amplitude of an ERG, scleral thickening, and/or slowing of axial length eye growth indicates an increase in the production of dopamine in the retina.
  • the amount of required light intensity given off by an XR eyewear ocular photo- bio-stimulation artificial light source is dependent upon the distance of the light source from the eye of the subject receiving ocular photo-bio-stimulation treatment, the age of the subject, and whether or not the subject is wearing an eyeglass that either filters or refracts light.
  • the light intensity needs to be 60 lumens or more leaving the ocular photo-bio- stimulation light source.
  • the preference is for 400 lux of ocular photo-bio-stimulation light or more to strike the retina of the eye of the subject for a period of time in order for the subject to have the desired physiological response.
  • the light intensity in lux given off from the XR eyewear ocular photo-bio-stimulation light source can be 250 lux or more, 500 lux or more, 1,000 lux or more, and so on.
  • the number of lumens given off from the ocular photo-bio-stimulation light source can be 10 lumens or more, 25 lumens or more, 50 lumens or more, 100 lumens or more, and so on.
  • the light intensity that strikes the retina can be 300 lux or greater, 400 lux or greater, 500 lux or greater, and so on.
  • Artificial intelligence (AI) and ML can be incorporated within the embodiment to optimize the desired physiological effect for the subject or user.
  • an ocular photo-bio-stimulation light source can comprise wavelengths of light within the range of 440nm to 700nm.
  • the white light can comprise peaks of light wavelengths of; 460nm +/- 10nm, 525nm +/- 10nm, or 620nm +/- 10nm.
  • the transmission peak of 460nm +/- 10nm can be greater than 80%.
  • the transmission peak of 525nm +/- 10nm can be greater than 70%.
  • the transmission peak of 620nm +/- 10nm can be greater than 60%.
  • Such a white lighted ocular photo-bio-stimulation light source can provide ocular photo-bio-stimulation.
  • the light intensity of lux given off from an XR eyewear ocular photo-bio-stimulation light source can be one of, 250 lux or more, 500 lux or more, 1,000 lux or more, and so on.
  • the number of lumens given off from the ocular photo-bio-stimulation light source can be 10 lumens or more, 25 lumens or more, 50 lumens or more, 100 lumens or more, and so on.
  • the light intensity that strikes the retina can be 300 lux or greater, 400 lux or greater, 500 lux or greater, and so on.
  • the transmission peak of the wavelength range that strike the eye’s retina falls within the wavelength range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm photo-bio-stimulation light source can be 250 lux or more, 500 lux or more, 1,000 lux or more, and son on
  • the number of lumens given off from the ocular photo-bio-stimulation light source can be 10 lumens or more, 25 lumens or more, 50 lumens or more, 100 lumens or more, and so on.
  • the light intensity that strikes the retina can be 300 lux or greater, 400 lux or greater, 500 lux or greater, and so on.
  • the blended light wavelengths of the light emitter(s) and also the ambient light comprises wavelengths of light that strike the eye’s retina falling within the wavelength ranges of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the retina is comprised of a central zone, mid peripheral zone and a far peripheral zone. Approximately an estimated 20% - 30% of each eye’s retina is not stimulated by light when looking straight ahead. This is because one’s nose and eyebrow interfere with light rays that could stimulate portions of the peripheral retina. Given the more retina of an eye that is stimulated the more robust the ocular photo-bio -stimulation response may be, or the greater efficacy it may have, it is important to apply the ocular photo-bio -stimulation light therapy to as much of the retina as possible.
  • inventive embodiments disclosed herein allow for this to occur.
  • XR inventive embodiments disclosed herein it is possible to stimulate areas of the retina of an eye by way of ocular photo-bio-stimulation in such a manner to stimulate the 20% - 30 % that is normally not stimulated.
  • Such desired wavelengths of light can be, by way of example only, one within the range of wavelengths of at least one of: 480nm +/- 30nm, 480nm +/- 20nm, 500nm +/- 30nm, 500nm +/- 20nm, 510nm +/- 30nm, 510nm +/- 20nm, 530nm +/- 20nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the range of wavelength band includes the peaks of the most sensitive spectral points of rhodopsin (500nm) and melanopsin (480nm). This way both rhodopsin and melanopsin can be stimulated or excited.
  • this can be accomplished by utilizing a filtered optic or lens that predominantly transmits within the wavelength range of 460nm – 520nm, 470nm to 520nm, or 480nm to 520nm, or by utilizing a light source or light emitter that predominately transmits within the wavelength range of 460nm- 520nm, 470nm to 520nm, or 480nm – 520nm.
  • the overall light transmission through the filtered optic or filtered lens can be 50% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 50% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens constricts when looking absent of the filtered optic or filtered lens.
  • the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered optic to have maximum vison clarity.
  • the light source can modulate between (by way of example only, a black image and blue image comprised of light wavelengths within the range of 450 nm – 530 nm).
  • a black image and blue image comprised of light wavelengths within the range of 450 nm – 530 nm.
  • the overall light transmission through the filtered optic or filtered lens can be 40% of less, while the light transmission within the predominant transmitted filtered wavelength range being transmitted to the eye can be 40% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the eye’s retina is exposed to blue light within the range of 450nm to 530nm, preferably 480 nm +/- 20 nm, the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered optic to have maximum vison clarity. However, in certain embodiments it is more important to provide ocular photo-bio-stimulation as opposed to maximum vision clarity. In these embodiments it is necessary to trick the wearer’s retinal neurological feedback that causes the pupil to constrict while still providing blue light within the range of 450nm – 530nm, preferably 480nm +/- 20nm, to strike the wearer’s / user’s retina.
  • the overall light transmission through the filtered optic or filtered lens can be 30% of less, while the light transmission within the predominant transmitted wavelength range being transmitted to the eye can be 40% or more.
  • the pupil of the eye enlarges when looking through the filtered optic or filtered lens and constricts when looking absent of the filtered optic or filtered lens.
  • the eye’s retina is exposed to blue light within the range of 450nm to 530nm, preferably 480 nm +/- 20 nm, the pupil of the eye constricts or remains constricted.
  • the constriction of the pupil when viewing through a filtered optic or filtered lens allows for the user / wearer of the filtered optic to have improved or maximum vison clarity. However, in certain embodiments it is more important to provide ocular photo-bio-stimulation as opposed to maximum vision clarity. In these embodiments it is necessary to trick the wearer’s retinal neurological feedback that causes the pupil to constrict while still providing blue light within the range of 450nm – 530nm, preferably 480nm +/- 20nm to strike the wearer’s / user’s retina.
  • the virtual image as seen with AR, VR, MR, Modified Reality, and/or XR eyewear as described herein is one or more of a blue light image (with wavelengths within the range of 480nm +/- 30nm), a green light image (with wavelengths within the range of 530nm +/- 20nm), and/or a red-light image (with wavelengths within the range of 650nm +/- 30nm or 700nm +/- 30nm).
  • the device embodiment can comprise a filter or a combination of filters for transmitting one or two virtual images.
  • the filter or filters can transmit light wavelengths, by way of example only, within one or more of the ranges of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the real image that passes through a filter(s) can be of any color, but a color that allows for the user to see the real image comprising wavelengths within the range of 480nm +/- 30nm in the morning and by switching the filter(s) red wavelengths of 650nm +/- 30nm in the afternoon.
  • the filter(s) can cause the real image to have a light transmission of 80% or less, 50% or less, or 40% or less.
  • the lower overall visible light transmission through the XR device to the eye, while at the same time transmitting the desired range of wavelengths for ocular photo-bio- stimulation, can enlarge the pupil diameter of the user of the XR device.
  • a virtual image can be of a black spot that moves around within the virtual image.
  • the virtual image can be of a black spot that moves around within the real image.
  • the real image can be of an image that moves around within the virtual image.
  • the virtual image can be of a colored (which includes black) or white spot that moves around within the real image.
  • one virtual image can comprise, by way of example only, a moving black spot that is moving within the perimeter of a second virtual image.
  • one virtual image can comprise, by way of example only, a moving black spot that is moving within the perimeter of the same virtual image.
  • the virtual image with the moving black spot that moves within the perimeter of the virtual image is part of the same virtual image. Thus, there is only one virtual image. In other embodiments the virtual image with the moving black spot that moves within the perimeter of the virtual image is a separate virtual image that appears within the perimeter but is really an overlapping virtual image. Thus, in this case there would be two virtual images.
  • Filter(s) can cause the real image to have a light transmission of 50% or less. The filter(s) can cause the real image to have a light transmission of 25% or less.
  • a real image can be an image of a solid color or black.
  • a virtual image can be an image of a color(s) including black.
  • the real image and the virtual image can both be images seen distance separated along the Z axis from the wearer’s eye.
  • the real image is the distance image
  • the virtual image is the nearer image, and vice versa.
  • the eyes can be fixated on the real image as it moves within the virtual image.
  • the eyes can be fixated on the real image as it moves within the virtual image.
  • the eyes can be fixated on one virtual image as it moves within, around, or in reference to a different virtual image.
  • a virtual image can comprise two or more parts with one part moving within the second part. Said another way, one portion of the virtual image can move while the other portion of the same virtual image can be stationary.
  • the eye of a user can fixate on the moving image while the stationary image paints the retina of the eye, or the eye can fixate on the stationary image while the moving image paints the retina of an eye of the user.
  • the eyewear comprises an electronic display attached to the eyewear that projects blue light, or green light, or red-light, through a wave guide to an optic housed within the eyewear.
  • the eyewear comprises an electronic display attached or integrated within a wave guide to an optic housed within the eyewear.
  • the eyewear comprises an electronic display that is attached to or integrated within an optic housed or supported by the eyewear.
  • the eyewear houses or supports an optic that incorporates an electronic display and wherein the wearer looks through the electronic display while the electronic display projects blue, or green, or red- light.
  • a non-see-through near eye display can be utilized to generate a lighted virtual reality image.
  • two non-see- through near eye displays are utilized to generate lighted virtual reality images.
  • a see-through near eye display can be utilized to generate a lighted virtual reality image.
  • two-see-through near eye display can be utilized to generate lighted virtual reality images.
  • a non-see-through near eye display optically aligned or in optical communication with a micro-lens array can be is utilized to generate a lighted virtual reality image.
  • two non-see-through near eye displays optically aligned or in optical communication with micro- lens arrays are utilized to generate lighted virtual reality images.
  • a see-through near eye display optically aligned or in optical communication with a micro-lens array can be utilized to generate a lighted virtual reality image.
  • the micro-lens array can comprise a filtering agent(s). The filtering agent(s) can be coated on to the micro-lens array.
  • a non-see-through near eye display optically aligned or in optical communication with micro-lens array can be utilized in optical communication (but slightly offset) with a second see-through near eye display to generate a lighted virtual reality image.
  • a non-see-through near eye display optically aligned or in optical communication with a micro-lens array can be utilized in optical communication (but slightly offset) with a see-through near eye display that can be aligned with a second micro-lens array to generate a lighted virtual reality image.
  • a see-through near eye display optically aligned or in optical communication with a micro-lens array can be in optical communication (but slightly offset) with a second see-through near eye display, which is aligned and in optical communication with a second microlens array, to generate a lighted virtual reality image.
  • a see-through near eye display optically aligned or in optical communication with a micro-lens array can be in optical communication (but slightly offset) with a second see-through near eye display which is aligned and in optical communication with a second microlens array, to generate a lighted virtual reality image while permitting the viewing of a real image through both see-through near eye displays and both microlens arrays.
  • the electronic display provides diffuse blue, green, or red-light all over.
  • the electronic display allows the wearer to see an object, image or words, displayed on the display, which is surrounded by blue, or green or red-light, or comprises blue, or green, or red-light peripheral to the object, image, or words being displayed.
  • VR Virtual Reality
  • AR Augmented Reality
  • MR Magnetic Reality
  • modified reality the blue, or green, or red light, can be provided in a diffused manner.
  • a targeting image or video that caused movement can cause the eyes to gaze while seeing the blue, or green, or red diffused light.
  • the blue, or green, or red light can be provided as the background light, by way of example only, a blue sky or blue ocean, or green grass, or a red sun.
  • a real image can be the object being viewed in the distance and the diffused and / or defocused light can be that of the virtual image. By utilizing this approach, it permits the pupil of the eye to be less constricted.
  • the image that is stationary is the image or scene that is providing the ocular photo-bio- stimulation to the retina as the eye moves in reference to this stationary image or scene.
  • the moving image on which the eye is fixated on is a moving image that focuses on the fovea or macula
  • the stationary image or scene is the image that is stimulating the one or more of rods, ganglion cells, or cones of the retina.
  • the fixated image is smaller than the stationary image that is painting portions of the retina as the eye follows the moving fixated image.
  • the stationary image provides the light of the desired wavelength and intensity for stimulating one or more of the rods, ganglion cells, or cones.
  • the stationary image paints with a band of desired wavelengths of light (by way of example only, 480nm +/- 30nm or 650nm +/- 30nm, or 700nm +/- 30nm) a portion or most of the peripheral retina because the eye is moving relative to the stationary image.
  • both images are moving, however the user fixates on one image as it moves relative to the other.
  • the image that paints with a desired band of light wavelengths the peripheral retina or a portion thereof is the image that is not fixated by the user’s macula, or fovea.
  • the stationary image can be a blue image having wavelengths of light within the range of 450nm – 500nm with over a 300-lux intensity or a red image of 500 lux intensity or greater having wavelengths of light within the range of 650nm +/-30nm or 700nm +/- 30nm, and the moving image can be of any color that stands out against the blue image or red image, including that of black or white.
  • the stationary image can be a red image having wavelengths of light within the range of 650nm- 700nm or near IR of 830nm +/- 30nm, and the moving image can be of any color that stands out against the red image including that of black or white.
  • the fixated moving image or that of a fixated stationary image whereby the fovea and or macula is fixated can be a red image having wavelengths of light within the range of 650nm- 700nm, 700nm +/- 30nm, or 830nm +/- 30nm.
  • the image that moves and is fixated on by one’s fovea can be that of black, dark grey, or red.
  • black or dark grey there is less light stimulation for causing the pupil of the eye of the viewer to constrict fully.
  • a red fixation target can allow for the pupil of the eye to be slightly larger.
  • embodiments of defocused light can be used for generating an image.
  • focused light can be used for generating an image.
  • one image can be generated with focused light and the other with defocused light.
  • defocused light it is possible to stimulate more (or a larger area) of the retina at one time with a light stimulus. This is true for a fixed image or an image that is moving relative to a fixed image.
  • Such a defocused image can be generated by a plus lens that focuses in front of the retina or a minus lens that focuses behind the retina.
  • focused light can be used.
  • a chromatic aberration focused lens can cause blue light wavelengths to move the focus from in front of the retina of the user’s eye, to on or in the retina of the user’s eye.
  • a focused lens being of a slight increase in plus power can move the focus of red wavelengths of light from the back of the retina to focusing within the retina.
  • the light source that generates ethe real image, virtual image or both can be generated, by way of example only, by one or more of, LED, OLED, TOLED, iLED, quantum dots, fluorescent, incandescent, sun light, laser, television set, electronic display screen.
  • the light source for either the first virtual image, or the second virtual image, or both can be, by way of example only, LED, TOLED, OLED, iLED, quantum dots, fluorescent, incandescent, sun light, electronic display screen, and/or laser.
  • the XR eyewear will comprise one or more ocular photo-bio- stimulation light sources.
  • the light source(s) can be a see-through near eye display or a non-see- through near eye display.
  • Such a display can be within 100mm or less of the cornea of the eye of the wearer. In other embodiments such a display can be within 50mm or less of the cornea of the eye of the wearer. In still other embodiments such a display can be within 15mm or less of the cornea of the eye of the wearer.
  • the light intensity of lux given off from the XR eyewear ocular photo-bio-stimulation light source can be 250 lux or more, 500 lux or more, 1,000 lux or more, or 2,000 lux or more.
  • the number of lumens given off from the ocular photo-bio-stimulation light source can be 10 lumens or more, 25 lumens or more, 50 lumens or more, 100 lumens or more, or 200 lumens or more.
  • the light intensity that strikes the retina can be 300 lux or greater, 400 lux or greater, or 500 lux or greater.
  • a system for maximizing the stimulation of dopamine and serotonin in the brain of an individual using the system can comprise using a combination of two or more of light, color, sound, aroma, and/or taste.
  • a combination of light and sound are utilized.
  • a combination of light and color are utilized.
  • a combination of light and aroma are utilized.
  • a combination of light and taste are utilized.
  • biofeedback can be sensed or measured.
  • sensing can be, by way of example only, sensing or measuring for an increase in the blink rate of the eye of the user of the XR device.
  • sensing can be, by way of example only, sensing or measuring for an increase in the pupil diameter of the eye of the user of the XR device [000832]
  • the light can comprise wavelengths of light that are predominantly or substantially light wavelengths within the ranges of one or more of: 480nm +/- 30nm, 530nm +/- 20nm, and/or 650nm +/-30nm.
  • Such a system can comprise any two or more of light, color, sound, aroma, and/or taste.
  • the sound can be, by way of example only, love songs.
  • the aroma can be by, way of example only, cookies being baked.
  • the taste can be, by way of example only, chocolate.
  • an XR system is utilized.
  • An XR system can be one or more of AR, MR, VR, and/or Modified Reality.
  • An XR system can be utilized on, in, or around the eyes of a wearer or user.
  • the XR system can be one or more of: AR, MR, and/or VR when used in combination with one or more of light, color, sound, aroma, and/or taste.
  • the XR system can comprise or display light.
  • the XR system can display color.
  • the color can be one or more, by way of example only, that of: red, yellow, and/or orange.
  • the XR system can comprise audio.
  • the XR system can comprise an odor emitting component.
  • smart eyewear can be utilized. Smart eyewear can be used in combination with one or more light, sound, aroma, and/or taste. Smart eyewear can comprise or display light. Smart eyewear can display color. The color can be one or more of, for example only, that of red, yellow, and/or orange.
  • the smart eyewear can comprise audio. Smart eyewear can comprise an odor emitting component. [000833]
  • an ocular photo-bio-stimulation instrument can be utilized.
  • the instrument can be used in combination with one or more of: light, color, sound, aroma, and/or taste.
  • the instrument can comprise or display light.
  • the instrument can display color.
  • the color can be one of: red, yellow, and/or orange.
  • the instrument can comprise audio.
  • the instrument can comprise an odor emitting component.
  • the light can comprise wavelengths of light that are predominantly or substantially light wavelengths within the ranges of one or more of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • the color can be one or more of, by way of example only, that of red, yellow, and/or orange.
  • the sound can be, by way of example only, love songs.
  • the aroma can be by, way of example only, cookies being baked.
  • the taste can be, by way of example only, chocolate.
  • an XR helmet or XR eyewear comprising a display can be utilized.
  • the helmet or eyewear comprising a display can be used in combination with one or more of light, color, sound, aroma, and/or taste.
  • the helmet or eyewear comprising a display can comprise or display light.
  • a helmet or eyewear can display color.
  • the color can be one or more of red, yellow, and/or orange.
  • the helmet or eyewear comprising a display can comprise audio aspects.
  • the helmet or eyewear comprising a display can comprise an odor emitting component.
  • the light can comprise wavelengths of light that are predominantly or substantially light wavelengths within the ranges of one or more of: 480nm +/- 30nm, 530nm +/- 20nm, 630nm +/-20nm, 650nm +/- 30nm, and/or 700nm +/- 30nm. Colors can be one or, by way of example only, that of red, yellow, orange. The sound can be, by way of example only, love songs.
  • an XR device e.g., AR, MR, VR, or Modified Reality
  • a display can be used in combination with one or more of light, color, sound, aroma, and/or taste.
  • the XR device comprises a display that can comprise or display light.
  • the XR device can display color. The color can be one of red, yellow, and/or orange.
  • the XR device comprising a display can comprise audio aspects(s).
  • the XR device comprising a display can comprise an odor emitting component.
  • the light can comprise wavelengths of light that are predominantly or substantially light wavelengths within the ranges of one or more of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/- 30nm, or 700nm +/- 30nm.
  • Colors can be one or more of, by way of example only, that of red, yellow, and/or orange.
  • the light, or color, or sound, or smell, or a combination thereof can be modulated within the range of one of 5Hz – 15Hz, 40Hz +/- 10Hz or 40 Hz +/- 20 Hz, by way of example.
  • an XR device provides or comprises a first lighted image and a second lighted image, wherein the first lighted image is moved relative to the second lighted image, wherein the first image is generated by a first light source, wherein the second image is generated by a second light source (or absence thereof) forming a black spot, wherein the peak transmission wavelengths fall within at least one of the following light wavelength bands: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650n
  • the XR device can provide ocular photo-bio-stimulation to the eye or eye’s retina.
  • One of the lights can comprise a band of wavelengths of light having a transmission peak of 50% or greater than any other transmission peak of visible light for that light.
  • the first image can move relative to a stationary second image.
  • the second image can move relative to the stationary first image.
  • the first image can move relative to a moving second image.
  • the first image can move relative to a moving second image.
  • the first image and the second image can both move.
  • the virtual image can be black (this can be formed by a combination of colored pixels or the lack of light).
  • both images are virtual images.
  • the black image can be a spot.
  • the black spot can be of any size or shape.
  • the black spot can move within or relative to the real image.
  • the real image can paint the retina as the eye follows the movement of the black spot.
  • the light source can be, by way of example only, that of a non-see-through near eye display comprising light emitters.
  • the light source can be, by way of example only, that of a see-through near eye display comprising light emitters.
  • the real image can be generated by, by way of example, a light source of one or more of: sun, ambient light, television, or an electronic display of a remote computerized device.
  • an XR device provides or comprises a first lighted image and a second lighted image, wherein the first image is moved relative to the second image, wherein the first image is generated by a first light source, wherein the second image is generated by a second light source (or absence thereof) forming a black spot, wherein the predominant wavelengths fall within at least one of the following light wavelength bands: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, or 650nm +/-
  • the XR device can provide ocular photo-bio-stimulation to the eye or eye’s retina.
  • One of the light sources can generate a band of wavelengths of light having a transmission of the predominant wavelengths being 50% or greater than any other transmission of visible light for that light.
  • the first image can move relative to a stationary second image.
  • the second image can move relative to the stationary first image.
  • the first image can move relative to a moving second image.
  • the first image can move relative to a moving second image.
  • the first image and the second image can both move.
  • the virtual image can be black (this can be formed by a combination of colored pixels or the lack of light).
  • both images are virtual images.
  • the black image can be a spot.
  • the black spot can be of any size or shape.
  • the black spot can move within or relative to the real image.
  • the real image can paint the retina as the eye follows the movement of the black spot.
  • the light source can be, by way of example only, that of a non-see-through near eye display comprising light emitters.
  • the light source can be, by way of example only, that of a see-through near eye display comprising light emitters.
  • the image is that of a real image the real image can be generated by way of example by a light source of one or more of, sun, ambient light, television, or electronic display of a remote computerized device.
  • a VR or Modified Reality device can be capable of painting with desired light wavelengths to most of the retina peripheral to the macula or fovea.
  • the VR device can provide focused, non-focused, scattered light. Illumination can be within the range of 400 lux to 20,000 lux.
  • Pixels can be comprised by way of example only one of: OLEDs, TOLEDs, microOLEDs, iLeds, Quantum Dots, or LEDs.
  • the moving virtual image #25301 it can be, by way of example only, one of continuous, periodic, intermittent movement from place to place of any desired colored dot including black, grey or white.
  • the moving image can be comprised of, by way of example, a combination of colors, lack of light, and/or lack of color.
  • Such ocular photo-bio-stimulation treatment can be done on a monocular basis or a binocular basis.
  • FIGs. 53, 54, and 55 show how, by way of example only, a non-see-through near eye display or a see-through near eye display can be curved to conform with the eyewear lens(es). Not shown is the curved micro-lens array that can be in alignment with and in optical communication with either the appropriate non-see-though near eye display or a see-through near eye display.
  • the first image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image.
  • the second image can paint portions of the far peripheral retina with light.
  • the second image can move relative to a stationary first image.
  • the first image can move relative to a stationary secondary image.
  • the first image can be a virtual image.
  • the second image can be a virtual image.
  • the second image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image fixated on by the fovea of the user’s eye.
  • the first image can paint portions of the far peripheral retina with light wavelengths.
  • the moving image (whether a virtual image or a real image) can be by way of example only, one of continuous, periodic, or intermittent movement, from place to place of any desired colored dot (including black, grey, or white). Such ocular photo-bio-stimulation treatment can be done on a monocular basis or a binocular basis.
  • the image (whether a virtual image or real image) which is painting the retina of an eye can be generated by a light emitter or emitters, by way of example only, having illumination within the range of 400 lux to 20,000 lux.
  • an electronic display when an electronic display is utilized for XR (such as by example only, one of a see-through near eye display, a near eye display, and/or a non-see-through near eye display), the electronic display can be located directly in front of the eye within the line of sight of the eye when the eye is looking straight ahead. In certain embodiments when an electronic display is utilized for XR (such as by example only, one of a see- through near eye display, a near eye display, and/or a non-see-through near eye display), the electronic display can be located in front of the eye but offset with regards to the line of sight of the eye when the eye is looking straight ahead.
  • the electronic display pixels can be comprised of, by way of example only: OLEDs, TOLEDs, micro-OLEDs, iLEDs, Quantum Dots, and/or LEDs.
  • the light can be that of focused, non-focused or scattered light.
  • the electronic display pixels can be, by way of example only: OLEDs, TOLEDs, micro-OLEDs, iLEDs, Quantum Dots, and/or LEDs.
  • the light can be that of focused, non-focused or scattered light.
  • the light emitter or emitters can have illumination within the range of 400 lux to 20,000 lux.
  • the XR eyewear can utilize one or more of a near eye display, see-through near eye display, non-see-through near eye display, or waveguide. Any one or more of those will allow for the embodiment of moving a first light that forms an image that is fixed upon by the eye of a user / wearer, while another the light that forms a second image paints the retina.
  • both images are virtual images.
  • one image (the moving fixated image) is that of a real image and the second image (stationary image) is that of a virtual image.
  • one image is that of a virtual image and the second image (stationary image) is that of a real image.
  • the XR device can be a VR or Modified Reality device (see, e.g., FIG. 53A-D and 54A-B).
  • the first image and the second image can be virtual images.
  • one of the virtual images can be black (this can be formed by a combination of colored pixels or the lack of light)
  • the first light can be focused light.
  • the black image can be a spot.
  • the black spot can be of any size or shape.
  • the black spot can move within or relative to the second virtual image.
  • the second virtual image can paint the retina as the eye follows the movement of the black spot.
  • the first light can be focused light.
  • the second light can be defocused light.
  • the first light can be defocused light.
  • the second light can be focused light.
  • the first light can be filtered light.
  • the second light can be filtered light.
  • the image movement can be continuous.
  • the image movement can be intermittent.
  • the image movement can be periodic.
  • the first light can be one of generated by one or more of: LEDs, OLEDs, TOLEDs, micro-OLEDs, micro-LEDs, micro-ileds, iLEDs, quantum dots, florescent lights, incandescent lights, sun, laser, plasma display, TV display, tablet display, cell phone display, computer display, and/or electronic display.
  • the second light can be generated by one or more of: LEDs, OLEDs, TOLEDs, micro-OLEDs, micro-LEDs, micro-ileds, iLEDs, quantum dots, florescent lights, incandescent lights, sun, laser, plasma display, TV display, tablet display, cell phone display, computer display, and/or electronic display.
  • the first image can modulate within the range of one of: 5Hz – 15 Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the second image can modulate within the range of: 5Hz -15 Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the first light can flicker.
  • the second light can flicker.
  • the first light can have an intensity of 300 lux or greater.
  • the second light can have an intensity of 300 lux or greater.
  • the time of ocular photo-bio-stimulation exposure can be for each treatment session, 5 minutes or less, 15 minutes or less, or 1 hour or less.
  • a filter or filters that block or filter light wavelengths within the wavelength range of 449nm – 380nm can be utilized.
  • the light that paints the peripheral retina can target rods.
  • the light that paints the peripheral retina can target ipRGCs (melanopsin containing ganglion cells).
  • the light that paints the peripheral retina can target amacrine cells.
  • the XR device can provide two or more of the following, each chosen with the goal of stimulating dopamine in the human body: light, color, sound, and/or smell. Taste can be added to further stimulate dopamine in the human body.
  • Another embodiment of the invention is that of an XR device (again, AR, MR, VR, or Modified Reality) comprising a first image and a second image, wherein the first image is generated by a first light, wherein the second image is generated by a second light, wherein one of the lights comprise a band of wavelengths of light having a transmission peak 2X or greater compared to any other transmission peak of visible light for that particular light, wherein the peak transmission wavelengths fall within at least one of the following light wavelength bands: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm
  • the XR device can provide ocular photo-bio-stimulation to the eye’s or both eyes’ retina.
  • One of the lights can comprise a band of wavelengths of light having a transmission peak of 50% or greater than any other transmission peak of visible light for that light.
  • the first image can move relative to a stationary second image.
  • the second image can move relative to the first image.
  • the first image and the second image can both move.
  • the first image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image.
  • the second image can paint portions of the peripheral retina with light.
  • the second image can move relative to a stationary first image.
  • the first image can move relative to a stationary secondary image.
  • the first image can be a virtual image.
  • the second image can be a virtual image.
  • the second image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image fixated on by the fovea of the user’s eye.
  • the first image can paint portions of the peripheral retina with light wavelengths.
  • the XR device can be a VR device. [000851] With the VR or Modified Reality device the first image and the second image can be virtual images.
  • the first light can be focused light.
  • the second light can be defocused light.
  • the first light can be defocused light.
  • the second light can be focused light.
  • the first light can be filtered light.
  • the second light can be filtered light.
  • the light wavelength band of one of: 480nm +/- 30nm, 530nm +/- 20nm, 575nm +/- 30nm, 630nm – 700nm, 650nm +/- 30nm, 700nm +/- 30nm, or 830nm +/- 30nm, can be generated by way of the use one or more of: an interference filter, absorption filter, neutral density filter, bandpass filter, and/or notch filter.
  • the light wavelengths can be by way of example only within the range of 650nm +/- 30nm or 620nm to 700nm, for treating the macula or fovea for slowing or stopping the progression of dry AMD.
  • the devices in FIG.54 can provide focused, non-focused, and/or scattered light. Illumination can be within the range of 400 lux to 20,000 lux. Pixels can be comprised by way of example only one or more of: OLEDs, TOLEDs, microOLEDs, iLeds, Quantum Dots, or LEDs.
  • Real world light can include, by way of example, LED, OLEDs, fluorescent light, incandescent light, ambient sun light, television, electronic display of a remote computerized device, etc. [000853] In reference to FIG.
  • the device can be used to treat the ganglion cells axons of optic nerve head or surrounding ipRGCs.
  • Wavelengths of virtual image #2 can be by way of example only within the range of one of 475nm +/- 30nm or 650nm +/- 30nm for treating the optic nerve head to generate retinal dopamine to slow or stop myopia progression.
  • the eye is to remains centrally fixated on image #1 which can be moving or stationary.
  • Virtual Image #2 is off set from virtual image #1 so that if the wearer fixates on virtual image #1 the optic nerve head is being treated by virtual image #2 or its light.
  • a stationary virtual image #1 the image for central fixation, can be comprised of a black dot.
  • the black dot can be comprised of by way of example only, one of; a combination of colors, lack of light, or lack of color (red wavelengths can be within the range of 600nm – 700nm.
  • Virtual image #2 which treats the optic nerve head with ocular photo-bio-stimulation, can be comprised of light wavelengths within the wavelength range of one of 480nm +/- 30nm or 650nm+/- 30nm.
  • FIG. 55A it shows that one of an AR, MR, or Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • the real-world image can be seen through the virtual image.
  • a “see through” near-eye display can be used to generate light, such as a pixelated, full color display, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • the wavelengths may be within a range of: 450nm – 510nm, or 520nm – 580nm, or 620nm – 680nm.
  • the moving real image it can be one of continuous, periodic, and/or intermittent movement from place to place of the real-world image.
  • the movement can be a constant continuous movement or a movement that jumps from one place to another.
  • the image can appear as a moving hole showing a real image or the real world or real-world image within the virtual image.
  • Such ocular photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • the devices in FIG.55a can provide one of, focused, non-focused, and/or scattered light.
  • the illumination that generates the virtual image can be within the range of 300 lux to 20,000 lux or greater.
  • the pixel light emitters which generate the virtual image can be comprised by way of example only one or more of: OLEDs, TOLEDs, microOLEDs, iLeds, Quantum Dots, or LEDs.
  • the real-world light that generates the real image can include, by way of example, one or more of, remote LED, OLEDs, fluorescent light, incandescent light, ambient sunlight, television, or display of a remote computerized device, which are capable of generating a real image seen at far, etc.
  • the real image movement can be continuous.
  • the image movement can be intermittent.
  • the image movement can be periodic.
  • the moving real image will appear as a moving hole filled in with a real distance image. As the eye fixates on the real moving image the virtual image will paint the retina of the user. [000855] In reference to FIG.
  • an AR, MR, or Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • the real-world image can be seen through the virtual image.
  • a “see through” near-eye display can be used to generate light, such as a pixelated, blue monochrome, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a stationary virtual image can include wavelengths within a range of 450nm – 510nm (can be used to treat, for example, myopia).
  • the real-world image can be seen through the virtual image.
  • the movement can be a constant continuous movement or a movement that jumps from one place to another.
  • the moving image can appear as a moving hole showing a real image within the virtual image.
  • Such photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • FIG. 55C it shows that one of an AR, MR, or Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • the real-world image can be seen through the virtual image.
  • a “see through” near-eye display can be used to generate light, such as a pixelated, green monochrome, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a stationary virtual image can include wavelengths within a range of 550nm +/-30nm (can be used to treat, for example, headaches).
  • the real-world image can be seen through the virtual image.
  • the movement can be a constant continuous movement or a movement that jumps from one place to another.
  • the moving image can appear as a moving hole showing a real image within the virtual image.
  • Such ocular photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • FIG. 55D it shows that one of an AR, MR, or Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • the real-world image can be seen through the virtual image.
  • a “see through” near-eye display can be used to generate light, such as a pixelated red monochrome, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a stationary virtual image can include wavelengths within a range of 650nm +/-30nm (can be used to treat, for example, retinitis pigmentosa or diabetic retinopathy).
  • the real-world image can be seen through the virtual image.
  • the movement can be a constant continuous movement or a movement that jumps from one place to another.
  • the moving image can appear as a moving hole showing a real image within the virtual image.
  • Such photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • one of an AR, MR, or Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • a “see through” near-eye display can be used to generate light, such as a pixelated, full color display, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a stationary real image can include, by way of example, light wavelengths within the visible range of 380nm – 700nm (sunlight). It can be used to treat, for example, myopia.
  • Such ocular photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • an AR, MR, or Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • a “see through” near-eye display can be used with a pixelated black color, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a real image can use ambient light of the real world that is filtered to allow blue wavelengths to pass.
  • a stationary real image can use a “filtered lens” allowing for wavelengths within the range of 450nm-510nm or 475nm +/- 20nm to strike/paint the retina. It can be used to treat, for example, myopia.
  • the eye fixates on a moving virtual image, the movement of which can be continuous, periodic, or intermittent movement from place to place of a black or grey dot, which can be comprised of by way of example only: a combination of colors, lack of light, or lack of color.
  • Such ocular photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • an AR, MR, Modified Reality ocular photo-bio-stimulation device can be capable of painting with desired light wavelengths most of the retina peripheral to the macula or fovea.
  • a “see through” near-eye display can be used with a pixelated black color, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a real image can use ambient light of the real world that is filtered to allow green wavelengths to pass.
  • a stationary real image can use a “filtered lens” allowing for wavelengths within the range of 550nm +/- 30nm or 510 +/- 20nm to strike/paint the retina. It can be used to treat, for example, headaches.
  • the eye fixates on a moving virtual image, the movement of which can be continuous, periodic, or intermittent movement from place to place of a black or grey dot, which can be comprised of by way of example only: a combination of colors, lack of light, or lack of color.
  • Such ocular photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • a “see through” near-eye display can be used with a pixelated black color, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a real image can use ambient light of the real world that is filtered to allow red wavelengths to pass.
  • a stationary, or 700nm +/- 30nm, real image can use a “filtered lens” allowing for wavelengths within the range of 650nm +/- 30nm or 700nm +/- 30nm to strike/paint the retina. It can be used to treat, for example, retinitis pigmentosa or diabetic retinopathy.
  • the eye fixates on a moving virtual image, the movement of which can be continuous, periodic, or intermittent movement from place to place of a black or grey dot, which can be comprised of by way of example only: a combination of colors, lack of light, or lack of color.
  • Such ocular photo- bio-stimulation treatment can be performed monocularly or binocularly.
  • a “see through” near-eye display can be used with a pixelated black color, which can be with or without a microlens array.
  • the microlens array can focus the virtual image one of: in front of the retina, in the retina, or behind the retina.
  • a real image can use ambient light of the real world that when focused by the lens peripheral to the central zone can cause blue wavelengths to strike/paint the periphery of the retina.
  • a stationary real image uses ambient light, such that the chromatic aberration focusing lens causes wavelengths within the range of 450nm - 510nm or 475nm+/- 20nm to strike/paint the retina. It can be used to treat, for example, myopia.
  • the eye fixates on a moving virtual image, the movement of which can be continuous, periodic, or intermittent movement from place to place of a black or grey dot, which can be comprised of by way of example only: a combination of colors, lack of light, or lack of color.
  • Such ocular photo-bio-stimulation treatment can be performed monocularly or binocularly.
  • the first image can modulate within the range of one of, 5Hz – 15Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the second image can modulate within the range one of, 5Hz – 15Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the first light can flicker.
  • the second light can flicker.
  • the first light can have an intensity of 400 lux or greater.
  • the second light can have an intensity of 300 lux or greater.
  • the time of ocular photo-bio-stimulation exposure for each treatment session can be 5 minutes or less, 15 minutes or less, or 1 hour or less.
  • the light that paints the peripheral retina can target cones.
  • the light that paints the peripheral retina can target rods.
  • the light that paints the peripheral retina can target ganglion cells.
  • the light that paints the peripheral retina can target melanopsin ganglion cells.
  • the light that paints the peripheral retina can target amacrine cells.
  • the XR device can provide two or more of the following, each chosen with the goal of stimulating dopamine in the human body: light, color, sound, and/or smell. Taste can be added to further stimulate dopamine in the human body.
  • Still another embodiment of the invention is of an XR device being one of, AR, MR, VR, or Modified Reality, comprising a first image and a second image, wherein the first image is generated by a first light source, wherein the second image is generated by a second light source, wherein one of the lights comprise a band of wavelengths of light having a transmission peak 2X or greater than any other visible light transmitted by the XR device to the eye of the user of the XR device, wherein the peak transmission wavelengths fall within at least one of the following light wavelength bands: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 5n
  • the XR device can provide ocular photo-bio-stimulation of the eye or eyes’ retina.
  • One of the lights can comprise a band of wavelengths of light having a transmission peak for the light transmitted to the eye of the user of 50% or greater than any other transmission peak of visible light for that light.
  • the first image can move relative to a stationary second image.
  • the second image can move relative to the first image.
  • the first image and the second image can both move.
  • the XR device can be one of an AR, MR, or Modified Reality device.
  • the first image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image.
  • the second image can paint portions of the peripheral retina with light.
  • the second image can move relative to a stationary first image.
  • the first image can move relative to a stationary secondary image.
  • the first image can be a virtual image.
  • the second image can be a virtual image.
  • the second image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image fixated on by the fovea of the user’s eye.
  • the first image can paint portions of the peripheral retina with light wavelengths while the second image stimulates the macula or fovea.
  • the first image can paint portions of the peripheral retina with light wavelengths while the eye fixates centrally on the second image.
  • the first image can move.
  • the second image can move.
  • the first image can move relative to the second image.
  • the second image can move relative to the first image.
  • the second image can paint portions of the peripheral retina with light wavelengths while the first image stimulates the macula or fovea.
  • the XR device can be VR or Modified Reality. With the VR device the first image and the second image can be virtual images.
  • the first light can be focused light.
  • the second light can be defocused light.
  • the first light can be defocused light.
  • the second light can be focused light.
  • the first light can be filtered light.
  • the second light can be filtered light.
  • the light wavelength band can be 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, 700nm +/- 30nm, or 830nm +/- 30nm, which can be generated by way of one or more of: an interference filter, absorption filter, neutral density filter, bandpass filter, or notch filter.
  • the image movement can be continuous.
  • the image movement can be intermittent.
  • the image movement can be periodic.
  • the first light can be one of: LED, OLED, iLED, quantum dots, fluorescent, incandescent, sun light, laser, plasma display, TV display, tablet display, cell phone display, computer display, or electronic display.
  • the second light can be one of: LED, TOLED, OLED, iLED, quantum dots, fluorescent, incandescent, sunlight, laser, plasma display, TV display, tablet display, cell phone display, computer display, or electronic display.
  • the first image can modulate within the range of one of, 5Hz -15 Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the second image can modulate within the range of one of, 5Hz -15 Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the first light can flicker.
  • the second light can flicker.
  • the light that is providing the ocular photo-bio-stimulation treatment or therapy can be 400 lux or more, 700 lux, or more 1000 lux or more, or 5,000 lux or more.
  • the time of ocular photo-bio-stimulation stimulation exposure for each treatment session can be 5 minutes or less, 15minutes or less, or 1 hour or less.
  • the light that paints the peripheral retina can target rods.
  • the light that paints the peripheral retina can target ganglion cells (ipRGCs).
  • Still another embodiment of the invention is of an XR device being one of AR, MR, VR, or Modified Reality, comprising a first image and a second image, wherein the first image is generated by a first light source, wherein the second image is generated by a second light source, wherein one of the lights comprise a band of wavelengths of light having a light transmission peak percentage of light wavelengths transmitted to the eye of a user of the XR device that can be 2X or greater than any other light wavelength transmission peak percentage of visible light wavelengths for that particular light that are transmitted to the eye of a user, wherein the peak transmission wavelengths fall within at least one of the following light wavelength bands: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm,
  • the XR device can provide ocular photo-bio-stimulation to the eye or eye’s retina.
  • One of the lights can comprise a band of wavelengths of light having a transmission peak 50% or greater than any other transmission peak of visible light wavelengths for that light.
  • the first image can move relative to a stationary second image.
  • the second image can move relative to the first image.
  • the first image and the second image can both move.
  • the first image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image.
  • the second image can paint portions of the peripheral retina with light.
  • the second image can move relative to a stationary first image.
  • the first image can move relative to a stationary secondary image.
  • the first image can be a virtual image.
  • the second image can be a virtual image.
  • the second image can be a real image fixated on by the fovea of the user’s eye.
  • the second image can be a virtual image fixated on by the fovea of the user’s eye.
  • the first image can paint portions of the peripheral retina with light wavelengths while the second image stimulates the macula or fovea.
  • the second image can paint portions of the peripheral retina with light wavelengths while the first image stimulates the macula or fovea.
  • the first image can paint portions of the peripheral retina with light wavelengths while the eye is fixated on the second image.
  • the second image can paint portions of the peripheral retina with light wavelengths while the eye is fixated on the first image.
  • the XR device can be a VR or a Modified Reality device.
  • the first image and the second image can be virtual images.
  • the first light can be focused light.
  • the second light can be defocused light.
  • the first light can be defocused light.
  • the second light can be focused light.
  • the first light can be filtered light.
  • the second light can be filtered light.
  • the image movement can be continuous.
  • the image movement can be intermittent.
  • the image movement can be periodic.
  • the first light can be LED, OLED, TOLED, iLED, quantum dots, fluorescent, incandescent, sun light, laser, plasma display, TV display, tablet display, cell phone display, computer display, or electronic display.
  • the second light can be LED, OLED, iLED, quantum dots, fluorescent, incandescent, sun light, laser, plasma display, TV display, tablet display, cell phone display, computer display, or electronic display.
  • the first image can modulate within the range one of, 5Hz -15 Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the second image can modulate within the range of one of, 5Hz -15 Hz, 10Hz +20Hz, 40Hz +/- 10Hz, or 40 Hz +/- 20 Hz.
  • the first light can flicker.
  • the second light can flicker.
  • the light that is providing the ocular photo-bio-stimulation treatment or therapy can be 300 lux or more, 700 lux or more, 1000 lux or more, or 5,000 lux or more.
  • the light that paints the peripheral retina can target rods.
  • the light that paints the peripheral retina can target ganglion cells.
  • the light that paints the peripheral retina can target amacrine cells.
  • the light that targets the macula or fovea can target mitochondria.
  • the XR device can provide light within the wavelength range 650nm +/- 30nm, 700nm +/- 30nm, or 830nm +/- 30nm, for increasing the number of healthy mitochondria within the eye.
  • the light used for the treatment can be of a light wavelength not visible to the human eye, such as, by way of example only, 830nm +/- 30nm.
  • the second image can be that of black or dark grey.
  • the display diameter can be any dimension within the range of 10mm to 50mm in diameter.
  • the display can provide a focused or a non-focused virtual image.
  • the view through this device is devoid of a real image. Illumination can be within the range of 300 lux to 20,000 lux.
  • Display Pixels can be comprised by way of example one or more of: LEDs, OLEDs, TOLEDs, microOLEDs, iLeds, or quantum dots.
  • the device can transmit blue wavelengths within the range of 450nm – 500nm, or 460nm +/-20nm, or 480nm +/- 30nm; the device can transmit green wavelengths within the range of 520nm +/- 10nm or 530nm +/- 20nm; or the device can transmit red wavelengths within the range of 660nm +/- 20nm, 630nm +/- 30nm, or 700nm +/- 30nm.
  • Such ocular photo-bio-stimulation treatments can be, by way of example only, for dry AMD.
  • the light used for the treatment can be of a light wavelength to which the human eye is caused less pupil constriction, such as, by way of example only, 650nm – 700nm.
  • the second image can be that of black or dark grey.
  • a first moving image (which can be a black or dark grey image) being fixated on by the fovea which moves relative to the second image
  • the second image which is used for the treatment can be of light wavelengths to which the human eye causes less pupil constriction, such as, by way of example only, 650nm – 700nm. This allows for the second image or light to paint the peripheral retina as the eye moves.
  • this inventive embodiment permits a light source or lighted image to treat the peripheral retina while not stimulating, treating, or harming the fovea or macula.
  • the second image can comprise defocused light.
  • a first moving image being fixated on by the fovea which moves relative to the second image can be a black or dark grey image
  • the second image which is used for the treatment can be of light wavelengths to which the human eye does not see, such as, by way of example only, 830nm +/- 30nm. This allows for the second image or light to paint the peripheral retina as the eye moves.
  • a band is a band of light wavelengths that run concurrently with a beginning wavelength and ending wavelength.
  • a transmission peak is the peak light wavelength or wavelengths having the highest light transmission that fall within a band of light wavelengths.
  • an image can be generated by light or by the absence of light (in the case of a black image).
  • eyewear can be any eyewear that is used on, in, or about the eye of the user of the eyewear. By way of example only, eyewear can be any of dress eyewear, designer eyewear, safety eyewear, industrial eyewear, military eyewear, shooting eyewear, driving eyewear, sunglasses, googles, face shield, helmet with face shield, or contact lenses.
  • the light can be that of 300 lux or more.
  • the light can be that of 700 lux or more.
  • the light can be that of 1000 lux of more.
  • black can be a color.
  • black can be generated by a plurality of colored pixels.
  • black can be generated by a devoid of light or lack of light.
  • paint as used herein means that light wavelengths strike and stimulate areas of the retina of one’s eye as either the eye moves relative to a light, or the light moves relative to the eye.
  • the use of the word target means to aim for the purposes of striking.
  • Ocular photo-bio-stimulation as used herein comprises the use of light for the purposes of eliciting a neurological change or response, or a physiological change.
  • an XR device can comprise lenses of optical power or no optical power.
  • an XR device can comprise a wearer’s best corrected optical prescription lens or lenses.
  • Embodiments can stimulate or provide ocular photo-bio-stimulation treatment to one or more of the three photoreceptors as desired: Cones, Rod, Ganglion Cells, including melanopsin Ganglion cells.
  • Embodiments can provide ocular photo-bio-stimulation treatment of amacrine cells.
  • a real image light source can be that of a plasma display, TV display, tablet display, cell phone display, computer display, electronic display, or outdoor or indoor ambient lighting.
  • the user watches a distance separated electronic display through their XR eyewear.
  • Such a display can give off the appropriate level of light intensity.
  • the light can be that of 300 lux or more.
  • the light can be that of 700 lux or more.
  • the light can be that of 1000 lux of more.
  • light which stimulates any of the three photoreceptors of an eye first enters through the pupil of the eye.
  • light which stimulates the retina of an eye first enters through the pupil of the eye.
  • an XR device can be that of one of AR, MR, VR, or Modified Reality eyewear, or one of AR, MR, VR, or Modified Reality contact lenses, or one of AR, MR, VR, or Modified Reality intra-ocular lens, or a combination of any of the three.
  • a prism can be added to the light or image that paints the retina prior to entering the pupil of the eye being ocular photo-bio-stimulation treated.
  • Embodiments of XR devices for providing ocular photo-bio-stimulation of the eye of the user can comprise appropriate safety guards. Such safety concerns can be addressed by one or more of: a timer, alarm, timed light switch, eye location sensor(s), retinal location sensor(s), cornea location sensor(s), and/or iris location sensor(s).
  • a timer can be set by either the user, automatically by the software for the XR device, or by a remote professional monitoring the treatment approach of the user.
  • An alarm being that of a light, sound, or vibration, can alert the user to turn off or take off the XR device.
  • the light or lights which provide the ontogenetic stimulation can be timed to turn off after a set time. This set time can be set by either the user, automatically by the software for the XR device, or by a remote professional monitoring the treatment approach of the user.
  • the location of retinal stimulation can be monitored by way of one or more of: cornea light reflex location sensor(s) or iris light reflex location sensor(s).
  • the sensors can include a camera.
  • the intensity of the light source and image can be monitored to ensure that the appropriate intensity of the ocular photo-bio-stimulation treatment is being provided. [000882] Such monitoring can be checked by the user or remotely by a third party.
  • the wavelengths of light being provided for the ocular photo-bio-stimulation treatment can be monitored by the user or by a remote third party.
  • the ability to monitor a specific area of the retina being painted or stimulated can be confirmed and calibrated for the XR device in advance of being dispensed for a user to use remotely from that of the eye care professional, neurologist, physician or other technician or professional.
  • Such calibration can be performed individually for each user of an XR device.
  • the use of the XR device by the user can be communicated in real time to the monitoring professional or remote third party.
  • the use of the XR device by the user can be communicated periodically to the monitoring professional. This allows for a remote third party to monitor the user’s compliance with the ocular photo-bio-stimulation treatment.
  • Messages can be communicated from the monitoring professional or remote third party to the user of the XR device by way of an image shown or displayed on the XR device. Messages can be communicated from the monitoring professional or remote third party to the user of the XR device by way of sound or audio heard from the XR device.
  • the communication from the XR device to the professional or from the professional to the XR device can be provided by way of wired or wireless communication. Such communication can be in part or whole by way of the internet.
  • the XR device can comprise all required electronics for enabling the use of the XR device as well as any form of communication needed. Downloaded software can provide updated treatment programs.
  • Such programs can affect the user experience, the treatment procedure or protocol, and / or the mechanical operation of the XR device.
  • the XR device can comprise all required electronic components to accomplish any one or all the preceding XR device modalities of use or performance.
  • An embodiment of a biomarker can be that of causing blue light (within the wavelengths of 480nm +/- 30nm) to strike the eye’s retina of a subject. If the subject’s pupil enlarges this can be a biomarker that additional dopamine is being generated in the subject’s brain.
  • One of the embodiments of this invention is by monitoring the pupil diameter of the eye(s) of the subject being treated it is possible to objectively tell that the desired ocular photo- bio-stimulation effect is occurring either in one or more of the eye, the body or the brain of the individual being treated with light.
  • an ocular photo-bio-stimulation treatment of the retina of eye of the subject being treated can be stopped when the pupil diameter shows an increase in size / diameter.
  • Such monitoring can be accomplished, by way of example only, by a vision system, pupilometer, handheld measurement tool, corneal topographer that captures dimensions of pupil, or device comprising one or more IR sensors.
  • the method can first measure the patient pupils prior to or at the start of the ocular photo-bio-stimulation treatment and immediately either before or after ceasing the ocular photo- bio-stimulation treatment.
  • the ocular photo-bio-stimulation treatment can be stopped within a period of time after the enlargement of the wearer’s pupils first occurs.
  • Such a measurement device or components can be built into, be attached to, or separately used to monitor the enlargement of the pupil of the subject.
  • the device can automatically communicate an alarm once the pupil is enlarged. The alarm can be that of a sound, voice, vibration, or light signal.
  • eyewear, smart eyewear, or XR eyewear can comprise a means to detect and measure the blink rate of a subject that wears such eyewear in response to ocular photo-bio-stimulation treatment.
  • Another bio-marker embodiment can be that of utilizing a subject’s blink rate. If the subject’s blink rate increases after (by way of example only) blue light (within the wavelength range of 480nm +/- 30nm) is utilized to strike the subject’s retina, the result can be that of a biomarker that dopamine is being generated in the subject’s brain. Once again this can be monitored and measured objectively.
  • Such measuring equipment for blink rate includes computerized vision system that monitors the eye and lids, eyewear or equipment having light or lights that shine on the cornea to generate a corneal light reflection and sensors that measure the on off of the reflection coming from the cornea, or certain eye tracking instruments.
  • the method can first measure the subject’s blink rate prior to or at the start of the ocular photo-bio-stimulation treatment and immediately either before or after ceasing the ocular photo-bio-stimulation treatment.
  • the ocular photo-bio-stimulation treatment can be stopped within a period of time after the enlargement of the subject’s blink rate first occurs.
  • Such a measurement device or components can be built into, be attached to, or separately used to monitor the blink rate of the subject.
  • the device can automatically communicate an alarm once the blink rate increases from the base line measured prior to the ocular photo-bio-stimulation treatment.
  • the alarm can be that of a sound, voice, vibration, or light signal.
  • eyewear, smart eyewear, or XR eyewear can comprise a means to detect and measure the blink rate of a subject that wears such eyewear in response to ocular photo-bio-stimulation treatment.
  • the XR ocular photo-bio-stimulation embodiments disclosed herein can utilize all required enabling components.
  • the embodiments disclosed herein can utilize all required software and communication components such as by way of example only, Wi-Fi and/or Bluetooth.
  • ocular photo-bio-stimulation XR embodiments when looking at an electronic display screen (by way of example only, a large thin plasma screen, OLED screen, iLED screen, or LED screen), software can be downloaded to the AR or MR device and or the electronic display screen, or to a VR device.
  • software in the form of, by way of example only, one or more YouTube videos can be created so that when loaded or communicating to the remote electronic display screen it shows movement of an image or images to be in coordination with the AR or MR device.
  • one or more YouTube videos can be created so that when loaded or communicating to the AR or MR device that is worn, the AR or MR device shows movement of an image or images to be in coordination with the electronic display screen. And still in other cases software in the form of, by way of example only, YouTube videos can be downloaded or communicated to each the AR or MR device and the remote electronic display screen.
  • the microarray can cause light to become defocused when it strikes the retina. This can occur by focusing in front of the retina or behind the retina.
  • the microarray can cause light to focus within the retina.
  • the correcting lens for myopia can focus centrally for far vision, and peripheral to the central zone causing a defocus or light scatter.
  • the correcting lens for myopia can focus centrally for far vision and peripheral to the central zone causing the band of blue light wavelengths to strike the retina as opposed to conventional lenses having chromatic aberration where the blue light wavelength band focuses in front of the retina.
  • an image virtual or real
  • it is the light that forms the image that provides the ocular photo-bio-stimulation treatment.
  • Ocular photo-bio-stimulation XR eyewear can comprise a see-through near eye display without a microlens array, a non-see-through near eye display without a microlens array, see through near eye display with a microlens array, and/or a non-see-through near eye display with a microlens array.
  • a microlens array permits with AR and MR the virtual image of a near eye display to be seen clearly. Without a microlens array the virtual image will be one or more of, out of focus, scattered, or dispersed.
  • the see-through near eye display and the non-see- through near eye display can be comprised with a curved electronic display and a curved microlens array.
  • a near eye display can be curved.
  • the see-through near eye display and the non-see-through near eye display can be comprised with a flat electronic display and a flat microlens array.
  • a near eye display can be flat.
  • the eyewear that supports AR, MR, VR, or Modified Reality components can comprise side shields for the purposes of blocking peripheral light rays.
  • the display diameter can be any dimension within the range of 10mm to 50mm in diameter.
  • the display can provide a focused or a non-focused virtual image.
  • the view through this device is devoid of a real image. Illumination can be within the range of 300 lux to 20,000 lux.
  • Display Pixels can be comprised by way of example, one of: OLEDs, TOLEDs, microOLEDs, iLeds, or quantum dots.
  • the XR device is attachable and detachable to one’s conventional eyeglasses.
  • Such an attachable XR device can be adjustable to align with the wearer’s pupils.
  • a device can comprise a means so that the near eye displays can be rotated out of position when not being used.
  • the see-through near eye display and the non-see- through near eye display can be comprised with a flat electronic display and a flat microlens array.
  • a near eye display can be flat.
  • the XR device can comprise a see-through near eye display.
  • the XR device can comprise a non-see-through near eye display.
  • the display can comprise or be in optical alignment with a micro-lens array. The display can transmit the desired wavelengths of light through the micro-lens array and in focus for seeing a virtual image clearly.
  • the display can be devoid of a microlens array.
  • the microlens array can transmit the desired wavelengths of light and cause light defocus or light scatter.
  • the display can transmit the desired wavelengths of light and cause light defocus or light scatter. (See, FIGs.59B and 60B.)
  • the see through near eye displays can be flipped out of position so not to be in the way of the wearer’s line of sight when not XR ocular photo-bio-stimulation is not being used.
  • the moving fixation target can be that of a dot, circle or similar shape.
  • the size of the target is no larger than the size of the user’s macula calculated and enlarged for the distance from the macula of the eye of the user to that of where the virtual image is located along the Z axis in space.
  • the average size of the macula of the eye is approximately 5mm in diameter.
  • the central vision fixation target could be a real image that moves, in which case it would be the virtual image that paints the desired wavelengths on the peripheral retina or retinas of the AR, MR, Mixed Reality wearer / user, or with AR, MR, Mixed Reality, the central vision fixation target could also be that of a virtual image that moves, in which case it would be the real image which paints the desired wavelengths on the peripheral retina or retinas of the wearer / user.
  • either the virtual image or the real image can paint the peripheral retina with light wavelengths within the wavelength range of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495nm +/- 20nm, 495nm +/- 30nm, 500nm +/- 5nm, 500nm +/- 10nm, 500nm +/- 20nm, 500nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm, while the eye of the wearer / user centrally fixates on a moving target.
  • peripheral retina is retina that is peripheral to the outer edge of the central retina.
  • central retina would be that of the macula.
  • peripheral retina can be further subdivided into that of the mid peripheral zone and the far peripheral zone.
  • peripheral retina can also include all or some of the mid periphery and or far periphery.
  • the desired wavelengths can be applied whether the central image is that of a moving image or a fixed still image, so long as the eye of the wearer / user remains fixated at the target that is applying the light stimulation.
  • 650nm +/- 30nm can be applied for treating dry macular degeneration.
  • the fixation target would be one of the virtual images.
  • the fixation target could be that of a real image or a virtual image.
  • the light / image that acts as the fixation target can be preferably a color of black, grey, or red. While any colored fixation target can be used, by using black, grey or red as the fixation target (whether moving or stationary) the pupil of the wearer’s eye can remain larger in size as compared to using yellow, blue, orange, or white, for the fixation target. It is also preferable in embodiments that the fixation target is a distance fixation target so it does not cause an accommodative pupil constriction, thus keeping the pupil diameter as large as possible.
  • the ocular photo-bio- stimulation XR in addition to with VR or Modified Reality the two virtual images moving relative to one another, or with AR, MR or Modified Reality, the virtual image moving relative to the real image, the ocular photo-bio- stimulation XR (one of AR, MR, VR, or Modified Reality) embodiment can comprise a defocusing lens or a prism optic.
  • the ocular photo-bio-stimulation XR embodiment can comprise a moving or rotating mirror that further enhances the painting of the peripheral retina of the user / wearer.
  • a mirror can be a pin mirror. In certain embodiments multiple mirrors can be utilized.
  • the ocular photo-bio- stimulation XR embodiment can comprise a moving or rotating mirror and a defocusing lens or a prism optic that further enhances the painting of the peripheral retina for the user / wearer.
  • the average monocular visual field consists of central vision, which includes the inner 30 degrees of vision and central fixation, and the peripheral visual field, which extends to 100 degrees laterally, 60 degrees medially, 60 degrees upward, and 75 degrees downward.
  • the entire retina, or a portion of the retina, or the optic nerve head can be stimulated or treated with light within the range of light wavelengths of 480nm +/- 30nm, 650nm +/- 30nm, or 700nm +/- 30nm.
  • the fovea and a large portion of the macula can be treated with light within the range of light wavelength of 630nm – 700nm, 650nm +/- 30nm, or 830nm +/- 30nm.
  • any ocular photo-bio-stimulation treatment can be with light within the range of light wavelengths of 650nm +/- 30nm, 700nm +/- 30nm, or 830nm +/- 30nm.
  • any ocular photo-bio- stimulation treatment can be with light within the range of light wavelengths of 650nm +/- 30nm or 830nm +/- 30nm.
  • an embodiment can treat most of the retina (including the mid and far- peripheral region) or just the optic nerve head with light wavelengths within the range of 450nm +/- 30n or 650nm +/- 30nm. Certain embodiments disclosed herein permit stimulating or treating the fovea and / or macula, but not the remainder of the retina.
  • the retina peripheral to the macula can be treated while the macula and fovea are not treated.
  • the most or all of the retina is treated.
  • Treatment is that of ocular photo-bio-stimulation light treatment or therapy.
  • the objective for treating dry AMD and/or retinitis pigmentosa and diabetic retinopathy with light is to increase the number of healthy mitochondria.
  • the objective for treating myopia with light is to increase dopamine in the retina. This is also the case of many other dopamine disorders as by increasing dopamine in the retina, dopamine and / or serotonin can be increased in the brain.
  • the reason for the offset is to allow for the light generating the virtual image seen by the eye to pass between or through the pixels of the see-though near eye display. Even though there is an offset, the non-see- through near eye display, its aligned microlens array, and the see through near eye display, remain in optical communication, thus allowing light to be projected to the retina of the eye of a user. [000909] In FIGs. 62B and 62C, the non-see-through near eye display aligned with its microlens array can be slightly offset with the see-through near eye display and its aligned microlens array.
  • the reason for the offset is to allow for the light generating the virtual image seen by the eye to pass between or through the pixels of the see-though near eye display and its aligned microlens array. Even though there is an offset, the non-see-through near eye display, its aligned microlens array, and the see through near eye display, remain in optical communication, thus allowing light to be projected to the retina of the eye of a user.
  • An embodiment can be that of an XR (one of AR, MR, VR, or Modified Reality) device wherein the XR device utilizes two light sources, wherein one light source generates a lighted real image and another light source generates a lighted virtual image, wherein the real image is that of a digital image or video and wherein the virtual image is that of a light that paints or stimulates areas of the retina of the eye of the wearer or user of the XR device.
  • the virtual image can be generated by a see-through near eye display that allows the real image to be seen through the near eye display.
  • the virtual image can be generated by a non-see-through near eye display that comprises a see-through central zone devoid of pixels or electronic components so as to have peripheral pixels that can be formed as one of, a ring, partial ring, or series of separated pixels.
  • the central zone that allows the real image to be seen can be of a diameter within the range of 6mm – 12mm in diameter.
  • the see-through near eye display can permit the real image to be seen without limitation to a central zone.
  • the see-through central zone can be filtered to cause the pupil of the eye to enlarge.
  • An embodiment is that of a device for providing extended reality (one of AR, MR, VR, or Modified Reality), comprising a light source providing light to stimulate a retina of an eye of a user of the device, wherein the light is chosen to result in a physiological response in the user’s eye or a body of the user, wherein the device causes the user to see a first lighted image and a second lighted image with a user’s same eye, wherein the device projects the first lighted image having light wavelengths that are substantially within a wavelength range of at least one of 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 4
  • the first lighted image can be a virtual image.
  • the second lighted image can be a real image.
  • the first lighted image can be a real image.
  • the second lighted image can be a virtual image.
  • the second lighted images can be virtual images.
  • the device is one of augmented reality eyewear, mixed reality eyewear, or virtual reality eyewear.
  • the device can comprise a see-through near eye display.
  • the device can comprise a non-see-through near eye display.
  • the XR device can comprise an electronic display comprised of a plurality of pixels.
  • the device can comprise a waveguide.
  • the device can comprise a microlens array.
  • the light of the first lighted image can be defocused light.
  • the light of the first lighted image can be a diffused light.
  • the light of the first lighted image can be focused light.
  • the light of the first lighted image can be filtered light.
  • the light of the second lighted image can be focused light.
  • the light of the second lighted image can be defocused light.
  • the light of the second lighted image can be diffused light.
  • the light of the second lighted image can be filtered light.
  • the first lighted image can be stationary / non-moving.
  • the second lighted image can be moving.
  • the first lighted image can be moving.
  • the second lighted image can be stationary / non-moving.
  • the second lighted image can be red, black, or grey.
  • the first lighted image and/or the second lighted image can be generated with light from one or more of the following light emitters: light-emitting diodes (LEDs), organic light-emitting diodes (OLEDs), transparent organic light-emitting diodes, micro-OLEDs, micro-LEDs, ionic liquids for electrochemical devices (iLEDs), micro-iLEDS, quantum dots, florescent lights, ambient light, or incandescent lights.
  • the light generating the first and/or second lighted images can be filtered by the filter or filters, and wherein the filter or filters can be one or more of: a bandpass filter, an interference filter, an absorption filter, a selective wavelengths filter, a notch filter, or a neutral density filter.
  • the physiological response can be one or more of, a generation of additional dopamine, additional serotonin, improved mitochondria function, and/or reduction of age-related inflammation in the eye of the user.
  • the physiological response can be a generation of additional dopamine or serotonin in the brain of the user.
  • the first and second lighted images can modulate, by way of example only, within the range of 5 Hz and 15Hz.
  • the device can comprise one or more of a timer, a wireless communication component, or an alarm.
  • the device can comprise one or more sensors for sensing and/or receiving biofeedback from the user.
  • the device can be capable of delivering to the user sound, smell, vibration, or combinations thereof.
  • the device can be capable of receiving biofeedback from the user.
  • Biofeedback can include, increased blink rate, measuring blink rate, increased pupil size, and/or measuring pupil size.
  • Another embodiment is of an XR device (VR or Modified Reality) for providing light to stimulate a retina of a user’s eye, the device comprising a non-see-through near eye display for providing the light and a microlens array for focusing or defocusing all or some of the light provided by the non-see-through near eye display, wherein the non-see-through near eye display produces a first lighted image, wherein a fixation target is seen within a perimeter of the first lighted image, wherein the first lighted image is substantially comprised of light wavelengths within the wavelength range of at least one of: 480nm +/- 30nm, 490nm +/- 5nm, 490nm +/- 10nm, 490nm +/- 20nm, 490nm +/- 30nm, 495nm +/- 5nm, 495nm +/- 10nm, 495
  • the light generating the first lighted image can be filtered light.
  • the light generating the second lighted image can be defocused light.
  • the light generating the second lighted image can be diffused light.
  • the light generating the second lighted image can be focused light.
  • the light generating the second lighted image can be filtered light.
  • One or both of the first lighted image and/or the second lighted image can modulate between 5 Hz and 15 Hz.
  • the fixation target can be stationery / non-moving.
  • the fixation target can move.
  • the fixation target can move relative to the first lighted image.
  • the fixation target can move relative to a second lighted image.
  • the fixation target color can be one of red, black, or grey.
  • the fixation target can be the first lighted image.
  • the fixation target can be the second lighted image.
  • the fixation target can be a third lighted image.
  • the second lighted image can be substantially comprised of light wavelengths within the wavelength range of one of: 480nm +/- 30nm, 475nm +/- 20nm, 530nm +/- 20nm, or 650nm +/- 30nm.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Signal Processing (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Prostheses (AREA)

Abstract

Des modes de réalisation de la présente divulgation peuvent fournir une photobiostimulation oculaire par stimulation lumineuse de longueurs d'onde spécifiques à la rétine de l'œil, et à la rétine de l'œil entier, à la rétine périphérique à la fovéa et/ou à la rétine périphérique à la macula. Dans certains modes de réalisation, la stimulation lumineuse est ciblée au niveau des tiges ou sur celles-ci. Dans d'autres modes de réalisation, la stimulation lumineuse est ciblée au niveau des cellules ganglionnaires ou sur ces dernières ou elle est ciblée au niveau des tiges et des cellules ganglionnaires ou sur ces deux dernières, les cellules ganglionnaires ciblées ou stimulées étant la mélanopsine contenant des cellules ganglionnaires (ipRGC) ou peuvent également être appelées mRGC.
PCT/US2025/012142 2024-01-20 2025-01-17 Photobiostimulation oculaire Pending WO2025155883A1 (fr)

Applications Claiming Priority (50)

Application Number Priority Date Filing Date Title
US202463623253P 2024-01-20 2024-01-20
US63/623,253 2024-01-20
US202463627703P 2024-01-31 2024-01-31
US63/627,703 2024-01-31
US202463550852P 2024-02-07 2024-02-07
US63/550,852 2024-02-07
US202463553226P 2024-02-14 2024-02-14
US63/553,226 2024-02-14
US202463553693P 2024-02-15 2024-02-15
US63/553,693 2024-02-15
US202463561266P 2024-03-04 2024-03-04
US63/561,266 2024-03-04
US202463569005P 2024-03-22 2024-03-22
US63/569,005 2024-03-22
US202463639892P 2024-04-29 2024-04-29
US63/639,892 2024-04-29
US202463648098P 2024-05-15 2024-05-15
US63/648,098 2024-05-15
US202463654566P 2024-05-31 2024-05-31
US63/654,566 2024-05-31
US202463671237P 2024-07-14 2024-07-14
US63/671,237 2024-07-14
US202463673746P 2024-07-21 2024-07-21
US63/673,746 2024-07-21
US202463674219P 2024-07-22 2024-07-22
US63/674,219 2024-07-22
US202463676855P 2024-07-29 2024-07-29
US63/676,855 2024-07-29
US202463684509P 2024-08-19 2024-08-19
US63/684,509 2024-08-19
US18/827,782 US12409337B2 (en) 2023-09-07 2024-09-08 Blue light ocular photo-bio-stimulation and moving fixation target
US18/827,786 US12409338B1 (en) 2023-09-07 2024-09-08 Red light ocular photo-bio-stimulation and moving fixation target
US18/827,782 2024-09-08
US18/827,786 2024-09-08
US202463697560P 2024-09-22 2024-09-22
US63/697,560 2024-09-22
US18/914,202 US20250082959A1 (en) 2023-09-07 2024-10-13 Filtering eyewear and optics for ocular photo-bio-stimulation
US18/914,202 2024-10-13
US18/928,126 2024-10-27
US18/928,126 US12472377B2 (en) 2023-09-07 2024-10-27 Filtering eyewear and optics for ocular photo-bio-stimulation
US18/951,274 2024-11-18
US18/951,274 US20250082961A1 (en) 2023-09-07 2024-11-18 Sunglass lens and sunglass optics for ocular photo-bio-stimulation
US18/959,511 2024-11-25
US18/959,511 US12337191B2 (en) 2023-09-07 2024-11-25 Color balanced sunglass lens for ocular photo-bio-stimulation
US202463729431P 2024-12-08 2024-12-08
US63/729,431 2024-12-08
US202463735232P 2024-12-17 2024-12-17
US63/735,232 2024-12-17
US202463740226P 2024-12-30 2024-12-30
US63/740,226 2024-12-30

Publications (1)

Publication Number Publication Date
WO2025155883A1 true WO2025155883A1 (fr) 2025-07-24

Family

ID=96471927

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2025/012142 Pending WO2025155883A1 (fr) 2024-01-20 2025-01-17 Photobiostimulation oculaire

Country Status (1)

Country Link
WO (1) WO2025155883A1 (fr)

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130211178A1 (en) * 2008-01-07 2013-08-15 Salutaris Medical Devices, Inc. Methods And Devices For Minimally-Invasive Extraocular Delivery Of Radiation To The Posterior Portion Of The Eye
US20150088231A1 (en) * 2012-03-28 2015-03-26 Cxl Ophthalmics, Llc Ocular treatment system and method using red and gold phototherapy
US20150142086A1 (en) * 2013-11-15 2015-05-21 Terumo Kabushiki Kaisha Accelerating method, optomedical device, and optomedical system
US20160022225A1 (en) * 2013-03-14 2016-01-28 Church & Dwight Co., Inc. Diagnostic test device with improved display
US20160067086A1 (en) * 2014-09-09 2016-03-10 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US20190258086A1 (en) * 2015-12-22 2019-08-22 Essilor International Method and Ophthalmic Element for Stimulating a Non-Visual Physiological Effect
US20220047887A1 (en) * 2018-12-13 2022-02-17 Seaborough Life Science B.V. Photobiomodulation (pbm) in general lighting
WO2022094678A1 (fr) * 2020-11-09 2022-05-12 Queensland University Of Technology Dispositif, procédé et système d'éclairage équilibré biologiquement
US20220233878A1 (en) * 2018-04-27 2022-07-28 Seoul Viosys Co., Ltd. Light source for eye therapy and light emitting device having the same
WO2022187279A1 (fr) * 2021-03-01 2022-09-09 Vivid Vision, Inc. Systèmes, procédés et dispositifs d'évaluation et de traitement de la vision
US20220413318A1 (en) * 2020-06-08 2022-12-29 Acucela Inc. Projection of defocused images on the peripheral retina to treat refractive error
US20230132952A1 (en) * 2021-11-03 2023-05-04 Jimmy Youngblood Photobiomodulation device
US20230389161A1 (en) * 2018-05-07 2023-11-30 Zane Coleman System for illuminating an environment with reduced shadows using two angularly varying light emitting devices

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130211178A1 (en) * 2008-01-07 2013-08-15 Salutaris Medical Devices, Inc. Methods And Devices For Minimally-Invasive Extraocular Delivery Of Radiation To The Posterior Portion Of The Eye
US20150088231A1 (en) * 2012-03-28 2015-03-26 Cxl Ophthalmics, Llc Ocular treatment system and method using red and gold phototherapy
US20160022225A1 (en) * 2013-03-14 2016-01-28 Church & Dwight Co., Inc. Diagnostic test device with improved display
US20150142086A1 (en) * 2013-11-15 2015-05-21 Terumo Kabushiki Kaisha Accelerating method, optomedical device, and optomedical system
US20160067086A1 (en) * 2014-09-09 2016-03-10 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments
US20190258086A1 (en) * 2015-12-22 2019-08-22 Essilor International Method and Ophthalmic Element for Stimulating a Non-Visual Physiological Effect
US20220233878A1 (en) * 2018-04-27 2022-07-28 Seoul Viosys Co., Ltd. Light source for eye therapy and light emitting device having the same
US20230389161A1 (en) * 2018-05-07 2023-11-30 Zane Coleman System for illuminating an environment with reduced shadows using two angularly varying light emitting devices
US20220047887A1 (en) * 2018-12-13 2022-02-17 Seaborough Life Science B.V. Photobiomodulation (pbm) in general lighting
US20220413318A1 (en) * 2020-06-08 2022-12-29 Acucela Inc. Projection of defocused images on the peripheral retina to treat refractive error
WO2022094678A1 (fr) * 2020-11-09 2022-05-12 Queensland University Of Technology Dispositif, procédé et système d'éclairage équilibré biologiquement
WO2022187279A1 (fr) * 2021-03-01 2022-09-09 Vivid Vision, Inc. Systèmes, procédés et dispositifs d'évaluation et de traitement de la vision
US20230132952A1 (en) * 2021-11-03 2023-05-04 Jimmy Youngblood Photobiomodulation device

Similar Documents

Publication Publication Date Title
US11480813B2 (en) Projection of defocused images on the peripheral retina to treat refractive error
US12427336B2 (en) Device for projecting images on the retina
US20220397775A1 (en) Contact lens for eye
WO2021252319A1 (fr) Projection d'images défocalisées sur la rétine périphérique pour traiter une erreur de réfraction
US20250377559A1 (en) Ophthalmic set for myopia progression control
US20250319325A1 (en) Filtering eyewear and optics for ocular photo-bio-stimulation
US20250295935A1 (en) Identification and Prevention of Myopia
US20250281770A1 (en) Color Balanced Sunglass Lens for Ocular Photo-Bio-Stimulation
WO2025155883A1 (fr) Photobiostimulation oculaire
CN102830506A (zh) 多效能眼疾保护镜片及其装配的成镜
WO2025117484A1 (fr) Verre de lunettes de soleil à équilibrage des couleurs pour photo-bio-stimulation oculaire
WO2025106986A1 (fr) Lentille de lunettes de soleil et optique de lunettes de soleil pour photo-bio-stimulation oculaire
WO2025096174A1 (fr) Lunettes de filtration et optique pour une photobiostimulation oculaire
HK40083613A (en) Projection of defocused images on the peripheral retina to treat refractive error

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 25742513

Country of ref document: EP

Kind code of ref document: A1